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One never notices what has been done, 
one can only see what remains to be done. 
 















Organofluorine chemistry has played a significant role in the majority of the 
spectacular scientific and technological developments of the past century. Two key 
challenges in organofluorine chemistry remain selective methods for the formation of 
carbon-fluorine bonds and the synthesis of complex fluorinated molecules under 
mild conditions. 
The incorporation of fluorine atoms into a pharmaceutical candidate is a well 
established approach to, for example, affect lipophilicity, pKa and metabolic stability 
of new chemical entities as part of drug discovery programs. Consequently, effective 
and inexpensive methodologies for the synthesis of selectively fluorinated 
multifunctional building blocks for incorporation into drug synthesis campaigns are 
very desirable. 
 
Scheme 1 Various fluorinated molecular systems investigated in this thesis  
In the context of developing the use of 2-fluoro-1,3-dicarbonyl substrates for the 
synthesis of more structurally complex fluorinated intermediates, we investigated 
routes to various fluorinated systems. As part of a general strategy aimed at 




assessing the effect of the carbon-fluorine bond attached to the reactive enolic site 
of the 2-fluoro-1,3-dicarbonyl system, we used this reactivity profile for the synthesis 
of pharmaceutically relevant fluorinated intermediates (Scheme 1). 
Several APIs present a fluoro-pyrimidinone structure, therefore a synthetic pathway 
giving access to functionalized fluorinated pyrimidinones has been established. 
Secondly, after testing various radical initiators, we applied a free radical chemistry 
strategy to reactions of 2-fluoro-1,3-dicarbonyl systems using Ceric Ammonium 
Nitrate (CAN) and various olefins, affording fluorinated nitro-oxy products by a 
catalytic oxidative addition. Finally, as the value of multicomponent reactions 
(MCRs) in drug development gives rapid access to large libraries of molecules 
possessing a high degree of functionality and structural diversity, we developed a 
synthetic strategy using β-fluoroketoesters and β-fluoromalonate substrates as MCR 
components in Mannich reactions involving various aldehydes and amines, using 
both batch and flow processes. 
Additionally, we investigated the potential use of fluorinated 1,3-dicarbonyl systems 
to act as nucleophiles in nucleophilic substitutions involving poly-fluorinated 
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Chapter 1   Organofluorine chemistry: importance 
and properties 
Apart from a few exceptions, molecules containing a carbon-fluorine bond are not 
present in nature, thus making organofluorine chemistry largely “man-made”. 
Interestingly, even if not noticeable, fluorinated organic molecules are present pretty 
much everywhere in our daily life, such as chlorofluorocarbon refrigerants, recently 
replaced by ozone-friendly hydrofluorocarbons, which are present in everybody’s 
kitchens. Moreover, the medical and pharmaceutical industries have been 
revolutionized by the appearance of fluorinated anaesthetics or products such as the 
well-known antidepressant Prozac®. In fact, the presence of fluorine atoms in those 
molecules conferred them their respective specific properties and biological 
activities. Applications of fluorinated molecules are also really diverse, fluoro-
polymers such as Teflon®, developed by DuPont, for non-stick coatings on 
cookware or Goretex®, invented by W. L. Gore, for the waterproof clothing are 
among the best proofs. Perfluorinated materials made supersonic flights and space 
travel possible and perfluorocarbon fluids were recently used as imaging agents for 
the diagnosis of heart disease and as oxygen-carrying blood substitutes. 
In the past few decades, organofluorine chemistry therefore appears to be quite 
successful in a wide variety of applications, opening a free space for further 
synthetic investigations and transformations, so broadening access to a full variety 
of fluorinated molecules is important. In this thesis, we are firstly going to describe 
briefly in this chapter the history of organofluorine chemistry and the specific 
properties conferred by fluorine atoms when present in molecules. The development 
of direct fluorination towards desired key fluorinated intermediates will also be 
discussed. 
1. Historical review 
The fluorine atom possesses some extreme properties, such as high 
electronegativity and oxidation potential, as predicted from its position on the 
periodic table of elements. Therefore, elemental fluorine is difficult prepare by 
chemical reaction, but Henri Moissan managed to isolate it in 1886 using scientific 
ingenuity, which gave him the Nobel Prize in 1906 thanks to the method he 
developed using electrolysis, which is still in use for industrial production of fluorine 
gas.[1,2] 
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However, many experts able to handle fluorine gas using specific laboratory 
equipment struggled to develop the field of fluorine chemistry really quickly after 
Moissan’s achievement and the first fluorinated chemicals were only synthesized on 
industrial scale in the late 1930s.[3] 
In fact, a really larger scale production of elemental fluorine was achieved due to the 
necessity of producing fissile Uranium 235. At this stage, uranium hexafluoride UF6 
was found to possess optimal physicochemical properties to separate the fissile U-
235 from heavier U-238 using a centrifugation processing strategy. As UF6 is a 
really corrosive compound, developing inert fluorine-based special materials, like 
polymers such as Teflon® was mandatory to achieve its production. At the same 
time, many methodological discoveries were made, such as developing electrophilic 
fluorinating agents, electrochemical fluorinations or strategies to deal with the violent 
reactivity of fluorine gas. Those approaches helped in a large part to develop 
synthetic organofluorine chemistry and to give access to fluorine-containing building 
blocks.[4] 
The idea of introducing fluorine atoms to alter properties of natural product 
molecules was almost unconceivable before the 1950s due to the abiotic properties 
of fluorine, and its applications were therefore limited to military and special 
materials needs. However, at this stage, the quite poisonous properties of a few 
naturally occurring fluorinated organic compounds were well-known and the first 
known fluorine-containing pharmaceutical compounds fludrocortisones 1 were 
discovered following a systematic study of series of 9α-halogenated cortisone 
derivatives (Figure 1). 
 
Figure 1 Molecular structure of fludrocortisone 
A link between the size of the halogen atom and the bioactivity of 9α-halogenated 
cortisones was discovered by Fried and Sabo in 1953.[5] Analyzing the anti-
inflammatory activity of 9α-halo-17α-hydroxycorticosterone acetates, Fried and 
Sabo, after studying the chlorinated, brominated and iodinated derivatives, were 
investigating the properties of the 9α-fluorinated derivative, also known as 
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fludrocortisone, and prepared it by reaction of the corresponding alcohol with 
anhydrous hydrogen fluoride. It indeed possessed a remarkable gluco-corticoid 
activity, which was ten times superior to the parent hormones.[6] 
Following this work, Heidelberger and coworkers demonstrated in 1957 that 5-
fluorouracil 2 was acting as an antimetabolite of natural uracil (Figure 2). 5-
Fluorouracil and many of its derivatives were also mechanism based inhibitors of 
thymidylate synthase, the enzyme responsible for transformation of 2-deoxyuridine-
5-monophosphate into 2-deoxythymidine-5-monophosphate.[7,8] 
 
Figure 2 Molecular structure of 5-fluorouracil 
Pointing to the remarkable antitumor-inhibiting activity of 5-fluorouracil, the 
development of easier synthetic strategies to obtain more potent and tumor-
selective analogs as useful pharmaceuticals remains an active research area. 
Indeed fludrocortisone and 5-fluorouracil constituted the starting point in terms of 
fluorine’s place in biology-related research, and the role of fluorine in life sciences 
has never ceased to increase since then, such as an enhancement of the 
therapeutic efficacy and improvement of pharmacological properties.[9] 
To summarize, it was clearly difficult before the 1960s to expect that introducing 
fluorine into natural products can result in beneficial biological properties, despite 
the fact that a certain number of past and current pharmaceutical products were 
either directly derived from or inspired by natural products.[10] But, in fact, until 1943, 
fluorine-containing natural products were not known in science and sodium 
monofluoroacetate was described to be hugely toxic and poisonous, despite the fact 
that it was the first isolated fluorinated naturally occurring compound.[11] 
2. Relevance of fluorine containing molecules 
2.1. General properties of fluorine atoms 
Nowadays organofluorine chemistry plays a significant role in the majority of the 
spectacular and technological developments of the past century, due to the specific 
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properties of the fluorine atom. Synthesis of fluoro-organic compounds has become 
a brand new research area and gives opportunity to access new fluorinated 
chemical space for different applications. The key step in developing new products 
and applications, involving fluorinated derivatives, is the synthesis of carbon-fluorine 
bonds by different fluorinating agents or using fluorinated “building blocks”. 
Bearing in mind the fact that fluorine is the most electronegative element in the 
periodic table, it forms the strongest bonds in organic chemistry, when attached to a 
carbon atom, material science became attractive for the incorporation of fluorine. 
Although highly polarized, the C-F bond gains stability from the resultant 
electrostatic attraction between C and F atoms. Application to materials is mostly 
based on the properties derived from the fluorine-carbon bonds, which are hardly 
attacked by any oxidants or chemicals. One of the main results is that such strong 
bonds between fluorine and carbon atoms inhibit normal metabolism in a living 
body. 
Fluorine is the 13th most common element on Earth’s crust, which is significantly 
more abundant than the other halogens but fluorine-containing natural products are 
extremely rare. Indeed, fluorine can be found on Earth in the form of insoluble salts 
fluorspar CaF2 or cryolite Na3AlF6, thus explaining the limitations to delivery to 
aqueous biological systems. Compared to other halogen elements, fluorine 
possesses the highest oxidation potential: -3.06V compared to -1.36V for chlorine, -
1.07 for bromine, -0.54 for iodine. Fluorine has also the highest hydration energy: 
117 kcal/mol compared to 84 kcal/mol for chlorine, 78 kcal/mol for bromine and 68 
kcal/mol for iodine, giving it a very poor nucleophilic behavior under aqueous 
biological conditions. The C-F bond is one of the strongest chemical bonds and its 
biological formation/cleavage requires extremely activated intermediates which are 
difficult to generate under biological conditions.[12] 
On the other hand, the van der Waals radius of fluorine is not significantly longer 
than hydrogen. Accordingly, organofluorine compounds are similar in steric size to 
non-fluorinated derivatives but quite different in electronic nature. The mimic effect 
of the fluorine atom compared to hydrogen is also an important aspect of fluorinated 
molecules, because enzymes cannot make any steric distinction between the 
fluorinated and the non-fluorinated molecule and, therefore, they can be 
incorporated into metabolic sequences. However the C-F bond strength stops the 
normal metabolism in a living body to cause various biological effects, due to the 
opposite polarization.[13] 
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Properties of organic compounds can be largely affected by fluorine or fluorine-
containing substituents. Fluorine’s electronegativity, size, lipophilicity and 
electrostatic interactions can clearly impact the chemical reactivity of a synthesized 
intermediate molecule. To give a few examples, replacing a methyl group by a CF3 
group leads to a completely different chemical outcome, especially during a 
metabolic cascade of reactions where even the presence of only one fluorine atom 
can modify all the properties of the resulting compound. Despite the fact that 
modified properties are sometimes difficult to predict, there are few examples where 
the fluorine element modified all initial properties, such as for mono-fluoroacetic 
acid.[14] 
Acidic or basic properties of organic molecules can also be affected by the presence 
of a fluorine atom, which can lead to modifications dealing with binding affinity, 
pharmacokinetic properties or bioavailability of any drug candidate.[15] The presence 
of -CF3, -S-CF3 or -O-CF3 groups can also clearly modify the lipophilicity of 
corresponding non-fluorinated molecules, which can be explained by the alterations 
of electrostatic repulsive interaction or attraction between the fluorine atoms and the 
surrounding functional groups, leading to the access of different conformers.[16] 
On aromatic rings, switching hydrogen atoms for fluorine atoms appears to be an 
effective strategy to modulate the metabolic stability and slow down significantly the 
oxidative metabolic step of a given drug by Cytochrome P450 monooxygenase 
enzymes. Fluorination has moreover an effect on hydrolytic metabolism by the 
electron-withdrawing property of fluorine, particularly affecting reaction rates, and 
the stability of intermediate metabolites.[17] 
2.2. Fluorine in pharmaceuticals 
Fluoro-organic molecules are key components in an ever increasing number of high-
value commercially important products particularly in the life science industries. The 
use of fluorinated systems in drug discovery programs has continued to grow and, at 
present, 20% of commercially available pharmaceuticals and 30% of agrochemicals 
contain a fluorinated group. Among all fluorinated pharmaceuticals, some of them 
are well-known pharmaceutical compounds sold all around the world.[17-19] Among 
the top-selling pharmaceuticals, we can find: Lipitor® as the best-selling drug in 
2008, Atorvastatin used for treatment against high cholesterol and triglyceride level 
and for the prevenetion of heart attacks and strokes, antidepressant fluoxetin, also 
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known as Prozac® and the antibacterial ciprofloxacin, well-known by its name 
Ciprobay (Figure 3). 
 
Figure 3 Examples of well-known fluorinated drugs 
The most common fluorinated systems in pharmaceutical structures contain 
fluoroaromatic sub-units or trifluoromethyl aryl systems (Figure 4), and can be 
synthesized using anhydrous hydrofluoric acid. However, new methodology for the 
incorporation of fluorine atoms located at sp3 centres is needed and synthetic 
conditions using fluorinating agents have been investigated. New selective 
fluorination processes by using both innovative chemoselective methodology and 
synthetic biochemistry can provide new synthetic strategies to introduce a fluorine 
atom into an organic system. 
 
Figure 4 Distribution of fluorine in drugs 
Developing fluorinated drug candidates firstly involves the design of molecules with 
the fluorine element in the right position. All the synthetic studies around fluorinated 
biological and medicinal fluorinated molecules allow us to predict the impact of the 
presence of the fluorine atom for a structural type of synthesized molecule.[20] 
Chapter 1                                                Organofluorine chemistry: importance and properties 
23 
 
2.3. Fluorine in agrochemicals and liquid crystals 
Among many other different applications of fluorinated systems, we can cite: aryl-
CF3 containing herbicides (Figure 5) synthesized by halogen exchange reaction 
(Scheme 2), anti-bacterial agents and insecticides synthesized by Balz-Schiemann 
(Scheme 3) or aromatic halogen exchange reactions (Scheme 4).[21] 
 
Figure 5 Examples of aryl-CF3 containing commercial herbicides 
 
Scheme 2 Reaction between benzotrichloride and SbF3 via halogen exchange process 
 
Scheme 3 Balz-Schiemann synthetic strategy towards fluorinated aromatics via diazotization 
in acidic conditions 
 
Scheme 4 Nucleophilic halogen exchange used in fluoroarene synthesis 
Liquid crystals are also largely synthesized using aromatic halogen exchange 
process which produces aromatic intermediate building blocks with low fluorine 
content.[22] Other applications are in thin film transistor – liquid crystal display, 
transparent fluorinated resin for plastic optical fiber or for semi-conductor 
manufacturing process and last but not least new lubricants used for hard disc 
drives.[23] 
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3. Development of direct fluorination reactions 
Introducing carbon-fluorine bonds into the various systems previously reported is 
largely using multistep nucleophilic fluorination processes. Even if alternative 
electrophilic fluorination methods exist, it seems that the potential for using fluorine 
gas as a reagent becomes more and more popular and recognized as a unique 2nd 
generation efficient fluorinating agent, aside of the first generation represented by 
HF and third generation, whose main examples are Selectfluor, or DAST (Figure 6). 
Indeed, there is a clear lack of reagents for the large scale transformation of a C-H 
bond to a C-F bond and elemental fluorine appears to be a fluorinating agent viable 
for industry scale applications. 
 
Figure 6 Generations of fluorinating agents used in organofluorine chemistry 
In this part, a brief history of the development of direct fluorination reactions using 
fluorine gas, some recent resulting synthetic challenges and a quick overview of 
alternative fluorinating agents will be presented. 
3.1. Historical overview of the use of elemental fluorine 
Henri Moissan in 1886 synthesized for the first time elemental fluorine in small 
quantities by electrolysis of anhydrous hydrogen fluoride. He was one of the 
pioneers carrying out reactions between neat fluorine and several organic 
compounds, but in the late 19th century, only decomposed products and explosions 
were obtained.[24,25] 
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Controlling the reactions using fluorine was one of the main challenges of the early 
20th century. One of the reported examples of explosions was the work of Bancroft 
and Jones in 1929 attempting the fluorination of benzene and toluene with molecular 
fluorine. Bancroft and coworkers repeated the same fluorination reaction two years 
later avoiding any explosions by using fluorine diluted by inert gases, only giving 
access to tarry products with high fluorine content though; confirmed a few years 
later by similar work by Beckmüller on several aromatic molecules.[26] 
Opening a new chapter through the investigations around fluorination conditions, the 
first samples of fluorocarbons were made during World War II by reaction between 
carbon and elemental fluorine catalyzed by mercury. The direct fluorination of 
benzene with elemental fluorine in the vapor phase over a copper catalyst was 
achieved by Bigelow and Fukuhara, and perfluorocyclohexane was synthesized by 
this way despite moderate degradation. Important to be noticed were the yields up 
to around 60% of perfluorocyclohexane from benzene, encouraging chemists to find 
a more suitable preparation of fluorocarbons, such as the CoF3 method that was 
reported few years later.[27,28] 
At this stage, modifying the high reactivity of fluorine appeared to be a key point to 
study and different apparatus was created to control direct fluorination, such as the 
vapor-phase apparatus, developed by Bigelow, which was reported to be more 
efficient for the synthesis of low-molecular-weight fluorocarbons. An interesting fact 
was the scaled-up production of perfluoropropane, commonly used as a dry plasma 
etchant in microelectronics industry.[29] 
Approximatively twenty years later, after trying to develop multiple fluorination 
apparatus, fluorination technique was improved by the appearance of the low 
temperature gradient fluorination, so called “LaMar” fluorination, named after Lagow 
and Margrave. The process was developed with various substrates which were 
condensed at low temperature into a tube packed with copper turnings through 
which fluorine, initially highly diluted in either helium or nitrogen, was passed. The 
concentration of fluorine and the reaction temperature were slowly increased over a 
period of several days to permit perfluorination. The only reported problems were 
the long reaction times required.[30] 
Trying to find an ideal combination between the process and its corresponding 
apparatus, a flow version was reported. The selected substrate was adsorbed onto 
the surface of fine sodium fluoride particles in a fluorination apparatus into which 
Chapter 1                                                Organofluorine chemistry: importance and properties 
26 
 
fluorine is introduced and the apparatus is warmed and UV irradiated to complete 
perfluorination.[31] 
None of the methods described so far were as efficient as the one developed by 
Exfluor-Lagow, who claimed a perfluorination of ethers and esters without UV 
irradiation, with the principle of a slow inverse addition of hydrocarbon substrates 
into an inert liquid dissolving excess fluorine gas. Development of this method 
showed that adding a tiny amount of a highly reactive hydrocarbon such as 
benzene, which reacted spontaneously with fluorine to produce a very high 
concentration of fluorine radicals, ensured perfluorination of the chosen substrates. 
The liquid-phase fluorination process developed by Exfluor-Lagow was providing 
products in high yields with the only drawback of using CFCs as solvents due to 
solubility problems, which are now fully regulated as part of the global environmental 
strategy.[32] 
Nowadays, fluorine gas is commercially available in various forms (pure or diluted 
with an inert gas, such as nitrogen) and on different scales, but large scale industry 
users prefer on-site generation (Figure 7). 
 
Figure 7 Fluorine cell room used in the manufacture of perfluorocarbon gases and fluids, at 
F2 Chemicals Ltd, Preston, UK 
3.2. Selective fluorination challenges 
In the last part of this chapter, we are going to describe the relatively recent work on 
selective direct fluorination methodology. The development of convenient, safe, 
efficient and economic methods to introduce fluorine into organic species opens a 
large field of investigations. The main problem with direct fluorination reactions is the 
large amount of heat generated by transforming the C-H bond into a C-F bond, 
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which could lead to uncontrolled reactions. Nowadays, fluorine has been tamed by 
dilution into an inert gas like nitrogen, and a lot of direct fluorinations have been 
reported to be effective using low temperature and appropriate solvents. Among 
those, the Durham group reported direct fluorinations in acidic media such as formic 
acid, i.e. the preparation of fluorinated 1,3-dicarbonyl compounds, scaled up by F2 
Chemicals Ltd (Scheme 5).[25,33] 
 
Scheme 5 Direct fluorination of ethylacetoacetate in formic acid 
The chemistry of fluoro-dicarbonyl systems will be developed in the next chapter but 
other direct fluorination reactions of many systems effectively carried out in acidic 
media have been reported. It gives access to synthetic strategies involving 
controlled selective fluorination of various systems such as heterocycles, aromatics 
and carbohydrate derivatives using recently developed techniques (Scheme 6).[34] 
 
Scheme 6 Direct fluorination of 1-nitro-4-methoxy-benzene in formic acid  
The last parts of this chapter will be dedicated to present various processes 
involving fluorination associated with further transformations, as it is relevant to our 
field of research, and a quick description of alternative fluorinating agents, for 
comparison with direct fluorination using elemental fluorine. 
4. Alternative fluorinating agents 
Considering the development of fluorination throughout the past decades, many 
other fluorinating agents have been developed, for fluorination of organic 
compounds. Among those, xenon di-, tetra-, and hexafluoride are known to be 
selective monofluorinating reagents, but they are unstable and quite expensive, 
which make them less popular than organic fluorinating agents, though they can be 
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used, for example, in the fluoro-decarboxylation of carboxylic acids, giving a good 
alternative to the Hunsdiecker reaction shown in Scheme 7.[35,36] 
 
Scheme 7 Hunsdiecker reaction 
Many nucleophilic fluorinations have been reported using inorganic ionic fluorides, 
such as cesium or potassium fluoride, which are synthetic reagents for achieving a 
fluorination step. In terms of using those metal fluorides, dipolar aprotic solvents 
often give the best results and addition of a crown-ether can sometimes be really 
beneficial, due to the low solubility of metal fluorides. 
Antimony fluoride plays an important role in the fluorocarbon industry and was 
widely used as synthesis of chlorofluorocarbons CFC’s or hydrochlorofluorocarbons 
HCFC’s.[37] The Balz-Schiemann chemical conversion, dealing with the use of 
fluoroborates, involving the formation of a diazonium tetrafluoroborate, is particularly 
useful for the conversion of arylamines to aryl fluorides (Scheme 3).[38,39] Halogen 
exchange (Halex) reaction between an activated chlorinated aromatic compound 
and a nucleophilic fluoride source like KF has also been reported as a possible 
method for the synthesis of fluoroarenes, despite being too expensive for large scale 
applications (Scheme 8).[39] 
 
Scheme 8 Halogen exchange fluorination of pentachloropyridine 
Last but not least, sulfur fluorides are powerful fluorinating agents, highly toxic in 
case of sulfur tetrafluoride, but diethylaminosulfur trifluoride (DAST) is more 
selective and easier to handle. A lot of fluorinations with DAST has been reviewed 
by Hudlicky, especially from alcohols to alkyl fluorides, carboxylic acids to acyl 
fluorides and carbonyl compounds to gemdifluorides (Scheme 9).[40]  




Scheme 9 General examples of fluorinations with DAST 
5. Conclusion 
The unique properties of fluorine-containing molecules have been showcased and 
we showed that the direct fluorination processes possess various advantages in 
comparison to many other fluorinating agents, either nucleophilic or electrophilic. It 
seems that nature has never learned how to use the fluorine element, but as its 
properties have demonstrated over many years that this element brings huge 
benefits to health and sciences field, especially in agrochemicals and 
pharmaceuticals. 
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Chapter 2 Fluorination of various 1,3-dicarbonyl 
systems and further applications 
1. Introduction 
Developing new methodologies for the formation of new C-F bonds represents an 
important topic in organofluorine chemistry and many fluorinating agents have 
already been developed over the past years. Many of them will be presented and 
discussed in the following review, with a focus on fluorination of 1,3-dicarbonyl 
systems such as malonic esters and acids, or various ketoesters, as they are 
particularly convenient and useful “building blocks” for the synthesis of fluorinated 
sophisticated heterocycles. 
Malonates and related 1,3-dicarbonyl compounds are very useful substrates in 
organic synthesis and often appear in many classic chemical reactions and 
retrosynthetic strategies. As a quick comparison between fluorinated and non-
fluorinated 1,3-dicarbonyl molecules, 1,3-dimethyl malonate represents a widely 
applied organic synthetic key intermediate and is an important raw material for the 
synthesis of medicine, agrochemicals, spices, dyestuff, antioxidant, light stabilizer, 
bauxite flotation desiccation chelating collector and hydrazine nitrate by various 
chemical reactions.  
Most of the processes that have already been developed and reported concerning 
the production of the 1,3-dimethyl-2-fluoromalonate are mainly involving the 1,3-
dimethylmalonate. As a quite recent type of fluorinated intermediate, 1,3-dimethyl-2-
fluoromalonate has synthetic potential in the application of agrochemicals, drugs, 
materials, aerospace and many more, and is clearly drawing attention from 
industries in the domain of biological engineering and science, due to its potential 
versatile reactivity and high selectivity. However, nowadays, only a few patents are 
dealing with the use of fluoro-malonates as building blocks for the synthesis of 
fluorinated biologically active systems.[41,42] 
This thesis describes the various fluorination processes towards fluorinated 1,3-
dicarbonyl products, their reported applications and our investigations to afford more 
sophisticated fluorinated intermediates using various new synthetic methodologies. 
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2. Fluorinations of 1,3-dicarbonyl compounds 
2.1. Synthetic strategies using fluorinating agents 
Fluorine gas and hydrogen fluoride are highly hazardous and reactive compounds, 
thus introducing fluorine into organic molecules presents a real challenge to 
synthetic chemists and has led to the development of specialized fluorination 
technologies and specific fluorinating reagents. Due to the relative weakness of the 
F-F bond (159 kJ/mol) and the great strength of bonds to most other elements, 
including hydrogen (566 kJ/mol), carbon (484 kJ/mol) and silicon (582 kJ/mol), 
elemental fluorine is one of the most reactive chemicals known. 
 
Scheme 10 Electrophilic fluorination of malonate enol derivatives 
Consequently, the first strategy for the synthesis of fluoromalonate derivatives that 
was developed was the replacement of the enolic hydrogen atom by fluorine using 
an electrophilic fluorinating agent. A few examples are listed in Scheme 10, and 
show different N-fluoro reagents, either N-fluoro-2-pyridone 35, prepared by 
fluorination of trimethylsiloxy-pyridine (method A), or N-fluoro-perfluoro-
alkylsulfonimides 36 reacting with carbanionic substrates (method C), and perchloryl 
fluoride (method B), not widely adopted because of its highly oxidising and 
potentially explosive nature.[43,44,45] 
N-Fluoro agents are usually stable, easily handled solids, have different fluorinating 
reactivity, from mild to moderate, depending on the molecular structure of the 
reagent and, of course, the nature of the substrate. Using those types of fluorinating 
agents has another huge advantage, free anhydrous hydrogen fluoride is not a 
major by-product in fluorination reactions, so specialist equipment is not required. 




Figure 8 N-Fluoro reagents 
During the past decade, two main N-fluoro reagents have been developed and often 
used as fluorinating agents. Among these, 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane-bis-tetrafluoroborate 39, known as Selectfluor®, and N-
fluorobenzenesulfonimide 38 (NFSI), N-fluoro-o-benzenedisulfonimide 37 (NFOBS), 
whose structures are presented in Figure 8, often appear as fluorinating agents in 
many publications, such as those presented in Schemes 11 and 12.[46,47] 
 
Scheme 11 NFSI used for the asymmetric fluorination of prochiral malonate esters 
 
Scheme 12 Fluoro-malonate prepared using Selectfluor
®
, towards potential pharmaceutical 
targets 
A few other synthetic strategies for the synthesis of fluorinated malonates have been 
investigated, including halogen exchange of chlorine by fluorine using a suitable 
source of fluoride ion. This method has been developed by Solvay and Bayer using 
amine hydrogen fluoride complexes starting from diethyl chloro-malonate 46 
(Scheme 13). HF-amine complexes are most of the time liquids and thus less 
volatile and easier to handle than HF itself, and appear to be more nucleophilic than 
HF. The two complexes used by Solvay or Bayer differ from the most frequently 
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used HF-pyridine, also known as Olah’s reagent, which is known as a reagent in the 
preparation of alkyl fluorides from alcohols or alkenes.[48,49] 
 
Scheme 13 Fluorination strategies developed by Bayer and Solvay 
Among others, the condensation of fluoroacetic acid derivatives with alkyl 
chloroformate allows the preparation of the desired fluorinated compound. 
Moreover, an early procedure deals with the reaction between ethyl chloroformate 
and sodium enolate of ethyl fluoroacetate to give 1,3-diethyl-2-fluoromalonate 47 in 
low yield. A similar procedure has been developed using the less toxic ethyl 
bromofluoroacetate 48 as starting compound, and reaction with tributylphosphine to 
form an acylated ylid which, combined with ethyl chloroformate, provides fluoro-
malonate (Scheme 14).[50,51] 
 
Scheme 14 Synthesis of fluoro-malonate from ethyl bromofluoroacetate 
Scheme 15 Sequential solvolysis of hexafluoropropene 
By a sequential solvolysis of hexafluoropropene, dialkyl 2-fluoromalonates can be 
easily synthesized, as shown in Scheme 15, representing a good way of 
synthesizing fluoro-malonates, as hexafluoropropene is an inexpensive starting 
material.[52] 
2.2. Elemental fluorine: versatile reagent for 2-fluoromalonate ester 
synthesis 
New synthetic strategies involving direct fluorination have been investigated to give 
access to a wide range of precursors of potentially bioactive molecules. Among 
Chapter 2                    Fluorination of various 1,3-dicarbonyl systems and further applications 
34 
 
those, a process for the synthesis of a fluoro-ketoester, first carried out in Durham 
University, was developed by F2 Chemicals Ltd (UK) for Pfizer company and forms a 
key starting material in the multi step synthesis of the widely used anti-fungal agent 
Voriconazole, which is one of the global top 100 best selling pharmaceutical 
products (Scheme 16).[53] 
Scheme 16 Synthesis of the fluoro-ketoester precursor of Voriconazole by direct fluorination 
Many examples of direct fluorination of different substrates, especially 1,3-
dicarbonyl systems, have been published recently, giving access to fluorinated 
dicarbonyl systems by using diluted fluorine gas into nitrogen. Direct fluorination of 
malonates using fluorine gas was believed to be impossible until it was developed 
on trimethylsilyl-malonate derivatives, fluorinated with 5% fluorine gas diluted in 
nitrogen in CFCl3 solvent (Scheme 17).
[54] 
 
Scheme 17 Selective fluorination of trimethylsilyl malonate derivative 
Mono and difluoro-compounds were synthesized by direct fluorination of sodium 
dialkyl malonate salts using acetonitrile, and it was proved that the amount of NaH 
used modifes the ratio between obtained mono and difluoro-compounds. Indeed, 
more molar equivalents of NaH provide a larger amount of synthesized difluorinated 
malonate. Substitution at the 2-position of dialkylfluoro-malonate has also been 
proved to have an impact on the obtained yield (Scheme 18).[55] 




Scheme 18 Reaction of substituted dialkyl malonate salts with elemental fluorine 
Studies around the fluorination of various ketoester and malonate substrates have 
been done by Chambers and coworkers. Their investigations focused on the 
different catalysts that can be used to achieve this process in the best possible 
conversion and yield towards the desired product. The results obtained for the 
fluorination of ethyl acetoacetate indicated that hydrated copper(II) nitrate catalysed 
the reaction to a significant extent in acetonitrile, but less efficiently than compared 
to the corresponding 1,3-dimethylmalonate. 
Table 1 Fluorination of 1,3-dicarbonyl molecules using various catalysts
a
 
Entry Catalyst Substrate Conversion [%] 
1 Cu(NO3)2.2.5H2O 1,3-diethylmalonate 100 
2 Ni(NO3)2.3H2O 1,3-diethylmalonate 70 
3 Co(NO3)3.6H2O 1,3-diethylmalonate 5 
4 Mn(NO3).6H2O 1,3-diethylmalonate 5 
5 CuCl2.2H2O 1,3-diethylmalonate 5 
7 Cu(OOCCH3)2.2H2O 1,3-diethylmalonate 5 
8 Cu(NO3)2.2.5H2O Ethyl acetoacetate 45 
a 
Substrate (20 mmol), catalyst (2 mol%), F2 (32 mmol over 2h), MeCN, 0-5°C 
Table 1 summarizes the different catalysts that have been tested and the resulting 
yields of the corresponding fluorination processes, showcasing that copper nitrate is 
clearly the most reliable option for such a process. Hydrated nitrates of manganese, 
cobalt, nickel and other salts of copper were evaluated but didn’t show any 
significant catalytic activity. Having a look on the mechanism of such a fluorination 
process, the importance of the catalyst used in the different synthetic conditions that 
were applied needs to be assessed. Scheme 19 shows that fluorine reacts with the 
enol form of the corresponding substrate and that enolisation appeared to be the 
rate-limiting step. Therefore, the catalytic activity of a salt must stem from the ability 
of the cation to accelerate the formation of the enolate. The quick release of the 
metal cation also remained crucial during this process, therefore being able to 
complex again with the starting dicarbonyl molecule to complete the cycle. Noticable 
is the impact of the side groups next to the carbonyl functional groups on k1 and k2 
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rates, in addition to the influence of the nature of the anion, cation and used 
solvent.[56] 
 
Scheme 19 Proposed mechanism of the fluorination of 2-ethylacetoacetate 
More recently, the synthetic conditions for the fluorination of 1,3-dimethylmalonate 
have been optimized, affording the dimethyl-2-fluoromalonate in a high yield, using 
Cu(NO3)2.2.5H2O as a catalyst, and elemental F2 (10% diluted in nitrogen, v.v
-1), in a 
flow of 40mL/min. A direct batch fluorination system has been designed to complete 
the fluorination at 0 °C during 5 h on a 0.5 mol scale. After distillation, the 1,3-
dimethyl-2-difluoromalonate was separated from the dimethyl-2-fluoromalonate, 
providing a yield close to 90% for a >99% pure mono-fluoro product (Scheme 20).[57] 
 
Scheme 20 Fluorination of 1,3-dimethylmalonate using F2/N2 
The synthesis of 2-fluoro-1,3-dimethylmalonate has been completed around 20 
times over the three years of this project, either in large scale (up to 300 mmol) or in 
smaller scale (down to 20 mmol), using the corresponding glass batches fitted with 
PTFE tubings and connection to a soda-lime scrubber neutralizing the excess of 
fluorine. Figures 9 and 10 show the two batch equipment used for these processes, 
with mechanical stirring for the larger scale and magnetic stirring (a large cross 
shaped magnetic stirrer) for the smaller scale. 
These two figures also show both inlets and outlets for the fluorine gas, as supplied 
from a commercial cylinder containing 20% F2 in nitrogen (v.v
-1) and transferred or 
diluted if required in smaller cylinders with an overall pressure not exceeding 5 bar. 
 




Figure 9 Large scale fluorination process set-up with mechanical stirring 
 
Figure 10 Small scale fluorination process set-up with magnetic stirring 
Figure 11 shows the main commercially available F2/N2 (20% v.v
-1) cylinder (bottom 
right) connected to nitrogen inlets and a four-valve system using stainless steel 
tubing able to dispatch fluorine gas to smaller storage cylinders (up to 5 bar) that are 
connected to fluorination set-ups. The two set-ups are provided with fluorine 
dispensed from storage cylinders at regulated flow rates controlled by Brooks mass-
flow controllers, typically from 10 to 200 mL/min and introduced under the liquid 
surface in the reactor through a narrow bore (1/8” OD) FEP tube. 




Figure 11 Pressure-controlled system between the commercially available F2/N2 (20% v.v
-1
) 
and smaller storage cylinders connected to reactive batch glass systems 
Excess gases containing residual fluorine, HF and solvent are directed to a solid 
scrubber filled with granular soda lime (mixture of CaO and CaCO3) to neutralize all 
corrosive and volatile waste. Work-up procedures for this method involved extracting 
solvent, pouring the reaction mixture into water and extracting with ethyl acetate, 
with classic washings with water, saturated sodium bicarbonate solution and drying 
over magnesium sulfate, before evaporating the solvent again resulting in a crude 
fluorinated mixture, ready for a further purification using distillation under reduced 
vacuum (approx. 10 mbar). Purification of the resulting crude mixture from the 
fluorination of 1,3-dimethylmalonate by distillation, afforded the desired 1,3-dimethyl-
2-fluoromalonate with a 98% purity (Figure 12). 
 
Figure 12 Molecular structure of 1,3-dimethyl-2-fluoromalonate 62 
To summarize the results previously obtained in the Durham group by A. Harsanyi 
for the optimization of the fluorination of 1,3-dimethylmalonate, it has been proved 
Chapter 2                    Fluorination of various 1,3-dicarbonyl systems and further applications 
39 
 
that the concentration of the malonate ester substrate in acetonitrile has no apparent 
effect on the outcome of the reaction, although solvent was required because 
malonate esters couldn’t dissolve the copper nitrate catalyst. Basically the use of 
high dielectric constant media such as acetonitrile was proved to be beneficial to 
control the selectivity of the electrophilic direct fluorination process. Moreover, the 
percentages of fluorine gas diluted into nitrogen, between 10% and 20% (v.v-1) does 
not impact the quality of the obtained fluorinated product, but reactions carried out at 
room temperature instead of 0-5 °C showed a decomposition of the copper catalyst, 
resulting in some insoluble copper species blocking the inlet gas tube, while 
processing at room temperature impacted the reactive mixture with a temperature 
increase, due to the exothermic nature of this fluorination strategy. Of course, 
lowering the amount of copper nitrate catalyst that was used avoided a quick 
reaction and required larger excess fluorine gas to be able to reach similar 
conversions as observed in previous optimized synthetic conditions.[58] 
As a summary on the fluorination process towards fluorinated dicarbonyl molecules, 
such as 2-fluoroethylacetoacetate or 2-fluoro-1,3-dimethylmalonate, the equipment 
used for batch processes enabled controlled reaction and the importance of solvent 
choice, cooling, dilution and mixing has been showcased. 
3. Reactions of 2-fluoro-1,3-dicarbonyl ester derivatives 
with carbon electrophiles 
2-Fluoro-1,3-dicarbonyl compounds appear to be useful “building blocks” for the 
preparation of potentially biological active molecules and have already been 
investigated as valuable reagents to build molecular structures, either reacting with 
carbon electrophiles or affording fluoro-heterocycles, as discussed briefly below. 
The reactivity of 1,3-dicarbonyl systems is mainly linked to the nucleophilicity of the 
corresponding carbanion. For this reason, due to the electron withdrawing fluorine 
atom removing the electron density from the carbanion, thus making it becoming a 
poorer nucleophile, alkylation reactions of fluoromalonates are slower than those 
using other malonate molecular systems. Scheme 21 shows an example of 
alkylation of fluoro-malonate, affording a precursor of an anti-anxiety drug molecule, 
involving an epoxide opening step with 1,3-diethyl-2-fluoro-malonate as starting 
substrate.[59] 




Scheme 21 Alkylation of 1,3-diethyl-2-fluoro-malonate carbanion 
A few other possible reactions involving fluoro-malonate esters and carbon 
electrophiles have already been investigated during the last decade, most of them 
deal with the use of a catalytic system, especially palladium-catalyzed, in either 
allylation or arylation processes (Schemes 22 and 23).[60] 
 
Scheme 22 Palladium-catalyzed allylation of 1,3-diethyl-2-fluoro-malonate 47 
 
Scheme 23 Palladium-catalyzed arylation of diethyl fluoro-malonate 
Palladium-catalyzed reactions allow cross-coupling of diethyl fluoromalonate with 
aryl bromide, employed for the synthesis of an aryl amide, used as potential cancer 
treatment drug candidates (Scheme 23).[61] Among these catalyzed reactions, a few 
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of them are Michael addition reactions, leading to the synthesis of a chiral product, 
using a chiral catalyst.  
One of the main examples of asymmetric Michael addition reactions of fluoro-
malonate deals with the reaction of an α,β-unsaturated aldehyde with diethyl fluoro-
malonate, catalyzed by a chiral pyrrolidine derived compound, giving access to the 
desired product with a good enantiomeric excess (Scheme 24).[62]
 
 
Scheme 24 Enantioselective Michael addition of 1,3-diethyl-2-fluoro-malonate to α,β-
unsaturated carbonyl derivatives 
Other chiral catalytic systems have already been reported, such as a chiral nickel 
complex catalyst and reactions between diethyl fluoromalonate and nitroalkenes 
provide the phenyl alkene product in good yield with good enantiomeric excess 
(Scheme 25).[63] 
 
Scheme 25 Enantioselective addition of dialkyl fluoro-malonates to nitroalkenes 
Beside the use of a catalytic system, Michael additions of fluoro-malonate to related 
systems have been used for the synthesis of more complex fluorinated structures, 
such as precursors of molecules with potential herbicidal activity (Scheme 26).[64] 
 
Scheme 26 Michael addition reaction of 2-fluoro-1,3-dimethylmalonate 
Dealing with other catalytic systems used in reactions involving fluoro-malonates as 
starting substrates, enantioselective addition of diethyl fluoro-malonate to N-Boc 
aldimines were reported using a chiral thiourea based organo-catalyst and show that 
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fluoro-malonates can easily react with molecular structures comprising a C=N bond, 
in a good yield and really good enantiomeric excess (Scheme 27).[65] 
 
Scheme 27 Reaction of fluoro-malonate with C=N bond 
2-Fluoromalonates can be used as starting substrates for functional group 
interconversion reactions, such as hydrolysis of one ester group of the fluoro-
malonate molecular system, by heating in an aqueous acidic media, allowing the 
simple synthesis of 2-fluoro-2-phenylacetic acid (Scheme 28).[66] They can also be 
reduced to 2-fluoro-3-hydroxypropanoates, when the monoester is firstly prepared 
by partial hydrolysis of the starting diester (Scheme 29).[67] 
 
Scheme 28 Acid hydrolysis of fluoro-malonate system 
 
Scheme 29 Reduction of fluoro-malonate esters 
4. Conclusion 
As a quick summary on the interest of fluorinated 1,3-dicarbonyl building blocks for 
further transformations, 2-fluoro-1,3-dialkylmalonate and 2-fluoro-alkylacetoacetate 
show that they are potentially versatile building blocks. However, not much of their 
chemistry is known despite their quick synthesis and potential applications. Despite 
the fact that a series of various reactions remain possible, the range of synthetic 
applications has still not been fully explored. 
The aims of this thesis are to repeat the direct fluorination processes to gain 2-
fluoro-1,3-dicarbonyl systems and to develop different types of chemistry on these 
Chapter 2                    Fluorination of various 1,3-dicarbonyl systems and further applications 
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substrates: building new fluorinated heterocycles, using radical initiators or finally 
developing multicomponent reactions and using a flow-process system with adapted 
conditions (Scheme 30). 
 
Scheme 30 Synthesis of fluorinated 1,3-dicarbonyl substrates and aims of this thesis  
 




Chapter 3 Functionalized fluoro-pyrimidinones and 
fragment-based screening 
A huge variety of possible reactions from 2-fluoro-1,3-dicarbonyl building blocks 
exists. In this chapter, we are going to present the high potential of 2-fluoro-1,3-
dicarbonyl derivatives as building blocks in the formation of fluorinated heterocyclic 
systems. The carbonyl carbons of the fluoro-malonate molecular structures are 
susceptible to nucleophilic attack, yielding in many cases different heterocyclic 
structures, which are going to be presented in this chapter, followed by our work on 
building a library of fluorinated pyrimidines to test them as potential bioactive 
fragments. 
1. Synthesis of fluorinated heterocycles from 2-fluoro-1,3-
dicarbonyl derivatives 
Fluorination of diketones has been recently investigated, affording cyclization of the 
intermediate fluoro-diketone by reaction with hydrazine derivatives, giving access to 
new 4-fluoropyrazoles using a flow process (Scheme 31).[68] 
 
Scheme 31 Synthesis of 4-fluoro-3,5-dimethylpyrazole derivatives 91 using designed flow 
reactor system 
Besides this flow process chemistry affording fluoro-heterocycles, reactions of 2-
fluoro-malonate and diamines provides the formation of a fluorinated seven-
membered heterocycle (Scheme 32).[69] 
 
Scheme 32 Synthesis of fluorinated diamides 
Moreover, the Durham group has recently reported the synthesis of fluorinated 
heterocycles by a two step reaction, involving firstly alkylation of fluoromalonate by a 




2-nitrobenzyl bromide derivative and secondly, after reduction, nucleophilic attack at 
the carbonyl carbon by the amine group, giving access to a new range of 
tetrahydroquinolone derivatives (Scheme 33).[70] A similar process using 1-fluoro-2-
nitrobenzene instead of 2-nitrobenzyl bromide has also been reported for the 
synthesis of 3-fluoroxindole.[71,72] 
 
Scheme 33 Synthesis of 3-fluorotetrahydroquinolone derivatives 
Dealing with the synthesis of potential antibacterial drug molecules, diethyl 2-fluoro-
malonate has been reported by Pfizer as a starting substrate for the large scale 
synthesis of 3-fluoroquinoline derivatives (Scheme 34).[73] 
 
Scheme 34 Synthesis of 3-fluoro-6-methoxyquinoline 99 using 1,3-diethy-2-fluoromalonate  
In the field of the synthesis of pyrimidines or derivatives, fluoro-malonates and 2-
fluoro-1,3-dicarbonyl derivatives play an important role. Indeed, a few syntheses 
affording different pyrimidine-based structures have been recently reported by 
different companies. Takeda Pharmaceuticals developed the synthesis of a 
potentially active pharmaceutical ingredient (Scheme 35).[74] 
 
Scheme 35 Synthesis of 6-fluoro-8-methylpyrido[2,3-d]pyrimidine-4,7-(3H,8H)-dione 




Bayer CropScience achieved the synthesis of a fluorinated precursor to 
Fluoxastrobin, a commercially significant herbicide (Scheme 36).[75] 
 
Scheme 36 Synthesis of 5-fluoro-pyrimidine derivatives 
One of the earliest examples of fluorinated heterocycle formation from a fluorinated 
dicarbonyl starting material was reported by Duschinsky and coworkers in 1957, 
who reacted pseudo urea salts with α-fluoro-β-ketoesters to produce a 5-
fluoropyrimidine derivative, which was reduced to form 5-fluorouracil, an effective 
anti-cancer agent, as presented in earlier chapters (Scheme 37).[76] 
 
Scheme 37 Synthesis of a 5-fluoropyrimidine from a 2-fluoro-1,3-dicarbonyl starting material, 
as reported by Duschinsky et al. 
Narrowing the heterocycles synthesis to fluorinated pyrimidines, the first example of 
4,6-hydroxy-5-fluoropyrimidine synthesis was presented by Bergmann et al. in 1959, 
followed by many different synthetic strategies towards fluoropyrimidine compounds, 
especially over the last decade.[50] For example, GlaxoSmithKline Plc. conducted a 
condensation reaction between various amidines and 2-fluoro-dialkylmalonate 
followed by further functionalization (Scheme 38).[77] 
 
Scheme 38 GSK’s synthesis of a functionalized 5-fluoropyrimidine derivative 




Aiming for a variety of bioactive molecules, the use of 4,6-dichloro-5-
fluoropyrimidine scaffold has been developed. Among all those methods, we were 
particularly interested in the synthesis of a potential cancer treatment from 2-fluoro-
1,3-diethylmalonate, developed by Pfizer Inc. in 2017 (Scheme 39). Indeed 5-
fluoropyrimidine shows anticancer properties.[78,79] 
 
Scheme 39 Pfizer Inc.’s synthesis of a potential cancer treatment, starting from diethyl 
fluoromalonate and proceeding via a 4,6-dichloro-5-fluoropyrimidine intermediate 
As well as 2-fluoro-1,3-dialkylmalonate, 2-fluoro-ketoesters are also convenient 
starting substrates for the synthesis of fluorinated heterocycles. As an example, 
Alantos Pharmaceuticals reacted 1H-pyrazol-5-amine with 2-fluoroethylacetoacetate 
to form an unusual library of fluorinated pyrazolo-(1,5a)-pyrimidines (Scheme 40).[80] 
 
Scheme 40 Synthesis of fluorinated pyrazolo-(1,5a)-pyrimidine 114 performed by Alantos 
Pharmaceuticals 
Deriving from 1,3-dicarbonyl 2-halogenated molecules, other new series of 
pyrimidines have been recently discovered to be potential sigma-1 receptor (σ1R) 
antagonists, which have been found to be associated with pharmacological 
antineuropathic pain activity. Those compounds have been evaluated in vitro in σ-1 
and σ-2 receptor binding essays. The molecular structure of the tested pyrimidines 
has been proved to be essential to the activity of such molecules and finally, the 
most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-




1-yl)propoxy)pyrimidine 117a which shows a high binding activity to σ1 receptor and 
acceptable pharmacokinetic properties (Scheme 41).[81] 
 
Scheme 41 Synthetic pathway towards pyrimidine derivatives from halogenated 1,3-
dicarbonyl compounds 
Among the various 2,4,6-substituted pyrimidines, fluorinated derivatives have been 
reported by Lan and coworkers (Scheme 42), which could be used in pain relief 
therapy, as the corresponding chlorinated system has shown pharmacological 
activity.[81] 
 




Aside of the synthesis of fluorinated pyrimidine scaffolds, interest is in the 
functionalization of fluoro-pyrimidines, especially further chlorination reactions of the 
hydroxy functional groups, as those positions can undergo further reactions like C-C 
bond formation, catalytic hydrogenation or, last but not least, reactions with O-, N- or 
S- nucleophiles. Industry has previously developed chlorination of fluorinated 
pyrimidines via the use of highly toxic phosgene, in yields up to 90%, which is 
difficult in laboratory-scale processes.[82] 





Scheme 43 Chlorination of 4,6-dihydroxy-5-fluoropyrimidine 111a using POCl3 
Zeneca Ltd. reported the use of neat POCl3 to achieve effective chlorination of 
pyrimidines (Scheme 43). Recent adaptations of the neat POCl3 chlorination method 
were using bases, such as N,N-dimethylaniline and NEt3, to catalyze the reaction. 
The group of Cheng and coworkers has used a combination of POCl3 and toluene 
as the solvent to ease extraction of the product. And finally in 2011, Sun et al. 
reported pyridine as an effective base, to reduce the attack at the chlorine site, 
therefore, increasing the reaction yield of the fluorinated dichloro-pyrimidines by 
reducing side-reactions.[83] 
We showed that fluorinated 1,3-dicarbonyl substrates have been recently used in a 
lot of various applications but lots of synthetic opportunities still remain possible 
towards the synthesis of fluorinated functionalized heterocycles, especially with a 
pyrimidine-based scaffold. The first part of our investigations is dedicated to the 
synthesis of a library of new fluorinated heterocycles possessing the pyrimidine 
molecular scaffold, starting from our previously synthesized fluorinated 1,3-
dicarbonyl substrates, and to optimize further effective substitutions to gain specific 
functionalized fluorinated intermediates. 
2. Towards the synthesis of various functionalized 
fluorinated pyrimidines 
2.1. Synthesis of 2-substituted-5-fluoro-pyrimidines 
2-Fluoro-1,3-dimethylmalonate and 2-fluoro-ethyl acetoacetate were synthesized 
using F2 methodology and used as starting substrates to develop the synthesis of a 
fluorinated pyrimidine fragment library. 2-Fluoro-1,3-dimethylmalonate and 2-
fluoroethylacetoacetate were used after purification by distillation, to remove the 
difluorinated analogue, as explained in the previous chapter in the method 
developed by Harsanyi et al. (Scheme 44). The purity of the starting fluorinated 
compounds was checked by 19F-NMR before further synthetic steps. 





Scheme 44 Synthetic strategy by direct fluorination towards 2-fluoro-1,3-dimethylmalonate 
Cyclization of 2-fluoro-1,3-dimethylmalonate or 2-fluoro-ethyl acetoacetate with a 
series of amidines was studied and attention was put on the structural shape of the 
obtained molecules (Table 2). We had the option to synthesize various amidines 
reactants using the Garigipatis procedure but we chose first to use commercially 
available amidines hydrochloride salts.[84] 
Table 2 Synthesis of fluoro-pyrimidinones from various synthesized amidines and fluorinated 
dicarbonyl systems 
 
Entry R R2 R3 Yield [%]a 
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OCH3 OCH3 111d, 76
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Isolated mixture of tautomers after acidic work-up;
 c
 Addition 
of 2-fluoro-1,3-dicarbonyl substrate diluted in MeCN and multiple 
filtration-evaporations in EtOH during work-up (less acidic work-up) 
We firstly achieved these reactions in methanol as the solvent and worked all the 
crude products up using dilute aqueous HCl and a single filtration. As an example, 




by this methodology, the 1H-NMR spectrum from fluorinated pyrimidinone 119d 
synthesized from benzamidine hydrochloride and 2-fluoro-ethyl acetoacetate shows 
two series of peaks, due to the keto and enol forms from the resulting pyrimidinone, 
which was due to the acidic work-up that has been tested. We observe an average 
ratio 65:35 between the keto and enol forms in Figure 13, which has been described 




H-NMR of fluorinated pyrimidinone 119d from benzamidine and 2-fluoro-ethyl 
acetoacetate 
 
Scheme 45 Keto-enol isomers formed in case of using 2-fluoro-ethyl acetoacetate as 
starting substrate 
Optimization of the reaction led us to perform the addition of the 2-fluoro-1,3-
dicarbonyl substrate diluted in acetonitrile, and after completion of the reaction and 
addition of dilute aqueous HCl, process multiple filtrations and evaporations under 
reduced pressure of the different filtrates from multiple washings with ethanol, 
yielding only the desired pyrimidines without any keto-isomers (Table 2) 
After optimizing the reaction and work-up procedure to a less acidic one to avoid 
any keto-enol products to be formed, the reactions were finally carried out in 
acetonitrile at 80 °C. Sodium was dissolved in methanol to generate sodium 
methoxide in situ, then the base activated the amidine to attack one of the 
electrophilic carbonyl groups of the 1,3-dicarbonyl species, followed by an 
















amidine group. Methanol, or ethanol and water, were released as by-products, 
depending on the substrate used. 
From the results presented in Table 2, it generally seems that higher yields are 
obtained in the case of using 2-fluoro-ethyl acetoacetate instead of 2-fluoro-1,3-
dimethylmalonate, while aromaticity of the chosen amidine plays a role on the 
stability of the resulting product and therefore on the obtained yield. However, all the 
products obtained by this synthetic method were isolated after filtration, considering 
their respective 1H-, 19F- and 13C-NMR spectra and mass analyses showed >99% 
purity for all those compounds, indicating an efficient optimization of the process and 
work-up for those reactions, avoiding any keto-enol equilibrium to be shown on NMR 
spectroscopy. As an example, by this method, the 1H-NMR spectrum of fluorinated 
pyrimidinone from benzamidine hydrochloride and 2-fluoro-1,3-dimethylmalonate 
only shows two sets of multiplets, for protons H1 and H5, and for H2, H3 and H4 




H-NMR of fluorinated pyrimidinone from benzamidine and 2-fluoro-1,3-
dimethylmalonate 
Acquisition of the NMR data was often problematic for these fluoro-pyrimidine 
compounds, as they are insoluble in most of the classic organic solvents, partially 
soluble in water and methanol, and only soluble in DMSO. Addition of sodium 
deuteroxide to D2O was required to increase the aqueous solubility of compounds 
via hydroxyl group-deprotonation. Efficient π-stacking of the planar compounds and 
hydrogen bond-donating -OH groups might be responsible for very high melting 
points obtained (> 180 °C). However, all compounds were obtained in convenient to 



















F-NMR of the fluorinated dihydroxy-pyrimidinone fragment library 
13C-NMR spectra of all the synthesized fluoro-pyrimidine fragments showed different 
doublets which can be easily assigned due to the various C-F couplings. Indeed 
carbons coupling to the fluorine atom resulted in various observable C-F coupling 
constants: 1JCF = ~ 220-280 Hz, 
2JCF = ~ 12-16 Hz and 
4JCF = ~ 6-10 Hz. As an 
example, figure 16 shows the 1H- and 13C-NMR spectra of the 2-cyclopropyl-5-
fluoropyrimidine-4,6-diol 111e with the different observed C-F coupling in the 13C-
NMR spectrum, while in the 1H-NMR spectrum, we observed that the protons on 
each face of the cyclopropyl ring are diastereotopic and magnetically inequivalent, 
resulting in a second order spectrum and two different multiplets for both -CH2 of 
this cyclopropyl ring at  around 0.65 ppm. 





Figure 16 For 2-cyclopropyl-5-fluoropyrimidine-4,6-diol 111e: 
1
H-NMR (D2O, 700 MHz, 298 
K, 0.45-1.70 ppm, top); 
13
C-NMR (D2O, 176 MHz, 298 K, 132-169 ppm, bottom) 
It has to be noticed that only a few attempts using different amidine structures were 
unsuccessful. Among them, the cyclization of 1H-pyrazole-1-carboxamidine 
hydrochloride 118g and 2-fluoro-1,3-dimethylmalonate 62 produced a highly 
insoluble pale pink powder, which might be due to the formation of poly-substituted 
products. 
 
Scheme 46 Reaction between 2-fluoroethylacetoacetate and either 1H-1,2,4-triazole-1-
carboxamidine hydrochloride or 1H-pyrazole-1- carboxamidine hydrochloride 
Identical mass spectrometry results were obtained from the reaction of 2-
fluoroethylacetoacetate 19 and both 1H-1,2,4-triazole-1-carboxamidine 
hydrochloride 118f and 1H-pyrazole-1-carboxamidine hydrochloride 118g, with an 
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product, coming from substitution of the azole groups by aromatic nucleophilic 
substitution with sodium methoxide (Scheme 46). In fact, triazole groups have 
already been reported as good leaving groups by Larsen and Harpp.[85] Therefore 
we focused our work on the use of non sensitive amidine substrates. 
Reactions between 2-fluoro-1,3-dimethylmalonate 62 and either malonamamidine 
hydrochloride 118h or chloroacetamidine hydrochloride 118i formed insoluble 
polymeric material, probably due to the low chemoselectivity of the chosen amidine 
in the first case or due to reaction at the alkyl halide centre in the second case. The 
insoluble properties of the resulting crude products made it difficult to obtain enough 
spectroscopic data to prove the structure of the products. Therefore, to limit side-
reactions and widen the scope of amidine derivatives suitable for cyclization, the 
amidine must either be linked to a non-reactive substituent or a protecting group 
should be previously introduced to the system. 
To briefly summarize this starting step, seven fluoropyrimidine compounds were 
successfully synthesized and fully characterized according to a procedure that has 
been conveniently optimized. An interesting side-reaction was observed, whereby 
sodium methoxide was suspected to substitute azole substituents of intermediate 
pyrimidines. 
2.2. Chlorination of 2-substituted 5-fluoropyrimidines 
Chlorination of the synthesized fluorinated pyrimidines was achieved by 
replacement of the hydroxyl groups (Table 3). The purpose of this reaction step was 
to place a halogenic group on the structural shape of the fragment library to gain 
access to a useful synthetic handle for further functionalization. Optimization of the 
synthetic conditions included modifications of temperature, reagents and addition 
mode. After obtaining the first chlorinated 2-benzo-5-fluoropyrimidinone (Table 3, 
entry 5), this part of the project was achieved by Alexander Melvin, a 4th year 
student in our research group in Durham University. 
 
 




Table 3 Synthesis of chlorinated 5-fluoropyrimidine derivatives 
 




OH Cl 15 104d, 31d 
2b 
 
OH Cl 15 104c, 27 
3b  OH Cl 20 104e, 37 
4b 
 
OH Cl 10 - 
5b 
 
Me Me 15 123d, 56 
6b 
 
Me Me 10 123c, 15 
7b  Me Me 15 123e, 41 
a
 POCl3, N,N-dimethylaniline (1 eq.), reflux, 3 h; 
b
 POCl3, triethylamine (1.1 eq. per –





First attempts to chlorinate the fluorinated pyrimidines were performed using neat 
POCl3 with N,N-dimethylaniline at 120 °C and 5-fluoro-4,6-dichloro-2-
phenylpyrimidine 104d was obtained in a crude yield of 31%. After trying to improve 
the crude yield by the addition of triethylbenzylammonium chloride as an extra 
source of chloride ions resulted in an unsuccessful attempt, forcing conditions 
promoted the formation of side-products. 
Looking for a model compound to test and optimize the different synthetic 
conditions, we focused our work on the 5-fluoro-6-methyl-2-phenylpyrimidin-4-ol 
substrate 119d, as it contains only one hydroxyl group to chlorinate. Softening the 
reaction conditions by using lower temperatures appeared to be beneficial. Due to 
the fact that triethylamine is a stronger base than N,N-dimethylaniline (pKa 10.78 
compared to pKa 5.07), further optimization was done using this stronger base. The 
mechanism of the chlorination step goes through the formation of a phosphate 
intermediate, followed by an aromatic nucleophilic substitution of the phosphate 
group by the formed chloride anion.[86] 




Therefore, a stronger base such as triethylamine should encourage the 
deprotonation of the hydroxyl group attached to the pyrimidine scaffold. The 
nucleophilic ability of the hydroxyl group to attack POCl3 and form the phosphate 
intermediate was increased by the induced deprotonation, and this was the reason 
for the reaction speed and efficiency to be increased. Further optimization of the 
reaction was achieved by stirring the reaction mixture at room temperature for 15 
minutes, followed by adding triethylamine and increasing the reaction temperature to 
80 °C while mixing. The synthesis of the new chlorinated fluoro-fragment was 
monitored by GC-MS (Figure 17). 
 
Figure 17 GC-monitoring of the synthesis of fragment 123d (retention time = 4.83 min) from 
fragment 119d using POCl3, NEt3 under inert atmosphere 
Optimized conditions for the chlorination to occur were found as follows: neat POCl3 
(15 eq.) was used and triethylamine (1.1 eq. per hydroxyl group attached to the 
pyrimidine scaffold) was added. After 15 minutes of stirring at room temperature, a 
number of different species were present in the reaction solution, including a small 
amount of product at a retention time of 4.83 minutes. After heating up to 80 °C and 
adding the triethylamine over a period of 45 minutes, significant conversion to the 
desired product was observed. Finally, after heating for a further 45 minutes at 80 
°C, full conversion to the desired product was obtained. Decreasing the reaction 
time, reducing the temperature, working under an inert atmosphere and adding a 
stronger base dropwise promoted an isolated crude yield of 80%, dropping to 56% 
after recrystallization in a chloroform-hexane solvent system. 
Table 3 summarizes the different conditions used for the syntheses of other 
chlorinated fluoro-pyrimidines in relatively moderate yields, except for two 
compounds. One of them decomposed (Table 3, entry 4), without any product being 
observed by NMR or GC-MS, basically due to the triazole functional group attached 
to the pyrimidine scaffold, which is quite unstable. We were able to confirm the 








Figure 18 Molecular structures of fragments 123c (left) and 123d (right) (confirmed by X-ray 
crystallography) 
As a brief summary, the chlorination of various 2-substituted 5-fluoropyrimidines has 
been optimized and six different products have been isolated, fully characterized 
and ready for further transformations. 
2.3. Nucleophilic aromatic substitution of chlorinated 5-
fluoropyrimidine compounds 
The final step of functionalization achieved by A. Melvin was to attach a nucleophile 
by replacing the chlorine atom of the fluoro-pyrimidine scaffolds. Finalizing the 
fragment library we built, we investigated suitable synthetic conditions for aromatic 
nucleophilic substitutions with O- and N- nucleophiles. The 4-chloro-5-fluoro-6-
methyl-2-phenylpyrimidine 123d was selected as a model compound to develop 
omtimized conditions. Aromatic nucleophilic substitutions results of fragment 123d 
with ethanol, phenol, piperidine, piperazine, benzylamine and aniline are 
summarized in Table 4. 
Mild basic conditions were used during those transformations, except with the use of 
aniline as nucleophile, which necessitated the use of a catalytic amount of 
concentrated hydrochloric acid. Due to their non-nucleophilic properties, carbonate 
catalysts were getting the priority as catalysts for these transformations. None of the 
tested reactions showed any significant competing side-reaction, therefore, 
promoting an efficient conversion of the starting material. However, using phenol 
and aniline as nucleophiles provided the desired products in low yields. Further 




purifications by recrystallization in an hexane-chloroform solvent system was 
necessary in the case of using aromatic nucleophiles during this transformation 
step, i.e. phenol, benzylamine or aniline, whereas after-work-up NMR and MS 
analyses showed pure products when using aliphatic nucleophiles, i.e. ethanol, 
piperidine or piperazine. 
Table 4 Aromatic nucleophilic substitution of chlorinated fluoro-pyrimidine 123d (achieved by 
A. Melvin) 
 









1 Ethanol  K2CO3 - 19 78 97
b 124a, 76 
2 Phenol Cs2CO3 MeCN 16 75 full
b 124b, 44 
3 Piperidine Cs2CO3 DMF 16 50 98
b 124c, 71 
4 Piperazine - EtOH 16 78 98c 124d, 91 
5 Benzylamine NEt3 MeCN 16 r.t. full
c 124e, 84 




 By GC-MS analysis; 
c
 By LC-MS analysis  
Again, we were able to confirm the structures of few synthesized products by X-ray 
crystallography (two examples in Figure 19). 
 
 
Figure 19 Molecular structures of fragments 124b (left) and 124c (right) (confirmed by X-ray 
crystallography) 




Almost full conversion was observed in case of using piperazine as nucleophile, 
requiring only little purification afterwards and providing almost quantitative yield. 
The piperazine moiety is a common functional group present in many commercial 
drugs, including Ciprofloxacin and Fluphenazine.[87,88] Piperazine’s four sp3–
hybridised carbons increase the fragments’ inherent 3D character, potentially raising 
target compound selectivity.[89] 
Table 5 Nucleophilic derivatisation of various pyrimidine scaffolds using piperazine as 
nucleophile 
 





72 125, 74 
2  Cl Cl 
 
16 126, 71 
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 Corresponding to the non-desired product 
The same synthetic conditions with various reaction times were applied to fragments 
123c, 104c and 104e (Table 5). In case of substituting the two chlorine atoms with a 
pyridinyl group attached to the main aromatic ring (Table 5, entry 1), we obtained a 
full 19F-NMR conversion after 72 hours. The expected product was isolated after an 
aqueous work-up. On the other hand, the same reaction with a cyclopropyl group 
attached to the aromatic ring (Table 5, entry 2), we only obtained a mono-
substitution after 16 hours and full conversion. Purification of the resulting product 
by column chromatography provided the isolated product in relatively high yield. The 
mono-substitution of the chlorine atome for the piperazine was ensured by the one-
to-one addition stoichiometry (Table 5, entry 2). 
Low conversion was obtained by using fragment 123c as starting substrate after 72 
hours mixing (Table 5, entry 3). Cesium carbonate was added during this test 
reaction to increase the nucleophilicity of the piperazine ring, however it only 




enhanced the ethanol to act as a nucleophile, resulting in getting a full conversion to 
give fragment 127. 
Full characterization of all the different obtained products was achieved by 1D- and 
2D-NMR spectroscopy and mass spectrometry. Only one example out of all these 
fragments is presented in Figures 19, 20 and 21 as the same method was used for 
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Figure 21 From left: COSY, HMBC and HSQC spectra of fragment 127 
We then conducted further synthetic studies around the development of new 
fragments for our functionalized fluorinated library. It quickly came that introducing 
chirality in those fragments was the next step in our research project. Indeed 
incorporating sp3 centres to fluorinated fragments appears interesting as part of the 
development of 3D-like molecules in a fragment-based drug discovery program. As 
the previously synthesized pyrimidine scaffolds possessed a planar molecular 
structure, adding chirality to those molecules was automatically linked to the 
molecular shape of the chosen nucleophile. We already introduced sp3 centres in a 
few of our previously synthesized fragments, i.e. by using cyclopropyl, piperidine or 
piperazine functional groups which all contain -CH2 moieties, but none of the 
previously synthesized fragments contained chiral centres. 
 
Scheme 47 Synthesis of 5-fluoro-6-methyl-N-[(1S)-1-phenylethyl]-2-phenylpyrimidin-4-amine 
128 
We chose (S)-(-)-phenylethylamine as a chiral nucleophile to achieve the 
nucleophilic aromatic substitution with previously synthesized fragment 123d 
(Scheme 47). The increased steric hindrance of the nucleophile relative to 
benzylamine (Table 4, entry 5) significantly increased the reaction time from 16 
hours to four days, after which we obtained 93% 19F-NMR conversion to the 




expected product (Figure 22). The resulting crude product was then purified by flash 






F-NMR spectroscopy monitoring of the conversion of 123d to 128 
In summary, we managed to synthesize various functionalized fluoro-pyrimidine 
fragments, starting either from 2-fluoro-1,3-dimethylmalonate or 2-fluoro-ethyl 
acetoacetate, and built a small library of fluoro-pyrimidines possessing a similar 
structure, that could be suitable to be part of a fragment-based drug discovery 
strategy. The concepts of fragment based drug discovery are described briefly 
below, followed by the screening of our fluoro-pyrimidine fragments. 
3. Fluorine and fragment-screening in drug discovery 
3.1. Advantages of fragment-screening in drug discovery 
New approaches for the development of chemical leads for novel drugs are 
required, despite the success of high-throughput screening (HTS). Various options 
such as screening low molecular weight weakly-binding molecules against a protein 
target, so called fragment-based drug discovery (FBDD), have emerged (Figure 23).  
 
Figure 23 Illustration of the concept of fragment-based drug discovery (the green circle and 
blue rectangle represent binding fragments that can be optimized and, sometimes, linked to 
form a high-affinity ligands) 




This dry screening process uses easy-access biophysical techniques, such as NMR 
spectroscopy and X-ray crystallography, to monitor the binding properties of 
synthesized fragments to the chosen protein targets and provides a better 
understanding of the binding-mechanism at the correct binding site to create lead-
like molecules. Furthermore, weak affinity binding fragments can sometimes be 
linked together to form a highly potent ligand. FBDD recently was taking an active 
part in the development of several drug candidates discovered in the last decades, 
such as FDA-approved drug Vemurafenib, which is a treatment for melanoma.[90,91] 
To compare the different screenings, FBDD interestingly presents different 
advantages. Firstly, the theoretical space that could be occupied by all possible 
compounds for a given set of conditions is indeed bigger in the FBDD strategy, as it 
can be covered by using various smaller fragments than by an extensive library of 
larger compounds prepared by parallel synthesis.[92] 
Limiting the size of molecules is providing a more efficient sampling of the chemical 
space available, and needs fewer systems to be tested to obtain final hits, which has 
been showcased by Hadjuk and coworkers in their work on combining 10000 
fragments in pairs with ten different linkers would generate one billion 
compounds.[93] Studies by Scanlon and coworkers also showed that major 
pharmaceutical companies fragment screening campaigns revealed high hit rates 
(around 8%) from their fragment libraries, suggesting efficient sampling of their 
chemical space.[94] 
Higher ligand efficiency was also obtained by FBDD technique, as compared with 
HTS hits. As ligand efficiency is defined as a ratio of the free energy of ligand 
binding against the number of non-hydrogen atoms in the ligand, Kuntz and 
coworkers studied the influence of the proportion of atoms on protein binding and 
they showed that the higher this proportion was, the better the contribution to the 
protein-binding event for molecules with up to 15 heavy atoms, compared to 
molecules with higher molecular weights.[95,96] 
Filtering fragment libraries by removing molecules which contain reactive or 
disruptive functional groups can reduce the time spent on screening non-drug-like 
molecules, which has been reported by Vulpetti and Dalvit. On another hand, Hann 
et al. reported that extra functionality present in complex molecules may direct or 
limit the extent of elaboration possible on a high molecular weight hit that is being 
developed into a lead.[97] 




Promising FBDD hits can be progressed with much more design control than HTS 
hits to lead-like molecules, giving the synthetic chemist more synthetic options and 
avoiding potential intellectual property violations. The easy access to FBDD strategy 
compared to industry HTS processes finally makes FBDD an efficient process in 
academia.[98] 
3.2. Physicochemical properties of synthesized and pharmaceutical 
fragment libraries 
To explore the required parameters in FBDD libraries, a basic analysis of the 
various criteria for fragment library synthesis was performed on all our combined 
small size synthesized fragments (Figure 24). 
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Figure 24 Synthesized fluorinated pyrimidine derivatives fragment library 
All the synthesized fragments should respect a few criteria, such as not containing 
any reactive functional group able to form covalent bonds with biological 
nucleophiles in the target protein backbone, as they are the source of many false 
positives in screening essays and not contain any common reactive groups such as 




acyl chlorides, aldehydes or epoxides, as they induce side reactions in screening 
assays. Effective fragments should have chemical handles or linkers, i.e. -OH, -Cl, -
NH functional groups for further elaboration, which is the case of 19 of our 
synthesized molecules out of 23.[99] 
Moreover, for large, non-fluorinated fragment libraries, Congreve et al. proposed a 
revised version of Lipinski’s famous “Rule of Five”: the “Rule of Three” (RO3). Based 
on analysis of the properties of common fragment hits, RO3 advises binding 
fragments usually have MW ≤ 300 Da, hydrogen bond donors ≤ 3, hydrogen bond 
acceptors ≤ 3, number of rotatable bonds ≤ 3, total polar surface area ≤ 60 Å2 and a 
value of log(P) ≤ 3, where P is the lipophilicity of the fragment. Additionally, a lower 
molecular weight limit of 150 Da is often implemented to reduce the chance of 
nonspecific binding.[100] 
A computational study was undertaken by A. Melvin on the full library of synthesized 
fluoro-pyrimidine derivatives to assess their RO3 properties (Table 6). We used 
JoeLib descriptors of physicochemical properties, performed with the chem-
informatics toolkit ChemMine Tools to assess the computational predictions.[101] 
Table 6 Comparison of physicochemical properties from up to twelve pharmaceutical 





























3 ± 1 2 ± 1 
2.0 ± 
0.6 
50 ± 20 
a
 Data for the literature-reported libraries was compiled from studies by Scanlon;  
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 Five literature reported pharmaceutical fragment libraries 
The various physicochemical properties are largely looking similar between both 
libraries, except the lipophilicity character expressed by log(P). Indeed we previously 




discussed that the presence of fluorine in molecular scaffolds has an impact on the 
liphophilicity on such molecules, especially with an extreme proximity with nitrogen 
atoms. Linking the high lipophilicity (log(P) > 3) and the low topological surface area 
(< 75 Å2), studies by Pfizer Inc. showed a significant increase of the likelihood of in 
vivo toxicity. High values of log(P) can also indicate that the synthesized compound 
may bind to multiple targets with moderate affinity.[102] 
Interestingly, the error values for each physicochemical parameters are relatively 
high, dealing with the fact that the fragments obtained by nucleophilic aromatic 
substitution using various -O or -nucleophiles possessed larger values for each 
parameter than the starting fluorinated pyrimidines and fluorinated chloro-
pyrimidines. The molecular weight limits set out by Jordan, indeed getting a 
molecular weight between 150 Da and 300 Da, are respected by 21 out of 23 
synthesized fragments.[103] 
Only the 2-cyclopropyl-5-fluoropyrimidine-4,6-diol 111e was fulfilling all the RO3 
rules, but if we removed the lipophilicity requirement, as it is largely modified by the 
presence of the fluorine atom, 14 synthesized fragments out of 23 are respecting the 
remaining five RO3 rules, when 17 of them are obeying at least four of the RO3 
remaining requirements. Finally, the computational comparison to the minimum 
parameters of a virtual screening showed that the fragments display most of the 
properties required for any industrial fragment library design program. 
3.3. 19F-NMR-based screening of the fragment library against β-catenin 
19F-NMR spectroscopy is particularly well suited to FBDD techniques due to the 
100% abundance of the spin ½ 19F nucleus and a sensitive transverse relaxation 
rate called R2. This R2 sensitivity parameter is the origin of 
19F-NMR’s intrinsic 
sensitivity to weak protein-ligand interactions. R2 increases on binding, causing 
significant line broadening of the 19F-NMR signal and allowing easy determination 
whether the fluorinated compound is binding to the protein or not (Figure 24). 





Figure 24 Illustration of the line-broadening effect, where b = bound molecule, f = free 
molecule and c = control molecule in A) presence of protein and B) absence of protein 
During the ligand binding, the main cause of the lengthening of R2 parameter is the 
fact that the rotation-correlation time (Ʈc), one of the main contributors to R2, 
increases because molecular tumbling of the large ligand-protein complex is now 
slow, compared to the free ligand. This causes an uneven magnetic field around the 
19F nucleus called chemical shift anisotropy (CSA) and results in line broadening of 
the ligand’s signal during any binding event.[104] 
As part of the Fluor21 Network European project, we developed a partnership with 
the University of Vienna to assess screening of the synthesized fluorinated 
pyrimidine fragments against β-catenin. This part of the project has been developed 
by Màté Solmyay, a PhD student in the University of Vienna, who carried out the 
NMR experiments. The main conclusions are recorded briefly here for 
completeness. 
 
Figure 25 Structure of β-catenin (green) bound to the transcription factor, Tcf4 (blue); 
structural data obtained from the Protein Data Bank (PDB – 1JDH) 
In fact, β-catenin is a well-known protein which forms a complex with Tcf4, a 
transcription factor, in the Wnt signaling pathway of colonic cancer cells (Figure 25). 
This β-catenin-Tcf4 complex is indeed promoting the transcription of many genes 
involved in cell proliferation, giving the result of a growth of malignant tumours. 
Investigations have been focussed on disrupting the binding between β-catenin and 
Tcf4 by attaching high affinity β-catenin ligands discovered through screening 
techniques. Since, 2,4-substituted-5-fluoropyrimidines have already been reported 
to have an anticancer activity, β-catenin was seen as a suitable target to choose for 
subsequent screening of our synthesized fragment library. 




A first criterion was applied to all the synthesized fragments: a solubility filter via 
quantitative 19F-NMR spectroscopy. Indeed, the assays were carried out in specific 
conditions in which the protein was stable (7.45 pH in 5% DMSO, 95% aqueous 
tris(hydroxymethylaminomethane) buffer solution) and, therefore, all the screened 
compounds had to be soluble in the same environment. Each compound was 
dissolved in a 1mM and 250 μM solution and their 19F-NMR signals were observed 
relative to 1mM and 250 µM NaF respectively. If the 19F-NMR signals of each 
compound were the same integrals (with a chosen ± 25% integral range) relative to 
the reference at each concentration, they were judged to be sufficiently soluble. 
Out of the twelve fragments analyzed, seven passed the solubility filter (111c-e, 
119c-d, 124c-d), however, four substrates out of the seven compounds showed 
broad 19F-NMR signals (111e, 119c-d, 124c) rendering them unsuitable for further 
analysis. This line-broadening effect was potentially due to a large exchange 
contribution to the relaxation time caused by tautomerisation of the pyrimidine ring. 
The three remaining pyrimidine fragments fulfilling all the required criteria were then 
screened against β-catenin (111c-d, 124c). 60 μM of each compound was dissolved 
in both a reference solution and a mixture containing 20 μM of β-catenin. In each 
assay, 0.5 mM dithiothreitol was used as a reducing agent to ensure that disulfide 
bonds didn’t cause the protein to aggregate in the presence of oxygen. Monitoring of 
these experiments was done by 19F-NMR spectroscopy, revealing a potential 
reduction in intensity and increase in line-broadening of a fragment signal, 
compared to the initial reference. In the case of observing these two phenomena, it 
was assumed that the fragment was bonding to β-catenin. Figure 26 shows that 
three tested fluoropyrimidine fragments showed a weak binding affinity but not 




F-NMR spectrum of the screening results: blue signal = 60 μM compound in the 
reference solution; red signal = 60 μM compound in 20 μM β-catenin (red signal shifted 
downfield by 0.2 ppm for clarity) 




4. Screening of the fragment library with Cunninghamella 
elegans 
As well as the 19F-NMR spectroscopy screening studies against β-catenin, the 
Fluor21 Network project allowed us to conduct studies on biotransformation of the 
synthesized fluorinated compounds using Cunninghamella elegans. This part of the 
project has been done in collaboration with the research group of Dr. C. Murphy in 
UCD Dublin, especially Shruti Mani, who identified how the synthesized fluorinated 
fragments were undergoing biotransformation when incubated with C. elegans (for 
72 hours at 28 °C with shaking at 200 rpm). The biotransformation pattern of these 
compounds was assessed by analyzing the results obtained by 19F-NMR 
spectroscopy and GC-MS spectrometry techniques. 
4.1. Studies around the microbial model of mammalian drug 
metabolism involving Cunninghamella elegans 
Several studies have suggested that microorganisms have the potential to mimic 
mammalian metabolism of drugs, as firstly observed by Smith and Rosazza in 
1976.[105] Further studies revealed that some microorganisms possess similar 
enzymes that carry out phase I and phase II metabolism of drugs in mammals.[106] 
As already known, phase I drug metabolism involves chemical reactions such as 
oxidation, reduction, and hydrolysis, but extensive pharmacokinetic and 
pharmacodynamic testing is required for a drug to be successfully approved for 
human consumption. Knowing the metabolism of a drug in mammalian system plays 
a vital role in determining its safety and efficacy and further evaluation of its 
pharmacological and toxicological activities. Therefore, metabolic studies allow the 
microorganisms to be used in toxicity assessment during drug development and 
subsequently reduce animal testing. Many microorganisms, including the soil fungus 
Cunninghamella and Actinomycetes bacteria are known to metabolize xenobiotic 
compounds in a similar way to those occurring in mammalian systems.[107] 
Microorganisms have been proved to be efficient models of mammalian metabolism, 
however, few of them can generate useful quantities of drug metabolic 
intermediates. Using microbes for this purpose is more desirable than extracting 
metabolic intermediates from dosed animals.[108] 




Cunninghamella have been largely studied for their ability to metabolise xenobiotics 
owing to the presence of cytochrome P450 enzymes and other associated enzymes 
present in mammals.[109] Studying the different phases of metabolism, it’s clear that 
phase 1 metabolism involves oxidation, reduction and hydrolysis of the drug into 
various metabolites, whereas phase 2 metabolism involves chemical reactions 
altering the drug or the metabolites formed during phase 1 metabolism to soluble 
molecules, classically excreted in urine. Metabolites formed in phase 2 are generally 
pharmacologically inactive.[110] 
Only a few studies on fluorinated drugs related to their metabolisms in 
microorganisms such as C. elegans have been conducted so far. These models of 
metabolism if successful can be used to produce metabolites that will otherwise be 
strenuous to synthesize.[111] Fungi cannot only metabolize pharmaceutical 
compounds in the comparable way to large quantities of metabolites as in mammals 
but they also offer an easy scaling-up.[112,113] 
Monitoring the metabolism of fluorinated compounds still remains challenging but 
19F-NMR spectroscopy has improved this process in several studies on the microbial 
biotransformation of fluorinated compounds. In our case, 19F-NMR was used for 
observing the degradation of fluorinated compounds and to determine which 
catabolic pathway is involved by revealing identities of the fluorine containing 
metabolites that accumulate in the culture medium, as it was previously used by the 
Murphy group in UCD Dublin to identify metabolites of Flurbiprofen.[114] 
4.2. Biotransformation of the synthesized fluorinated pyrimidine 
fragments using C. elegans 
Incubation of 5-fluoro-6-methyl-2-phenylpyrimidin-4-ol 119d and 5-fluoro-6-methyl-2-
(pyridine-2-yl)pyrimidin-4-ol 119c with C. elegans gave different products. 19F-NMR 
spectroscopy and GC-MS spectrometry analyses indeed revealed two different 
behaviors of the selected fluorinated fragments.  
5-Fluoro-6-methyl-2-(pyridine-2-yl)pyrimidin-4-ol 119c was not completely 
biotransformed, giving only access to a single fluorometabolite, identified by a 
singlet in 19F-NMR spectroscopy, showing that the methyl group had been altered 
from -CH3 to -CO2H (Figure 27). On the other hand, biotransformation of 5-fluoro-6-
methyl-2-phenylpyrimidin-4-ol 119d was completed, resulting in the formation of 4 




different fluorometabolites, each giving quartets by 19F-NMR, indicating that the 




F-NMR spectra of 5-fluoro-6-methyl-2-(pyridine-2-yl)pyrimidin-4-ol 119c 
standard (top), and product 129 of uncomplete biotransformation of 5-fluoro-6-methyl-2-





F-NMR spectra of 5-fluoro-6-methyl-2-phenylpyrimidin-4-ol 119d standard (top), 
and product 130 of complete biotransformation of 5-fluoro-6-methyl-2-phenylpyrimidin-4-ol 
119d with C. elegans (bottom) 
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Figure 29 GC-MS analysis of 5-fluoro-6-methyl-2-(pyridine-2-yl)pyrimidin-4-ol 119c (abiotic 
control, top) and of the resulting mixture from the biotransformation of 5-fluoro-6-methyl-2-
(pyridine-2-yl)pyrimidin-4-ol 119c and C. elegans (bottom) 
 
 
Figure 30 GC-MS analysis of 5-fluoro-6-methyl-2-phenylpyrimidin-4-ol 119d (abiotic control, 
top) and of the resulting mixture from the biotransformation of 5-fluoro-6-methyl-2-
phenylpyrimidin-4-ol 119d and C. elegans (bottom) 




GC-MS analyses of the resulting mixtures confirmed these observations and 
revealed the presence of carboxylated metabolite in a tiny amount in the first case, 
and monohydroxylated metabolites in the second case (Figures 29 and 30). 
This comparison demonstrated how a single structural change, a replacement of 
aromatic ring by pyridine, can alter the biotransformation pattern drastically, 
reflecting the less easily oxidation of the electron poor pyridine ring compared to the 
phenyl ring. These results confirmed the potential of the fungus Cunninghamella to 
transform a wide range of xenobiotic compounds.[115] 
5. Conclusion 
Over this part of the project, we described and optimized easy access to various 
fluorinated pyrimidine structures using 2-fluoro-1,3-dicarbonyl systems. Diverse 
functionalizations have been conducted on the obtained structures, giving access to 
a range of 23 various fluorinated pyrimidine fragments. As the molecular shapes of 
the obtained fragments has biological activity, they have been studied as potential 
linkers to β-catenin, using a 19F-NMR screening developed in the University of 
Vienna, which highlighted three fragments out of the full library as weak binders. 
Last but not least, biotransformation studies have been conducted at the UCD in 
Dublin, to investigate the impact of the functional groups attached to the pyrimidine 
ring of the synthesized fragments, and revealed different behaviors of such 
molecules when reacted with Cunninghamella elegans. 




Chapter 4 Free radical chemistry of 2-fluoro-1,3-
dicarbonyl building blocks 
While all the reactions presented in the previous chapters mainly involve anionic 
additions or substitutions, radical chemistry represents an interesting alternative 
synthetic strategy, possessing a huge potential to achieve many reactions involving 
2-fluoro-1,3-dicarbonyl compounds (Scheme 48).  
 
Scheme 48 Addition of olefin to 2-fluoro-1,3-dicarbonyl substrates via (a) anionic strategy 
and (b) radical chemistry 
Developing catalytic systems involving radical initiators has never been explored in 
the case of using 2-fluoro-1,3-dimethylmalonates or 2-fluoroketoesters as 
substrates, which may offer a large opportunity to access new strategies to 
fluorinated “building blocks”. For this reason, a brief literature review on the use of 
different radical initiators, especially related to reactions involving 1,3-dicarbonyl 
compounds, is going to be presented in this chapter, followed by our synthetic 
investigations on the oxidative addition of various olefins to 2-fluoro-1,3-dicarbonyl 
substrates. 
1. Overview of the oxidative addition of various olefins to 
dicarbonyl substrates 
Oxidative addition of carbonyl compounds to alkenes has been largely investigated 
in the last decade, especially using reactions promoted by metal ions. Indeed, a 
wide range of different metal salts, such as manganese(III), cobalt(II), copper(II), 
silver(I), vanadium(V) and cerium(IV), has been used to generate carbon-centred 
radicals.[116] Oxidative strategies involving metal salts as radical initiators have 
received most attention for linking many different alkenes to 1,3-dicarbonyl 




compounds. A few papers have shown the different ability of radical initiators to 
afford the desired addition compounds.[117] 
1.1. Additions to olefins initiated by Manganese salts 
For literature procedures using 1,3-dimethylmalonate as substrate, Mn(OAc)3 is 
known as the most common oxidant/initiator for plenty of radical reactions, but in the 
termination step, its oxidative ability is limited. Indeed γ-carboxy-radicals (secondary 
and tertiary) will be oxidized to carbocations, tertiary radicals will be oxidized to 
carbocations to give alkene or to form a tertiary acetate, allylic radicals will be 
oxidized to allylic acetates, but primary and secondary radicals won’t be oxidized. If 
no oxidant is present they will be quenched by H-abstraction from the solvent. 
Cu(OAc)2 oxidizes secondary radicals 350 times faster than Mn(OAc)3, reacts 
rapidly with radicals (∼ 106 M/sec) to form alkyl-Cu(III) species, primary and 
secondary radicals are taken to alkenes via direct oxidative elimination from the 
alkyl-Cu intermediate (E-olefins and the less substituted alkene), allylic tertiary 
radicals are oxidized to carbocations.[117] 
Acetic acid is the most common solvent used with Mn(OAc)3, but DMSO, MeOH, 
dioxane, and acetonitrile can also be used although they require higher temperature 
and the yields are sometimes lower. EtOH is a better H-donor than acetic acid so it 
is preferred when vinyl radicals are involved in the termination step (vinyl radicals 
cannot be oxidized so they need to be quenched). Radical chemistry involving 
manganese(III) acetate as a radical initiator, combined with copper(II) acetate, to 
link nucleophilic alkenes to 1,3-diethyl-malonates has already been reported 
(Scheme 49).[118] 
 
Scheme 49 Reported radical chemistry with diethylmalonate using Mn(II)/Cu(II) catalytic 
system 
Among all the metal oxidants, Mn(OAc)3 has received particular attention and its use 
often appears in different synthetic strategies for various oxidative additions. 
Moreover, its use has most of the time been associated with the synthesis of 
different precursors of natural products showing biological activities.[119] 1,3-
Dicarbonyl compounds have been investigated as substrates in manganese(III)-




mediated oxidative free radical cyclizations of alkenes. Indeed, new C-C bonds can 
be easily made using an efficient oxidative method mediated by metal salts. For 
example, cyclization of methylenecyclopropanes (MCPs) has been reported using a 
manganese(III)-mediated free radical strategy for the synthesis of precursor 
skeletons of many natural products (Scheme 50).[120] 
 
Scheme 50 Reaction mechanism of the synthesis of (Z)-2,4-dihalobutenes 
Diethyl malonate and diethylalkyl malonates react with olefins and manganese(III) or 
cobalt(III) acetates in the presence of copper(II) acetate to give diethyl-alk-2-
enylmalonates which produce, upon hydrolysis, γδ-unsaturated acids and γ-lactones 
(Scheme 51).[118]  
 
Scheme 51 Oxidative radical addition to alkenes: a convenient route to γδ-unsturated acids 
and γ-lactones 
In this reported process, catalytic amounts of copper(II) acetate alter the course of 
the reaction initiated by Mn(OAc)3 and only diethyl hept-2-enylmalonate 151 was 




isolated. Oxidation of the radical intermediate 150 gives selectively the isomer 151, 
showing that the elimination of the hydrogen in the δ-position is preferred to the β-
position, due to the polar effect of the CO2R group preventing the nucleophile from 
attracting the β-hydrogen atom. 
Similarly, ketoesters have been used as starting substrates with manganese(III) 
acetate catalytic systems, especially in the synthesis of substituted tetralones, via a 
two step route combining oxidative addition and cyclization (scheme 52). This 
method has been reported to afford molecular skeletons generally used for the 
synthesis of 4-arylnaphtalenes, which are known biologically active molecules.[121] 
 
Scheme 52 Synthesis of substituted tetralones 
 
Scheme 53 Catalytic radical addition of carbonyl compounds to alkenes by Mn(II)/Co(II)/O2 
Radical addition to alkenes was also successfully achieved through a catalytic 
process using a system combining manganese(II), cobalt(II) and dioxygen. The 
mechanistic pathway for this reaction was studied and is reported in Scheme 53.[122] 




On another hand, a few of the processes reported in the literature also showcased a 
trapping strategy involving different functional groups, either -CO or -OH. The 
manganese(III)-induced oxidative addition of carbonyl compounds to alkenes has 
attracted renewed attention in recent years and some other procedures involving 
malonates have been developed, using other synthetic conditions to find an 
alternative to the use of copper(II) salts to assist in the termination step. For 
example, carbon monoxide trapping in manganese(III)-induced oxidation processes 
have been reported (Scheme 54).[123] 
 
Scheme 54 Carbon monoxide trapping in a manganese(III)-induced oxidation system 
Scheme 55 shows the different products obtained either from malonates or 
ketoesters using a manganese(III) acetate and carbon monoxide catalytic system. 
 
Scheme 55 Products obtained from ketoesters or malonates with Mn(OAc)3/CO 
In a similar procedure, manganese(III) acetate mediated reaction of dimethyl 
malonate with 2-methyl-pent-2-ene has been reported to give two products due to 
an alternative cylization affording a stabilized cation, following the synthetic pathway 
shown in Scheme 56.[116] 





Scheme 56 Suggested mechanistic pathways for the reaction between dimethyl malonate 
and 2-methylpent-2-ene in methanol 
Another Mn(OAc)3 catalytic system has been developed for the one-step synthesis 
of γ-lactones. A SET synthetic strategy is involved and provides carboxyalkyl 
radicals first, followed by oxidation of the radical adduct to a carbocation species, 
affording compound 175 (Scheme 57). Related stimulations by ultrasound irradiation 
have also been investigated, and reported to afford α-substituted-γ-lactones in good 
yields and short reaction times.[124] 
 
Scheme 57 Sonochemical lactonization of olefins 
Finally, dealing with an intramolecular strategy, a few other examples using 
manganese(III) acetate combined with copper(II) acetate as a radical initiator 
system have been reported. Among these examples, one of them describes an 
intramolecular addition of an olefin to a ketoester function (Scheme 58).[125] 
 
Scheme 58 Oxidation of acetoacetate towards a 6-endo-cyclization 




1.2. Cerium ammonium nitrate as radical initiator 
Several comparisons have been done between catalytic systems involving different 
transition metal oxidant species, among which is cerium ammonium nitrate (CAN) 
(Figure 31). Ceric ammonium nitrate has proved to be an efficient SET reagent and 
widely used as an α-carbonyl alkyl radical generator. 
 
Figure 31 Molecular structure of Ceric Ammonium Nitrate (CAN) 
Ceric ammonium nitrate is known due to recent work on oxidative addition of 
ketones and carboxylic acids to alkenes. Indeed, CAN possesses huge synthetic 
potential to form C-C bonds and was firstly reported as a reagent in the addition of 
1,3-dicarbonyl compounds to buta-1,3-diene and malonylation of arenes. CAN-
mediated addition of dicarbonyl compounds to cyclic and acyclic alkenes to afford 
2,3-dihydrofurans in good yield has also been previously reported (Scheme 59).[116] 
 
Scheme 59 Ceric ammonium nitrate-mediated addition of dicarbonyl compounds to cyclic 
alkene 
The efficiency of CAN in the synthesis of α-carbomethoxy-γ-lactones from olefins 
has been reported, when combined with Cu(OAc)2, which is a fast oxidizer of the 
secondary alkyl radical to the carbocation, avoiding side-products.[126] Table 7 shows 
the effect of ultrasound irradiation on the reaction. Indeed, the trend is that 
ultrasound irradiation provides better yields for styrene derivatives and cyclohexene. 
 
































30 49 41 51 
a 
At room temperature; 
b
 At 5-10 °C 
The CAN-mediated addition of dimedone, acetylacetone and ethyl acetoacetate to 
alkenes presents a simple method for the synthesis of dihydrofurans in good yields, 
and the addition of 1,3-dimethyl-malonate to alkenes provides lactones in moderate 
yields. The solubility of CAN in organic solvents such as methanol, acetonitrile, and 
THF, milder reaction conditions, experimental simplicity, generally higher yields of 
products, suggests that CAN is a superior alternative to commonly used 
manganese(III) acetate (Table 8). 








R1 = H, R2 = R3 = (CH2)4, R
4 = Me 
 
57 (47) 
2 R1 = H, R2 = Et, R3 = R4 = Me 60 (41) 
3 
 
R1 = H, R2 = R3 = (CH2)4, R
4 = Me 
 
40 (39) 
4 R1 = H, R2 = Et, R3 = R4 = Me 60 (39) 
5 
 
R1 = H, R2 = R3 = (CH2)4, R
4 = Me 
 
20 (33) 
6 R1 = H, R2 = Et, R3 = R4 = Me 37 (45) 
a
 Yields obtained with Mn(OAc)3-mediated reactions are given in parentheses 




Relative rates for the addition reactions of the malonyl radical to substituted styrenes 
have been reported, using either cerium(IV) ammonium nitrate or tributyltin hydride 
as the radical initiator. The two processes exhibit practically identical ρ+ values, 
suggesting that the coordination between the metal and the radical does not play a 
significant role in the CAN-promoted oxidative addition to styrene-based olefins. 
Table 9 shows the yields obtained for the products 192 to 194 corresponding to the 
reaction between dimethylmalonate and a styrene derivative with CAN, and to the 
reaction between diethyl-chloromalonate and a styrene derivative with tributyltin 
hydride.[127] 





by CAN {192+193} [%]a 
Reaction induced 
by Bu3SnH {194} [%] 
1 p-Methylstyrene 190 90 (0.7) 40 
2 Styrene 184 93 (2.9) 50 
3 p-Chlorostyrene 191 86 (2.7) 50 
a
 In parentheses the ratio [192/193] 
Relative rates for both reactions are reported in Table 10, electron-donating groups 
increase and electron-withdrawing groups retard the reaction rate. Applying the 
Hammett equation to these values, with corrected σ+ substituent constants, ρ+ 
values from the Hammett trend plot don’t show so much difference between the 
reaction induced by CAN (-1.0895) and that induced by Bu3SnH (-1.0451), showing 
an identical selectivity for the two reactions (Figure 32). 
 








induced by CAN 
Reaction 
induced by Bu3SnH 
1 p-CH3 2.1 1.1 
2 H 1.0 1.0 
3 p-Cl 0.70 0.40 
4 m-Cl 0.35 0.25 
5 p-OMe / 4.6 
6 m-NO2 0.18 / 
7 p-NO2 / 0.10 
 
Figure 32 Hammett plots and trend plots of the CAN- (red) and Bu3SnH-induced (blue) 
addition of malonyl radical to substituted styrenes 
1.3. Other radical initiators 
2-Halogenated malonates, such as iodo-malonates, have already been investigated 
as excellent substrates for radical cyclizations by an atom transfer strategy. Indeed, 
several alkenes have been previously tested as acceptors for the addition reactions 
to iodo-malonates using tributyltin hydride as a radical initiator (Scheme 60). Malonyl 
radicals are considered as electrophilic and pair with electron rich alkene acceptors 
in additions, whereas most radical reactions pair nucleophilic alkyl radicals with 
electron-deficient alkene acceptors.[128] 
y = -1,0451x - 0,1787 
R² = 0,968 
y = -1,0895x - 0,0158 

























Scheme 60 Addition reactions of iodomalonates to various alkenes 
The addition of alkenes to bromo-malonates has also been reported in an annulation 
experiment (Scheme 61).[128] 
 
Scheme 61 Annulation experiment with bromo-malonate 
On another hand, free radical addition of an ester to an olefin in the presence of 
peroxide initiators can be used for the synthesis of aliphatic acids from malonic 
acids. Radical alkylation of malonic ester and related 1,3-dicarbonyl compounds, 
such as ketoesters, has also been reported using peroxides, as the radical initiator. 
An efficient, convenient and direct alkylation of diethyl malonate has been 
developed, using a one-step process involving a free radical initiated addition of the 
reactive species to suitable olefins. This synthetic strategy has been applied to few 
olefin substrates such as 1-octene, cyclohexene or 1-decene and the synthetic 
pathway is shown in Scheme 62.[129] 





Scheme 62 Radical-alkylation of malonic ester using ditertbutylperoxides 
Last but not least, oxidation of malonic esters in the presence of olefins has been 
reported using iron(III) perchlorate nonahydrate (FEP) in acetonitrile. Inter- and 
intramolecular additions of dialkyl malonates to olefins such as styrenes or dienes 
can be achieved to provide 3,5,5-trisubstituted-2-oxotetrahydrofuran-3-carboxylic 
esters in high yields or γ-lactones with low selectivity from other alkenes (Scheme 
63). This process shows another alternative to commonly used metal oxidants such 
as manganese(III) acetate or ceric ammonium nitrate (CAN), as the FEP reagent is 
relatively inexpensive.[130] 
 
Scheme 63 Efficient oxidation of enolizable carbonyl compounds to α-carrbonylalkyl radicals 
by iron(III) salts 
All the free radical initiation methods that have been reported are used in reactions 
with non-fluorinated dicarbonyl substrates or intermediates and their respective 
applications, corresponding synthetic approaches have never been tested on 2-
fluorinated starting molecules and our research on this topic will be presented in the 
next part. 




2. Catalytic oxidative addition of fluorinated 1,3-dicarbonyl 
compounds to olefins using radical chemistry 
Throughout this next part, we present our different synthetic investigations to 
achieve the oxidative addition of our synthesized fluorinated 1,3-dicarbonyl 
substrates to various olefins, studying the nature of the catalytic system to process 
such reactions. 
2.1. Manganese acetate Mn(OAc)3 as initiator 
By similar procedures to those reported in the literature, we tested a range of 
different manganese(III)-based catalysts, Mn(OAc)3, Mn2O3, or Mn(acac)3 using 
previously synthesized 2-fluoro-1,3-dimethylmalonate, with two different olefins, 
either cyclohexene or 1-octene. Cu(OAc)2 was used as a co-catalyst in some cases 
(Table 11). No conversion was obtained in the cases of using either Mn2O3 or 
Mn(acac)3 as catalyst, even with a reaction time of 3 days. Adding Cu(OAc)2 as a 
co-catalyst didn’t improve the conversion of the starting substrate into the desired 
product. 




Entry Olefin [eq.] Catalyst [eq.] Time [h] Yield [%]c 
1 1-Octene 182 [0.5] Mn(OAc)3 [0.5] 5 - 
2 1-Octene 182 [0.5] Mn(OAc)3 [0.5] 20 17 
3b 1-Octene 182 [0.5] Mn(OAc)3 [0.5] 20 18 
4 Cyclohexene 183 [0.5] Mn(OAc)3 [0.5] 24 7 
5b Cyclohexene 183 [0.5] Mn(OAc)3  [0.5] 24 10 
6 1-Octene 182 [1.0] Mn2O3 [1.0] 72 - 
7 1-Octene 182 [1.0] Mn(acac)3 [1.0] 72 - 
8 1-Octene 182 [1.0] Mn(OAc)3 [1.0] 120 48 
a
 AcOH, 80°C; 
b





Using cyclohexene lowers the conversion, therefore longer chain alkenes, such as 
1-octene were used in the further reactions. Longer reaction times and more molar 
equivalents of Mn(OAc)3 gave better conversion and it has been shown that the 




efficiency of the electron transfer to generate radicals is mainly dependent on the 
olefin used.[131] 
 
Figure 33 Picture of reaction mixtures containing 2-fluoro-1,3-dimethylmalonate, olefin and 
Mn(OAc)3 with and without Cu(OAc)2 as co-catalyst 
Before attempting any further purification, improving the synthetic conversion of 
linking alkenes to 2-fluoro-1,3-dimethylmalonates using Mn(OAc)3 was done by 
heating the mixture up to 100 °C and adding the alkene at 100 °C. Different 
synthetic conditions were tested (Table 12). More molar equivalents of 2-fluoro-1,3-
dimethylmalonate gave higher conversion of the 1-octene to the desired product. 
Using 2-fluoro-1,3-dimethylmalonate as a solvent, without acetic acid, provides 
really good conversion (Table 12, entries 6 to 10), and more molar equivalents of 
the Mn(III) catalyst also improve the conversion (Table 12, entries 8, 9 and 10). 
Table 12 Addition of alkene to 2-fluoro-1,3-dimethylmalonate using Mn(OAc)3 catalyst 
 
Entry Reaction time [h] 62 [eq.] Mn(OAc)3 [eq.] Yield [%]
b  
1 24 1 1 22 
2 72 1  2 77 
3 72 2 2 20 
4 72 2 1 25 
5 72 4 1 45 
6a 72 10 1 39 
7a 72 15 1 50 
8a 72 20 2 93 
9a 72 30 2 95 
10a 72 40 2 quant. 
a
 Without AcOH; 
b
 Isolated 
Various attempts at purification of the addition product were carried out, combining 
distillation under reduced pressure and column chromatography, providing the 




corresponding product. Whereas the purification of the crude product by a distillation 
method on a larger scale makes this synthetic strategy potentially interesting, 
problems of huge excess of 2-fluoro-1,3-dimethylmalonate made this an unrealistic 
synthetic process. 
 
Scheme 64 Synthetic comparison between 2-fluoroacetoacetate and 2-fluoro-1,3-
dimethylmalonate substrates 
Investigations around the impact of the starting fluorinated substrate were made 
(Scheme 64) and the use of fluorinated malonate gave less than full conversion 
towards the desired product but 2-fluoro-ethyl acetoacetate gave full conversion, 
accessing the desired molecule in convenient yield after very difficult purification 




F-NMR (-215 to -130 ppm) of crude products from Mn(OAc)3-induced addition of 
1-octene to 2-fluoro-1,3-dimethylmalonate (left) or 2-fluoroethylacetoacetate (right) 
2.2. Other Manganese-based radical initiators 
Improving the conversion of linking alkenes to fluorinated malonates was 
investigated using two other procedures (Scheme 65), involving the use of 
Mn(OAc)2, or KMnO4.
[132] Both procedures, either using 1,3-dimethylmalonate or 1,3-
dimethyl-2-fluoromalonate, gave full conversion of the 1-octene but the desired 
products were only obtained when the non-fluorinated malonate was used as a 
starting substrate. Due to the presence of many by-products (19F-NMR), purification 
of the crude mixtures was not achieved. Similar conditions were tested using a 




different olefin, cyclohexene, but again gave poor conversion and many by-products 
were observed (19F-NMR). 
 
Scheme 65 Radical chemistry involving fluoro- and non fluoro-malonates using other 
manganese-based radical initiators 
We also tested the catalytic radical addition of carbonyl compounds to alkenes by a 
Mn(II)/Co(II)/O2 system (previously shown in Scheme 53), and we tested 1,3-
dimethyl-2-fluoromalonate as a potential substrate using this combination. Whereas 
using 1,3-dimethylmalonate was reported to give the desired product,[122] the 
presence of the fluorine atom did not allow any conversion of the substrate and the 
yield of the desired product could not be determined due to the large amount of by-
products, when the fluorinated malonate (15 eq.) was the starting compound. For 
this reason, this method was not investigated further. 
2.3. Ditertbutylperoxide (tBuO)2 as initiator 
Synthetic aspects of free-radical addition of alkenes to 1,3-dicarbonyl compounds 
has been reported in a few literature reviews, but the influence of the fluorine atom 
in the α-position has never been investigated for tBuO. initiator processes (Scheme 
66). 
 
Scheme 66 Addition of alkene to 2-fluoro-1,3-dimethylmalonate using ditertbutyl peroxide as 
radical initiator 
To discover the optimal conditions of the addition of 1,3-dicarbonyl substrates such 
as malonates to alkenes, a series of experiments were previously reported by Allen 
and coworkers,[129] with varied temperatures, reactions times, ratios of reactants and 
nature of the peroxide initiator (Table 13). It has been reported that peroxidic 
initiation at elevated temperatures is more effective than photo-initiation at room 
temperature and high ratios of reactive methylene compound to olefin are essential 
for good conversions. 




Table 13 shows the reported results of addition of 1,3-diethylmalonate to 1-octene 
induced by peroxide. Clearly, to avoid the formation of the product 208, the best 
synthetic strategy (Table 13, entry 4), that has been reported for 1,3-
diethylmalonate, involved addition of a mixture of the olefin (1 mol), the reactive 
malonate compound 47 (1 mol) and ditertbutylperoxide (0.1 mol) over 6 hours to the 
same reactive malonate compound 47 (7 mol) at around 150°C. At those 
temperatures, ditertbutyl peroxides decompose to give methyl radicals in addition to 
tertbutoxy radicals, modifying the efficiency of the initiation processes. Entries (5) 
and (6) showed that reducing the amount of peroxide has no impact on the obtained 
yields corresponding to both products. Finally, the best conditions to give higher 
yield of product 206, were found in entry (7), and these synthetic conditions were 
applied to 1,3-dimethyl-2-fluoro-malonate. 
Table 13 Addition of 1,3-diethylmalonate to 1-octene (1 mol) induced by ditertbutyl-peroxide 
(0.15 mol) at 105 °C (reaction time: 4 days) 
 
Entry 1 2 3 4 5 6 7 8 9 
1,3-diethylmalonate [mol] 2 5 8 8a 20 20b 30 40 50 
206 [%] 6 11 13 47 67 67 79 60 73 
208 [%] 6 6 11 / 14 11 6 11 10 
a
 Malonate (1 mol), 1-octene (1 mol), peroxide (0.1 mol) added to malonate (7 mol) 
at 150 °C during 6 hours then heated for a further 1.5 hour; 
b
 Ditertbutylperoxide (0.05 mol) 
Following the conditions of entry (7), a similar addition to 1,3-dimethyl-2-
fluoromalonate was achieved and, after Kugelröhr distillation of excess 1,3-dimethyl-
2-fluoromalonate, the resulting crude mixture shows by 19F-NMR the presence of the 
desired product in some cases (Table 14). Unfortunately, related processes using 
ditertbutylperoxide with substrates such as styrene derivatives did not provide any 








Table 14 Addition of 1,3-dimethyl-2-fluoromalonate to olefin induced by ditertbutyl-peroxide
a
 
Entry Olefin (tBuO)2 Yield [%]
b Product 
1 1-octene [0.033 eq.] 0.005 eq. 66 
 
2 Styrene [0.1 eq.] 0.01 eq. - - 
3 vinyl-cyclohexane [0.1 eq.] 0.01 eq. - - 
4 Cyclohexene [0.1 eq.] 0.01 eq. - - 
5 4-methyl-styrene 0.1 eq. - - 
a





These experiments have only been done on a µL-scale, and a good purification 
method of the resulting crude mixtures was not possible, especially in case of using 
styrene derivatives as substrates, which gave polymerization. 
2.4. Tributyltin hydride/Azobisisobutyronitrile (Bu3SnH/AIBN) as 
initiator 
Tin initiators dominate free radical chemistry and they have proved particularly 
serviceable to replace hydrogen by hydroxyl, amino, nitro, thiol, selenide, 
carboxylate, and halogen groups.[133] Tributyltin hydride combined with 
azobisisobutyronitrile (AIBN) is most commonly used in synthetic sequences and so 
we tested this initiator combination in reactions between 1,3-dimethyl-2-
fluoromalonate and 1-octene (Scheme 67). 
 
Scheme 67 Addition of 1-octene to 1,3-dimethyl-2-fluoromalonate using 
tributyltinhydride/AIBN 







H-NMR of resulting product from the addition of 2-fluoro-1,3-dimethylmalonate to 
1-octene using tributyltin hydride as radical initiator 
Different synthetic conditions have been tested on the 1,3-dimethyl-2-
fluoromalonate:1-octene (1:1) substrates system, using 1, 2 or 3 molar equivalents 
of tributyltin hydride either in benzene or toluene. After work-up, only Bu3SnF was 
obtained in all the tested experiments (1H- and 19F-NMR) (Figure 35). Those results 
can be explained by the fact that KF is used during the work-up of the reaction to get 
rid of the unreacted tributyltin hydride, after converting unreacted Bu3SnH to Bu3SnI 
by using iodine, meaning that Bu3SnF can be formed during the work-up, so this 
method has not been investigated further. 
2.5. Cobalt acetate Co(OAc)2 initiator and fluoro-ketoester as 
substrates 
Cobalt(II) acetate promoted oxidative addition of 1,3-dicarbonyl compounds to 
alkenes under aerobic conditions has already been reported (Scheme 68).[134] 
Cobalt(II) acetate oxidizes the acetoacetate to give a cobalt(II) enolate, likely to 
behave as an enol radical and react with the chosen alkene to yield an organocobalt 
compound. Anaerobic conditions provides the compound 214, while the insertion of 
dioxygen in the carbon-cobalt bond gives the peroxo-cobalt(III) complex, giving the 
alkoxy radical by homolytic cleavage. This radical abstracts an hydrogen atom to 
give hydroxy compound 216, which undergoes an intramolecular ketalisation to yield 
the hemi-ketal 217. 





Scheme 68 Mechanistic pathway of the addition of acetoacetate to alkene using Co(OAc)2 
 
Figure 36 Picture of the reaction mixture containing 2-fluoroacetoacetate, olefin and 
Co(OAc)2 
A molar ratio [2:2:3] for [Co(OAc)2:fluoro-ketoester:alkene] was used and different 
synthetic conditions were tested to find a suitable procedure (Table 15). Choosing a 
longer chain alkene with the double bond in the terminal position, such as 1-octene, 
provided a better yield than styrene derivatives and heating up the reaction mixture 
gave higher yields. 
 




Table 15 Addition of 2-fluoroacetoacetate to various olefins using Co(OAc)2 
 






3 C6H13 90°C 4 67 
a





Those tested synthetic conditions showed that fluorinated ketoester are probably a 
much better option as a starting compound for any type of radical initiator system, 
but purification was very difficult. 
2.6. Ceric ammonium nitrate (CAN) as initiator 
Ceric ammonium nitrate is well-known as an efficient SET reagent and literature 
procedures have reported that the molecular system CAN:alkene:mono-methyl ester 
malonic acid has been used in a 4:1:5 molar ratio for 2 hours at room temperature, 
using either acetonitrile or acetic acid combined with the use of Cu(OAc)2 as a co-
catalyst.[126] We tested these synthetic conditions on 1,3-dimethyl-2-fluoromalonate 
using two types of olefin, 1-octene or styrene (Table 16). 







Solvent Yield [%]d 
1b C6H13 - MeCN - 
2b C6H13 Cu(OAc)2 AcOH 11 
3b C6H5 - MeCN - 
4b C6H5 Cu(OAc)2 AcOH 12 
5c C6H5 - MeCN - 
6c C6H5 Cu(OAc)2 AcOH 10 
a
 3 Days, r.t.; 
b
 2-Fluoro-1,3-dimethylmalonate:styrene:CAN with molar 
ratio 5:1:4; 
c 











Figure 36 Picture of the color monitoring of the reaction from the resulting reaction mixtures 
containing 2-fluoroacetoacetate, olefin and CAN with or without Cu(OAc)2 
The obtained results show that using acetonitrile avoided the formation of any 
expected product, and that acetic acid combined to Cu(OAc)2 provided only a small 
amount of desired product, thus confirming the previous observation that using 1,3-
dimethyl-2-fluoromalonate was probably a less efficient option as a starting 
substrate than a 2-fluoroketoester. As previously written, these results showed the 
importance of an eventual co-catalyst, because Cu(OAc)2 possesses a quicker 
oxidizing power of secondary alkyl radicals. No further purification was attempted 
here as the resulting yields were too low. 
Another literature review has reported another procedure using CAN in 
methanol,[135] and, therefore, CAN has been tested with 1-octene and 1,3-dimethyl-
2-fluoromalonate in a molar ratio of 2:4:1 in methanol (Table 17). The obtained 
results showed that using CAN in methanol gave low conversion of the starting 1,3-
dicarbonyl compound, even with heating or longer reaction times, and so this 
method was not investigated further. 
Table 17 Addition of 1,3-dimethyl-2-fluoromalonate to olefin using CAN in methanol 
 
Entry R Temperature [°C] Time [h] Yield [%]a 
1 F r.t. 24 - 
2 F 60 24 5 





The same synthetic procedure has been tested on the molecular system [2-
fluoroacetoacetate:styrene:CAN] using a molar ratio of [5:2:4]. After purification by 
column chromatography, a mixture of diastereomers was clearly obtained as the 




major product in moderate yield (Table 18). 1H-, 13C- and 19F-NMR analysis of the 
obtained product was consistent with the mixture of diastereomers. Elemental 
analysis was also confirming the molecular structure of these products. 
Table 18 Addition of various olefins to 2-fluoroacetoacetate using CAN radical initiator 
 
Entry R Yield [%]a 
Diastereomers ratio 
[major:minor]b 
1 Ph 219a, 56 1:1 
2 C6H13 219b, 35 1:1 
3 cyclohexyl 219c, 31b 3:2 
4 p-Cl-Ph 219d, 56 1:1 
5 o-Cl-Ph 219e, 57 1:1 
6 o,o-Cl2-Ph 219f, 59 1:1 
7 p-F-Ph 219g, 60 1:1 
8 F5-Ph 219h, 62 5:4 
9 p-Me-Ph 219i, 20b 1:1 







Indeed, 19F-NMR clearly showed two doublet of doublet of quadruplets (Figure 35), 
confirming the presence of diastereomers and the three fluorine-hydrogen 
couplings, 4.5 Hz, 11.4 Hz and 29.1 Hz for the doublet of doublet of quadruplets at -
166.95 ppm, and 5.0 Hz, 15.0 Hz and 22.4 Hz for the doublet of doublet of 
quadruplets at -167.18 ppm. Thus we observe accurately the couplings between 
fluorine and protons in α- and β-positions characterized by their 3JH-F and 
4JH-F 
coupling constants. The presence of diastereomers was confirmed by the analysis 
of the 1H-NMR (Figure 36), clearly showing that every peak was consistent with a 
pair of diastereomers and the presence of a proton around 6 ppm, representative of 
a proton in α-position of a -ONO2 functional group. 











H-NMR of ethyl 2-acetyl-2-fluoro-4-(nitrooxy)-4-phenylbutanoate 219a 
In the present work, we compared three different structures of olefins, indeed 1-
octene, vinyl cyclohexane and styrene. Reaction with styrene derivative clearly 
 
ddq, J = 29.1, 11.4, 4.5 Hz ddq, J = 22.4, 15.0, 5.0 Hz 
 




shows a higher yield, due the relative lower stabilizing effect of the octyl and 
cyclohexyl groups on the synthesized radical intermediate. The presence of the 
fluorine atom on the β-position of the fluorinated ketoester seemed to stabilize the 
radical intermediate 220, and that stabilization was enhanced by the structure of the 
styrene derivative, as long chain alkenes provided less efficient conversion towards 
the desired nitro-oxy products (Scheme 68). 
 
Scheme 68 Mechanistic pathways of CAN mediated addition of 2-fluoroacetoacetate to 
styrene derivatives 
To rationalize the obtained results, a tentative mechanism has been established for 
2-fluoro-ethyl acetoacetate (Scheme 68). The addition of ketoester radical, 
generated by Ce(IV), to styrene, would give the radical 220. The formation of the 
mixture of diastereomers is due to the oxidation of 220 and the trapping of the cation 
221, resulting from the Ce(IV) oxidation by NO3
-, consistent with additions involving 




non-fluorinated malonates shown in Table 9 (page 83). Major products from non-
fluorinated 1,3-dicarbonyl systems are the corresponding non-fluorinated 224 and 
225 but non-fluorinated equivalent of 219 was observed, either as trace or minor by-
product.[135] 
NO3
. radicals possess a high electrophilicity combined with a high oxidation potential 
(Ered = 2.0V), so they can react with hydrocarbons with a relative high selectivity, due 
to substantial polarization of the transition structure for CH-hydrogen abstraction.[127] 
Ceric ammonium nitrate photo-initiation has already been studied to prove the 
generation of NO3
. radicals and the low oxidation potential of CAN and NO3
. radicals 
has been demonstrated not to be high enough to oxidize saturated hydrocarbons, 
meaning that the NO3
. radical may attack directly the strained hydrocarbon 
moiety.[127] 
After getting the proof that styrene substrate was the only one providing nitro-oxy 
diastereomers as main products in relatively convenient yields, it was also important 
to investigate the presence of different electron donating and electron withdrawing 
functional groups on the different positions of the styrene ring. We observed that in 
the case of the presence of halogeno-groups such as chlorine or fluorine atoms, 
reactions gave the desired products, whereas methyl and tertbutyl functional groups, 
whatever the position they were attached to the benzene ring, did not afford any 
significant transformation towards these molecules. 
This mechanistic pathway has precedent, although other oxidizing species deriving 
from CAN can be present in the reaction crude mixture. Nevertheless, a similar 
mechanistic pathway has been already reported using 1,3-dimethylmalonate as 
starting substrate affording similar products, but using a non-fluorinated substrate 
was providing some different major products. Indeed corresponding lactone 225 and 
further oxidized product 224, which were not obtained at all in our studied case, 
showing that fluorinating the starting 1,3-dicarbonyl substrate was impacting the 
reaction.[135] 
3. Conclusion 
Throughout this chapter, we reviewed the various radical initiators to accomplish the 
oxidative addition of olefin to fluorinated 1,3-dicarbonyl substrates and revealed that 
starting from 2-fluoroketoester appeared to be more successful. After many 
synthetic investigations, we developed a significant methodology reacting 2-fluoro-




ethyl acetoacetate and various olefins using Ceric ammonium nitrate as radical 
initiator, and CAN-mediated reactions of styrenes and 2-fluoro-1,3-dicarbonyl 
compounds gave reasonable yields to generate the corresponding radical fluoro-
intermediate to access the desired nitro-oxy products. Importance of the halogeno-
groups attached to the benzene ring of styrene derivatives has been largely 
showcased, in comparison to various alkyl groups in the different positions of the 
benzene rings. 




Chapter 5 Multicomponent reactions from 
fluorinated dicarbonyl systems 
As the main idea of our general project was to develop the use of fluorinated 
dicarbonyl substrates in synthetic chemistry, after developing the synthesis of 
fluorinated heterocycles and applying radical chemistry methods, we then focused 
our work on processes to transfer fluorine to more complex functionalized 
molecules, which could be obtained in easy synthetic one-pot processes in high 
yields. Multicomponent reactions remain perhaps the best option to rapidly access 
complex fluorinated molecular scaffolds. Therefore, in this chapter we present the 
various advantages of multicomponent processes, describing recently reported 
multicomponent methods on fluorinated substrates, and showcase a method to 
access functionalized fluoro-products from 2-fluoro-1,3-dicarbonyl synthesized 
molecules via various three-component Mannich-type synthetic strategies. 
1. Multicomponent reactions: introduction 
Multicomponent reactions (MCRs) can be described as any synthetic process with 
more than two substrates generating a simple and flexible building block. The main 
advantages of such processes are their practical, time-saving and one-pot reaction 
conditions. Therefore, multicomponent strategies can build libraries of various 
compounds, especially in the field of drug discovery and automated synthesis.[136] 
Many areas of chemistry are taking advantages of MCRs properties, such as 
electron paramagnetic resonance (EPR)-spin labeling, synthesis of biocompatible 
materials (artificial eye lenses for example), polymers with novel properties, chiral 
phases for HPLC analytical methods, natural product synthesis, peptide-nucleic 
acids or even agrochemicals synthesis. 
An inherent formation of various bonds in one procedure summarizes the MCR 
synthetic strategy without isolating the corresponding intermediates while being able 
to switch various reaction parameters and adding additional reagents. 
Multicomponent reactions can be defined as convergent reactions in which three or 
more starting materials react to form a product, where basically all or most of the 
atoms contribute to the newly formed product (Figure 37). By a series of simple 
chemical reactions, the final product can be obtained via an irreversible step in most 
cases. 






Figure 37 Comparison between (left) divergent one-component reaction and (right) 
convergent five-component reaction 
However, the multicomponent process always appears challenging as it needs to be 
conducted in such a way that the network of pre-equilibrated reactions give the main 
desired product and do not yield side products. This challenging process explains 
why the result is so dependent on experimental conditions, i.e. the solvents, reaction 
temperatures, substrate concentrations, potential need of an identified catalyst, 
presence of any specific functional groups and, of course, the starting materials. All 
these criteria together are linked to the success of the design and discovery of new 
multicomponent processes. 
As a brief history of multicomponent reactions, the first officially reported MCR was 
the Strecker synthesis of α-amino acid in 1850, which began a large number of 
syntheses being developed from isocyanides (Scheme 69).[136] 
 
Scheme 69 Strecker synthesis, first reported by Laurent and Gerhardt (1838) and Strecker 
(1850) 
However, one of the pioneers of the development of a four-component reaction was 
Ivar Ugi (Scheme 70), followed by a few other contributors who developed variations 
of this multicomponent synthetic strategy from the Ugi reaction, such as Bienayme, 
Weber, Schreiber, Armstrong and Bossio. So far, the Ugi reaction appears to be the 
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Scheme 70 Four-component reaction developed by Ugi (1959) 
The most useful MCRs have been reported to be isocyanide-based MCRs, also 
called IMCRs, as previously shown in the Ugi four-component reaction. They mainly 
involve commercially available substrates allowing the synthesis of a large number 
of easy-accessible molecular scaffolds. The topological nature of isocyanides confer 
them a significant particular reactivity, making the IMCRs quite different from the 
MCRs, indeed these functional groups can react with both electrophiles and 
nucleophiles on the same atom to form a reactive α-adduct intermediate, which is 
the starting point of further rearrangements and synthetic transformations towards 
the desired products, especially in the field of natural product synthesis. This way 
they appear similar to carbon monoxide and carbenes. Among all the reported 
syntheses involving IMCRs, Scheme 71 shows one of the different synthetic 
approaches towards natural products reported by Fukuyama using a four-
component reaction.[137] 
Assembling complex molecules in one-pot is clearly the main advantage of MCRs, 
conferring MCRs with many applications in areas of applied chemistry, as accessing 
target molecules requires a minimum of synthetic effort, when efficiently optimized 
and simply processed. 
Starting from a certain amount of starting materials (Sm), the number of different 
products that can be obtained by a N-component process becomes high really 
quickly, indeed Sm
N. As an example, a three-component reaction with 10 starting 
materials of each class will result in a library of 1000 compounds from a simple one-
pot reaction.[138] 





Scheme 71 Total synthesis of the natural product (-)-lemonomycin using four-components 
reaction IMCR by Fukuyama 
Ugi and coworkers also showcased that MCR strategies represent an easy access 
to large collections of compounds to assess structure-activity relationship by varying 
functional groups contained in the target molecules. This work was pursued further 
on an industrial scale to access an enormous chemical structure space for patent 
applications, especially in the field of drug discovery. For example, a linear 6 step 
synthesis will typically take 6 months to be fully optimized and achieved, when the 
same process applied to MCRs strategy can reduce considerably development time 
and give access to a wide variety of molecular scaffolds. “Hit-to-lead” transitions can 
be accomplished promptly and physicochemical properties can also be modified 
easily, i.e. the lipophilicity, solubility, molecular weight, number of hydrogen donors 
or acceptors, number of rotatable bonds and polar surface area, either on a 
laboratory scale or to industrial amounts.[139] 
Performing one-pot reactions is synonymous to performing the addition of reagents, 
controlling, quenching, extracting, and purifying the reaction at one time. Last but 
not least, analyzing the resulting products is also carried out only once. The 
preferred approach for such MCR strategies remains a solution phase approach, 
which allows an automatic process with multiple liquid dispensers.  




Bond forming efficiency, developed by Tietze and coworkers,[140] is one of the key 
criteria to determine the quality of a mutlicomponent reaction, related to forming 
several bonds in one operation without isolating the intermediates, changing the 
reaction conditions or adding further reagents. 
2. Organofluorine chemistry and multicomponent reactions 
2.1. Multicomponent reaction on fluorinated substrates 
In this part, we have summarized the different multicomponent processes as applied 
to fluorine-containing compound synthesis. Various fluorinated heterocycles have 
already been reported to be synthesized via the application of MCRs, especially in 
the fields of agrochemical and pharmaceutical industries.[141] 
The synthesis of fluoropyridine-N-oxide from Averina et al. gave route to fluoro-
pyrimidines. This approach has been made through the use of 1-bromo-1-fluoro-
cyclopropanes and NOBF4 in the presence of a selected nitrile as solvent (Scheme 
72). Dihalocarbene are first treated with an olefin to access the cyclic intermediate 
followed by heterocyclization via ring opening. The products scope was extended by 
the use of PCl3/chloroform to reduce the N-oxide functional group to give various 
fluorinated pyrimidines.[142, 143] 
 
Scheme 72 Synthesis of fluorinated N-oxide-pyrimidine and fluorinated pyrimidine 
Moreover, Song et al. developed a one-pot four-component synthesis of 
dihydropyridine derivatives using an aromatic aldehyde, Meldrum’s acid, ethyl-4,4,4-
trifluoro-1,3-dioxobutanoate 248 and ammonium acetate, to afford ethyl 2-hydroxy-
6-oxo-4-aryl-2-(trifluoromethyl)piperidine-3-carboxylate 250, a useful CF3-containing 
substrate used for the synthesis of a wide variety of heterocycic compounds with 
potential biological activity (Scheme 73).[144, 145] 





Scheme 73 Synthesis of 1,4-dihydropyridine with trifluoromethane analogs 
Various fluoro-2,3-substituted quinazolin-4-(3H)-ones 253 have an antifungal activity 
and were synthesized in 2004 by Dandia and coworkers. The three components 
they used were anthranilic acid, phenyl acetyl chloride and substituted anilines 
under microwave irradiation and neat reaction conditions (Scheme 74). All the 
synthesized compounds showed antifungal activity with different pathogenic 
fungi.[146] 
 
Scheme 74 Fluorinated derivatives of quinazolines by MCRs in a microwave 
We were particularly interested in the recent development of Mannich-type reactions 
via a multicomponent process and Lavilla et al. reported a Mannich-Ritter 
transformation towards fluorinated heterocycles, using aromatic or functionalized 
nitriles to achieve the formation of cyclic amidine (Scheme 75).[147] 
 
Scheme 75 Amidine synthesis from reaction of dihydropyrane, various fluorinated cyclic 
imines and alkyl nitriles 
The use of fluorinated derivatives of ketoesters in MCRs is already developed. 
Shaabani and coworkers reported the synthesis of fluorinated tetrahedropyrimido-
[1,2-β]-benzothiazole 259 by a three-component process under solvent-free 
conditions (Scheme 76).[148] 





Scheme 76 Three component reaction towards the fluoro-tetrahedronpyrimido[1,2-β] 
benzothiazole 
Multicomponent reactions can also be applied to 18F-fluorine radiolabelling, as 
radiolabeled probes are often required for in vivo studies by PET. Increasing the 
synthetic efficiency and diversity of 18F-labeled radiotracers can be performed by 
rapid construction of functionalized 18F-radiotracers from 18F-labeled starting 
materials with the label positioned on an aryl motif. A significant example 
showcasing the use of keto-ester towards the formation of a fluorinated pyrimidine 
scaffold by a classic Biginelli three-component process involving radiolabeled 4-
(18F)benzaldehyde 260 is shown in Scheme 77.[149] 
 




2.2. Mannich-type three component reaction from 2-fluoro-1,3-
dicarbonyl substrates 
While carbonyl compounds have played a crucial role in the development of multi-
component reactions, the corresponding use of α-fluorinated carbonyl compounds 
have been much less investigated as MCR substrates. Applications of Mannich-type 
reactions utilizing related fluorinated substrates have been reported previously such 
as, for example, the synthesis of β-fluoronitro(phenylsulfonyl)ethylamines from 
fluoro-ketosulfone substrates described by Prakash and Olah (Scheme 78).[150] Of 
particular relevance to the research reported here, during the course of this thesis 
research, Zhang and coworkers developed a Mannich reaction involving various 
fluoro-ketoesters catalyzed by zinc nitrate and irradiated by microwave at high 
temperature, to which our work will be compared to in the next part (Scheme 79).[151] 





Scheme 78 Direct synthesis of diverse β-fluoroethylamines by a mutlicomponent protocol by 
Prakash and coworkers 
 
Scheme 79 One pot reactions of β-ketoesters developed by Zhang et al. 
Our aims of this part of our work is dedicated to the use of 2-fluoro-ethyl 
acetoacetate and 2-fluoro-1,3-dimethylmalonate as MCR components in Mannich 
reactions involving formaldehyde and different types of amines as educts to give 
poly-functional fluorinated products bearing amine and carbonyl functionalities using 
batch protocols in simple, scalable reaction processes. 
In initial studies we investigated reactions of 2-fluoro-ethyl acetoacetate with an 
amine and formaldehyde in multi component Mannich-type processes. Reactions 
were carried out by first mixing both amine and formalin together before addition of 
the fluorinated dicarbonyl substrate which limits the formation of any alcohol by-
product by aldol condensation with residual formaldehyde (Scheme 80). 
 
Scheme 80 Competing formation of fluoroalcohol by-products 272 involved in the three-
components Mannich-type reaction 




The first tested reactions were achieved using primary amines (Table 19), and a 
quick comparison was made with the use of 2-fluoro-1,3-dimethylmalonate as 
starting substrate. 
Table 19 Three-component Mannich-type reaction of 2-fluoro-ethylacetoacetate or 2-fluoro-
1,3-dimethylmalonate, formaldehyde and a chosen primary amine 
 

































The low reactivity of the primary amines did not give good conversion of the starting 
fluorinated substrate, only allowing us to observe the desired product by 19F-NMR in 
a low yield, encouraging us to use forcing conditions using primary amines (by 
reflux) and secondary amines. 19F-NMR of one example of the obtained crude 
product from reaction with allylamine is presented in Figure 38. Purifications of 




F-NMR spectrum of crude product from Mannich-type reaction between 2-fluoro-
ethylacetoacetate, formaldehyde and allylamine 
We then achieved successfully Mannich-type reactions of 2-fluoro-
ethylacetoacetate, formaldehyde and various more nucleophilic secondary amines 
in significantly high yields under different conditions of solvent, and reflux conditions 
(Table 20).  
Our optimized conditions were found to be 1.7 molar equivalents of amine and 1.5 
molar equivalents of formaldehyde, stirred together for two hours, preceding the 
addition of the 2-fluoro-ethyl acetoacetate and further reaction at room temperature. 
In addition, reactions involving less reactive amines such as benzylamine were 
carried out at 90 °C, providing the corresponding Mannich products in full 
conversion (Table 20, entry 1). Use of additional NaH as a base was also tested on 








Table 20 Three-component Mannich-type reaction of 2-fluoro-ethylacetoacetate, 
formaldehyde and a chosen amine 
 

































 At reflux temperature;
 c
 Carried out in MeCN; 
d
 Using NaH (1 eq.) as a base 




During the course of this work, related Mannich reactions of fluorinated 1,3-
dicarbonyl compounds catalyzed by Zn(NO3)2 using microwave irradiation at 120 
oC 
were reported.[151] However, the method we have described above does not require 
such vigorous heating and allows access to various products, for example 275b and 
275c, which reportedly cannot be obtained by the zinc nitrate catalyzed method. 
Furthermore, Mannich reactions of 2-fluoro-1,3-dimethylmalonate ester were not 
described. Moreover, in the method described by Zhang and coworkers,[151] zinc 
nitrate has surprisingly been chosen as a second step catalyst in the corresponding 
process despite the fact that it can decompose over 110 °C and when heated, it 
forms zinc oxide, nitrogen dioxide and oxygen. 
Noticing that some of the desired molecules were not obtained by Zhang’s method, 
especially involving para-methoxyaniline as the amine substrate, and that the 
method we previously developed did not require any catalysts, heating or microwave 
process, analogous reactions between fluorinated dicarbonyl systems with a 
secondary amine and benzaldehyde were also performed leading to high yields of 
Mannich products (Table 21). 
We observed that the synthesis of the desired products can be achieved without any 
heating of the reaction mixture, showing that primary amines can be used with 
aromatic aldehydes, such as benzaldehyde, and afford desired products in high 














Table 21 Three-component Mannich-type reaction of fluorinated dicarbonyl system, 
benzaldehyde and a chosen amine 
 


























 Starting ethyl 2-fluoro-3-oxo-3-phenylpropanoate substrate commercially 
available
 
At this stage of our investigations, we observed the formation of diastereomers from 
the three-component Mannich-type reactions and we were easily able to observe 
the diastereomers using NMR spectroscopy. Indeed, as a selected example, Figure 
39 shows the two sets of multiplets that have been identified for the corresponding 









C-NMR of Ethyl-2-(phenyl(phenylamino)methyl)-2-fluoro-3-oxobutanoate 275b 
The synthetic conditions developed above were then applied to reactions between 
2-fluoro-1,3-dimethylmalonate ester and a range of amines (Table 22), resulting in 








δC 200.56 (d, J = 28.3 Hz, -CB(O)CH3), 
200.90 (d, J = 29.4 Hz, -CA(O)CH3) 
δC 102.32 (d, J = 206.2 Hz, -CB(F)-), 
103.03 (d, J = 204.7 Hz, -CA(F)-) 




Table 22 Three-component Mannich-type reaction of 2-fluoro-1,3-dimethylmalonate, 
formaldehyde and a chosen amine 
 
































 Using NaH (1 eq.) as a base 
Functionalization by various fluorinated groups on the para-position of the primary 
benzo-amines allowed us to test the developed conditions towards more 
sophisticated fluorinated molecular systems. Using 2-fluoro-1,3-dimethylmalonate as 
substrate did not provide any desired product, despite reflux conditions, confirming 
our general observation that fluorinated di-esters give low conversion, whereas 




reflux conditions on 2-fluoroethylacetoacetate substrate afforded better conversion 
(Table 23). 
Table 13 Synthesis of β-fluoro(dicarbonyl)alkylamines from 2-fluoro-1,3-dicarbonyl systems, 
fluorinated primary benzo-amines and formaldehyde or benzaldehyde 
 


























 Reaction carried out under reflux 





A direct Mannich-type three component MCR reaction has been developed for the 
ready synthesis of β-fluoro(dicarbonyl)ethylamines starting from fluorinated 
dicarbonyl substrates further demonstrating that fluorinated 1,3-dicarbonyl molecular 
systems are particularly useful as starting substrates for further transformations or 
functionalization, opening up opportunities for the synthesis of more complex 
fluorinated systems for life science projects from simple, readily accessible 
fluorinated systems. 
With this idea in mind, we then referred to the synthesis of tropinone as a double-
Mannich type of reaction, which was reported by Robinson in 1917, to adapt this 
multicomponent process to an intramolecular synthetic strategy.[152] Therefore, it 
rapidly came that the fluorination of multi-carbonyl molecules, with similar molecular 
scaffolds as the previously reported keto-esters or malonates, appears as the next 
part of our research project, in the following chapter. The idea of such a process is 
to adapt the same approach to a fluorinated version of the starting tricarbonyl 
system and develop the same Mannich-type multicomponent reactions, using 
fluorinated tricarbonyl substrates. 




Chapter 6 Fluorination of functionalized multi-
carbonyl systems 
After investigating the fluorinations of dicarbonyl substrates and their different 
applications on various fields such as the synthesis of fluorinated heterocycles, 
radical chemistry or multicomponent synthetic strategies, we focused our research 
project on the potential fluorination of carbonyl starting material possessing a 
different functionality. 
Therefore, this chapter shows our investigations on getting fluorinated multi-carbonyl 
systems with different functional groups via direct fluorination using F2 (Figure 39) 





Figure 39 Development of the direct fluorination process from known direct fluorination of 
1,3-dicarbonyl systems 
1. Functionalized fluoro-carbonyl systems 
1.1. Synthesis of fluorinated functionalized carbonyl systems and 
applications 
Mono-carbonyl functionalized molecular systems are molecules possessing, for 
example, either a nitro, cyano, phosphono or sulfono group on the other side of the 




ester functional group. These molecules present a structural shape close to the 1,3-
dicarbonyl structures described in previous chapters, therefore of interest in our 
project. Few fluorination processes of these systems and applications of the 
resulting products have been featured in recent reviews, because there is a clear 
lack of simple methods to access them. 
First on the list of such molecules are the cyano-esters, whose fluorination and 
applications have been rarely reported, despite a chemically interesting potential. 
Most of the synthesis methods previously described exhibited the use of fluorinated 
substrates such as hexafluoropropene as starting materials, leading to the desired 
alkyl α-fluoro-α-cyanoacetate 278 via a two step process (Scheme 81). This reaction 
shows the use of the nitrile 277, produced from hexafluoropropene bubbling into an 
ammonia-dioxane solution, following by a reaction with alcoholic potassium 
hydroxide solution and acidic work-up.[153] 
 
Scheme 81 Synthesis of ethyl-α-fluoro-α-cyanoacetate from hexafluoropropene 
Electrophilic monofluorination of active methylene compounds has been reported by 
J. Hu and coworkers, especially on active methylene cyano and sulfonyl substrates 
(Scheme 82). This work revealed that the presence of zinc chloride activates the 
fluorination of such molecules and lowered undesired overfluorination. Mechanistic 
studies showed the crucial role of the zinc chloride catalyst through its interaction 
with a Brönsted base to control the deprotonation of the starting substrates over the 
corresponding mono-fluorinated products.[154] 
 
Scheme 82 ZnCl2-mediated monofluorination of active methylene cyano and sulfonyl 
compounds 




Similarly, fluorination of different enolates has been reported by Davis et al., but this 
method was developed using NFOBS fluorinating agent (Schemes 83 and 84).[155] 
 
Scheme 83 Synthesis of NFOBS by fluorination of o-benzenedisulfonimide 
 
Scheme 84 Fluorination of phosphono and sulfono enolates using NFOBS 
To show briefly an application of 2-fluoro-2-(phenylsulfonyl)acetate 288, the 
synthesis of α-fluorinated sulfones 290 using a one-pot tandem substitution/Krapcho 
reaction sequence in acceptable yield has been reported (Scheme 85).[156] 
 
Scheme 85 Synthesis of α-fluorinated sulfones from fluoro-2-(phenylsulfonyl)acetate 
On another hand, the direct fluorination of an alkyl phosphono substrate has never 
been investigated. However, the process developed by Grell and Machleidt showed 
the use of perchloryl fluoride on the potassium enolate of diethyl phosphono diethyl 
oxo acetate to gain access to the mono fluorinated phosphono-product (Scheme 
86).157] 




Secondly, the work of J. Tessier and coworkers promoted the use of direct 
fluorination by F2/N2 (10-20% v.v
-1) with good yields, and surprisingly avoiding any 
difluorinated product being formed (Scheme 86).[158] 
 
Scheme 86 Synthesis of (O,O-diethylphosphono)-2-fluoro-2-ethylacetate (a) by Grell and 
Machleidt and (b) by Tessier, Demoute and Truong 
Last but not least on the list of various functionalized carbonyl molecules, the 
fluorinated nitro-esters represent a large category and their chemistry have been 
reported in a few reviews. Their syntheses have been reported by Baum and 
coworkers, following previous research done by Martynov in 1965. They described 
the synthesis of the desired fluoro-nitro-esters 295 from 1,2-difluoro-
tetranitroethane, which can be obtained by the direct fluorination of the di-potassium 
salt of tetranitroethane in a aqueous solution. The main property of the 1,2-
difluorodinitroethylene intermediate 294 was its ability to be handled under normal 
ambient conditions indefinitely in a freezer, despite its slight hygroscopicity, unlike 
tetrahydroethylene (Scheme 87).[159] 
 
Scheme 87 Synthesis of 2-fluorinated nitro-esters from difluorotetranitroethane 
Two main reports on asymmetric synthesis of α-fluoro-α-nitro esters have appeared; 
first of all, Togni et al. reported an asymmetric electrophilic fluorination of α-nitro 
esters to synthesize chiral α-fluoro-α-nitro esters with up to 40% enantiomeric 
excess.[160] 
Catalysis of the fluorination of a range of 2-substituted carbonyl compounds have 
already been studied by Chambers and Hutchinson, such as the fluorination of 
diethyl-2-fluoromalonate by hydrated copper nitrate. Fluorinations of other 2-
substitued carbonyl compounds such as phosphonates, sulphones and nitriles have 




also been discussed, showing the importance of the choice of the catalytic system. 
Indeed, the use of hydrated copper nitrate appeared in many cases as the one 
providing higher yields in the synthesis of the mono-fluoro desired product (Table 
24).[161] 
Table 24 Fluorination of 2-substituted carbonyl compounds developed using various 
conditions 






1a NCCH2CO2Et 46 50 8 
2a O2NCH2CO2Et 54 52 20 
3b NCCH2CO2Et 73 40 25 
4b O2NCH2CO2Et 62 50 7 
5c (EtO)2P(O)CH2CO2Et 73 35 15 
6c MeSO2CH2CO2Et 62 36 7 
a 
F2 (3.2 eq. over 4 h), Cu(NO3)2.2.5H2O, MeCN, 0-5 °C; 
b 
F2 (2.7 eq. over 4 h), anhydr. 
KF, MeCN, 0-5 °C; 
c




In this part of our research, we tried to optimize the access to various fluorinated 
functionalized carbonyl intermediates for the development of subsequent chemistry. 
Neither of the methods developed in this previous work gave satisfactory 
conversions and yields, but pre-reactions with sodium hydride forming the 
corresponding anions, which then were applied to fluorination, were giving fair 
yields, despite few C-S and C-P cleavages (Table 24, entries 5 and 6).[161] 
1.2. Fluorination of various functionalized mono-carbonyl substrates 
In this project, fluorinations using similar synthetic conditions as fluorination of 
dimethylmalonate were attempted (Cu(NO3)2.2.5H2O used as a catalyst, F2/N2 (10% 
v.v-1, 40 mL/min)) in a small batch reactor at 0 °C (Figure 40) and different 
substrates have been tested (Scheme 88). 









Scheme 88 Carbonyl substrates applied to direct batch fluorination 
19F-NMR of the different crude resulting mixtures show the presence of either the 
monofluoro-product, the difluoro-product and in some cases the presence of by-
products, but the monofluoro-product appears to be the major product (Table 25). 
Table 25 
1
H-NMR yields of the fluorination of functionalized carbonyl compounds 
Table 25 shows that better yields were obtained when using alkyl-nitroacetates as 
starting compounds, assessed by NMR of the crude product mixture. It has already 
been shown that the lower yields for fluoro-methylphosphonoacetate and fluoro-
methylsulfonylacetate can be in part explained respectively by C-P bond and by C-S 
bond cleavages. 



















H-NMR, corresponding to the mono-fluorinated product 




Attention was put on the purification of fluoro-methylnitroacetate by distillation, 
providing different fractions with different ratios of 2-methyl-2-fluoro-nitroacetate to 
other by-products. Large batch fluorination of methylnitroacetate at 0 °C under F2/N2 
(20%, 80 mL/min) flow gave mainly two products (Scheme 89), and separation was 
attempted using a micro-distillation strategy. 
 
Scheme 89 Resulting compounds from the fluorination of methylnitroacetate 
Repeated attempts at distillation only allowed us to enrich the fractions of mono-
fluorinated product up to 85% of mono-fluorinated methyl-nitroacetate 295a but gave 
no pure product due to similar boiling points, meaning that, so far, 2-
fluoromethylnitroacetate is not a viable building-block. 
2. Development of the fluorination of tricarbonyl substrates 
The chemistry of fluorinated tricarbonyl systems remains unexplored, compared to 
the chemistry of simple fluorinated mono- or di-carbonyl molecules, so we aimed to 
develop a more efficient method to access fluorinated tricarbonyl derivatives. 
2.1. Fluorinated tricarbonyl molecules 
Poly-fluorinated tricarbonyl derivatives have been reported as products of acid-
catalyzed hydrolysis of substrates possessing a molecular structure similar to 
intermediate 302, coming from tetrafluoroethylene 300. These tricarbonyl systems 
have been developed as part of a wider research program dealing with the synthesis 
of poly-fluorinated monomers 311, affording water-wettable, dyeable and electrically 
conductive copolymers (Scheme 90).[162] 





Scheme 90 Process towards poly-fluorinated monomers and alternative direct fluorination 
pathway 
The disadvantages of this process is the lower yields obtained during the synthesis 
of intermediate 302 (52%), and the dimethyl tetrafluoroacetone-1,3-dicarboxylate 
303 (69%), resulting in a 36% overall yield for the multistep process (Scheme 90). 
Dimethyl tetrafluoroacetone-1,3-dicarboxylate 303 has been already showcased in 
different industrial patents used for the synthesis of fluorinated dioxolanes (Scheme 
91), developed by C. G. Krespan. In this report, polyfluoroalkyl-1,3-dioxolanes are 
considered to be potential inhalation anaesthetics, despite the fact that they 
received little attention compared to fluoroethers anaesthetics. [163] 
 
Scheme 91 Synthesis of fluorinated dioxolane systems from dimethyl tetrafluoroacetone-1,3-
dicarboxylate 303 




The preparation of 2-fluoro-1,3-diethylmalonate also revealed that a similar type of 
fluorinated diethylacetone-1,3-dicarboxylate could be obtained as a side product 
(21%) by the reaction of ethyl-fluoroacetate with ethyl-chloroformate (Scheme 
92).[164] 
 
Scheme 92 Diethylacetone-1,3-dicarboxylate synthesis as a side product of the 
condensation of ethyl-fluoroacetate and ethyl-chloroformate 
Looking at a potential link between 2-fluoro-1,3-dimethylmalonate or 2-fluoro-ethyl 
acetoacetate, it has been reported that asymmetric one-sided fluorinated multi 
carbonyl systems can be accessed from a key intermediate 317, which is 
synthesized in two steps from the previously described 2-fluoro-ethyl acetoacetate 
via the use of trimethylsilyl chloride and LDA in a satisfying yield (Scheme 93).[165] 
 
Scheme 93 Access to fluorinated multi-carbonyl products from 2-fluoro-ethylacetoacetate 
Nevertheless, none of the processes previously described were involving a direct 
fluorination of the tricarbonyl susbstrates using F2 in nitrogen. Therefore we 
conducted studies around the synthetic conditions of this direct fluorination strategy. 
2.2. Comparative fluorination of symmetric and asymmetric tricarbonyl 
compounds 
Similar studies to those conducted in the case of the direct fluorination of malonate 
esters have been conducted using tricarbonyl substrates. Our focus was on finding 
the right synthetic conditions in terms of fluorine gas molar equivalents, flow rates, 




and reaction times, to achieve firstly the direct fluorination of dimethylacetone-1,3-
dicarboxylate 307. In contrast to the direct fluorination of malonate esters, we can 
expect that fluorinating dialkylacetone-1,3-dicarboxylate molecules (Scheme 94) 
could afford four different fluorinated products, i.e. α-monofluoro- 308, bis-α,β-
monofluoro- 309, α-mono-β-difluoro- 310, bis-α,β-difluoro- 303 compounds, and 
their respective enol forms, thus affording a total of eleven potential fluorinated 
products (Figure 41). We also postulated that different stereoisomers could be 
obtained by this method. 
 
Scheme 94 Direct fluorination of dimethylacetone-1,3-dicarboxylate 307 
 
Figure 41 Potential fluorinated products from direct fluorination of dimethylacetone-1,3-
dicarboxylate 
Computational DFT-calculations conducted by Dr Mark Fox (Durham University), 
dealing with the potential 1H- and 19F-NMR chemical shifts showed that the fluorine 




atoms may have different shifts, resulting from the stereochemistry at the carbon 
atoms (Figure 42). 
 
Figure 42 Calculated 
19
F-NMR shifts of respective fluorinated species from the fluorination of 
dimethylacetone-1,3-dicarboxylate 307 
We carried out numerous direct fluorinations on tricarbonyl substrates, varying the 
conditions, and the collected fractions extracted from the different purifications, 
either by distillation or by column chromatography, were then analyzed by NMR 
spectroscopy and compared with the obtained DFT-calculations (Scheme 95). 
 
Scheme 95 Direct fluorination of dimethyl-1,3-dicraboxylate 307 
In the first experiment, we applied a large excess of F2/N2 to be able to identify the 
different 19F-NMR shifts of the resulting products by analyzing their abilities to 
couple with the potential protons nearby resulting in different J coupling constants. 
Figure 43 presents the 19F-NMR spectrum from the crude product from direct 
fluorination of the dimethylacetone-1,3-dicarboxylate using a large excess of F2/N2, 
which we can assign by comparison with calculated 19F-NMR shifts (Figure 42). 







F-NMR of the crude product from direct fluorination of dimethylacetone-1,3-
dicarboxylate 307 using large excess F2/N2 (10% v.v
-1
) 
Analyzing the 19F-NMR spectrum obtained by this method, we could easily identify a 
few products which are listed in Table 26. The shift corresponding to the bis-
difluorinated product 303 (Table 26, entry 1) has been easily identified due to the 
absence of H-F coupling, both enantiomers of 310 (Table 26, entry 2) and their 
respective E/Z enol forms have been identified by the associated coupling constants 
JFF and JHF but differentiating these two enantiomers by their shifts at this stage is 
impossible using 19F-NMR spectroscopy. The compounds 308 and their respective 
E/Z enol forms (Table 26, entry 3) in addition to the compounds 309a-b (Table 26, 
entries 4-5) have been identified as their shifts give a single coupling H-F but we are 
unable to unambiguously identify each of them at this stage. The ratio 2:1 between 
the 19F-NMR shifts corresponding to compounds 309a (Table 26, entry 4) and the 
bis-monofluorinated compound 309b (Table 26, entry 5) allowed us to identify their 
respective shifts. We also observe that the various shifts obtain match in the large 
majority to the DFT-calculations, as the 19F-NMR shifts obtained by experimental 
processes only differ from DFT-calculated shifts by ± 4 ppm. 
 
 






F-NMR shifts of the corresponding products from direct fluorination of 




19F-NMR shift [ppm] 
J [Hz] Product 
-CF2 -CFH 








4JFF (Zenol) 7.5 
4JFF (Eenol) 18.3 




















Having identified the different shifts for the corresponding mono- and bis-fluorinated 
products, we then applied different synthetic conditions to this fluorination reaction to 
be able to identify which product can be obtained in major proportion depending on 
the amount of F2/N2 used, either higher or lower molar equivalents and higher or 
lower percentage of F2 in N2, but also the length of the reaction and the flow rate. 




Table 27 Fluorination of dimethylacetone-1,3-dicarboxylate in batch using various conditions 
 
Entry 1a 2a 3a 4b 5b 6b 
F2/N2 [%] 10 10 10 20 20 10 
Flow rate [mL/min] 20 40 20 80 20 40 
Reaction time [min] 180 180 300 180 168 168 

















6 8 9 39 29 1 
 
9 20 18 31 29 6 
 
15 17 24 7 14 8 
 
60 47 35 20 21 65 
 
8 8 8 2 7 20 
a
 Reaction achieved on 30 mmol scale; 
b
 Reaction achieved on 25 mmol scale 




The results presented in Table 27 showcased that the major products after applying 
the different tested synthetic conditions are always the bis-mono-fluorinated 
enantiomers 309a (R,S) and (S,R). It clearly appears that more equivalents of F2/N2 
using similar reaction time increased the formation of α-mono-β-di-fluorinated 
isomers 310 (entry 1 compared to entry 2). However, slower addition of F2/N2 
encouraged the formation of α-mono-fluorinated isomers, while still achieving α-
mono-β-di-fluorinated enantiomers 310 formation in higher yields, due to the larger 
molar equivalents of F2/N2. By using forced conditions via F2/N2 (20% v.v
-1), we then 
synthesized more α-mono-β-di-fluoro- and α-difluoro-β-difluoro- products, 
respectively 310 and 303 (entries 4 and 5), whose ratios are more than 50% of the 
overall present products. By a more controlled experiment on the reaction time and 
molar equivalents, we were able to gain the bis-mono-fluorinated enantiomers 309a 
(R,S) and (S,R) as major products again in similar 19F-NMR ratios as entry 1 (entry 
6), with the exception of being able to obtain one-sided bis-mono-fluorinated isomer 
309b in a larger proportion. 
To compare the results with another fluorinating agent, fluorination was achieved 
using Selectfluor®. Indeed the chosen dimethyacetone-1,3-dicarboxylate was mixed 
with THF, and this solution was added to a suspension of NaH in THF, to get the 
resulting suspension stirred at room temperature until no more hydrogen evolved, 
Selectfluor® (2.2 eq.) was then added and the resulting mixture stirred overnight at 
room temperature. After work-up, the crude product was then analyzed by NMR 
spectroscopy and the resulting spectra were compared to the corresponding 
reported 19F-NMR shifts (Table 28). 
The obtained results showed that similar 19F-NMR shifts were obtained for the 
previously listed fluorinated products and the molar equivalents of fluorinating agent 
has a large impact on major products formed. In the case of using Selectfluor®, 










Table 28 Fluorination of dimethylacetone-1,3-dicarboxylate using Selectfluor
®
 and NaH 
 
Entry 1 
NaH [eq.] 1.1 


























At this stage, it appeared impossible to selectively mono-fluorinate and di-fluorinate 
one side of the symmetric tricarbonyl molecule. Therefore, we combined most of our 
obtained fluorinated products from the direct fluorination of dimethylacetone-1,3-
dicarboxylate using F2/N2 and submitted them to a further purification by distillation 




under reduced pressure, in an attempt to purify one product, and we analyzed all the 
different fractions collected by NMR spectroscopy. We indeed managed to separate 
fractions possessing a richer percentage of corresponding fluorinated entities, in 
order of low to high boiling points: bis-α,β-difluoro-richer (303) fractions, followed by 
α-mono-β-difluoro-richer (310) fractions, then bis-α,β-monofluoro-richer (309a-b) 





F-NMR spectroscopic monitoring of the distillation of combined crude products 
from direct fluorination of dimethylacetone-1,3-dicarboxylate 307 using F2/N2 
This distillation strategy included forcing conditions to collect the last fractions under 
reduced pressure, but this gave a large amount of black tar, considerably reducing 
any potential yield. However, it seemed at this stage that working on different 
substrates with a similar molecular scaffold was necessary to gain a better selective 
fluorination methodology. 
We decided to synthesize an asymmetric version of the tricarbonyl molecule, hoping 
for better selectivity at the CH2 positions. The methyl 3,5-dioxohexanoate 323 was 
synthesized by the literature method (Scheme 96) and we then tested different 
conditions of the direct fluorination on this synthesized asymmetric substrate, indeed 















F-NMR spectra of crude product from the direct fluorination of methyl-3,5-
dioxohexanoate 323 with F2/N2 (10% v.v
-1
) (2.2 eq.; top) (1.1 eq.; bottom) 
As predicted, adding more F2/N2 to the reaction mixture allowed us to obtain more 
di-fluorinated products, as the corresponding 19F-NMR shifts (around -115 ppm) 
increased. We were also able to identify the main mono-fluorinated products formed 
after analyzing the multiplicity of the signals (Table 29). 
Table 29 
19
F-NMR shifts of the corresponding mono-fluorinated products from direct 











1 -194.06 (dt) 
2JHF 47.4 
4JHF 3.9  
1 1 
minor 












Summarizing this part of our investigations, we were able to fluorinate symmetric 
and asymmetric tricarbonyl substrates and showed the clear impact of the amount of 
F2/N2 and its corresponding flow rate on the resulting fluorinated products ratios. 
However, at this point, we were looking at an alternative strategy, involving a quick 
modification of the substrate to be able to achieve this fluorination selectively. 
2.3. Towards the fluorination of a one-sided protected asymmetric 
tricarbonyl substrate 
Analyzing the effects of the molecular shape of the tricarbonyl structure, we decided 
to modify the keto-group by protecting it with a dioxolane functional group before 
fluorination. Accessing such an intermediate in a 84% isolated yield was possible by 
a three steps process starting from the commercially available ethyl 2-(2-methyl-1,3-
dioxolan-2-yl) acetate 324 via successful reaction with potassium hydroxide firstly 
and then synthetic conditions using Meldrum’s acid, DCC and DMAP followed by 
mixing in methanol and toluene to access the desired mono-protected tricarbonyl 
system (Scheme 96).[167] 
 
Scheme 96 Synthesis of methyl 4-(2-methyl-1,3-dioxolan-2-yl)-3-oxobutanoate intermediate 
327 from ethyl 2-(2-methyl-1,3-dioxolan-2-yl) acetate 324 
Fluorination of the resulting protected dicarbonyl system 327 was achieved on 
different scales at 0-5 °C using 10 mol% of hydrated copper nitrate catalyst. Table 
30 summarizes the controlled fluorination as assessed using 1H-NMR and 19F-NMR 
sampling. The percentage of the mono-fluoro product was determined by relative 
comparison between the doublet formed for the proton of the -CHF group and the 

























1 10 10 3.2 32.00 130.80 0.13080 0 
2 20 19.5 3.15 61.92 253.12 0.25312 0 
3 30 29 3.13 91.66 374.66 0.37466 0 
4 40 38.5 3.13 121.39 496.20 0.49620 1 
5 50 47 3.12 147.91 604.60 0.60460 3 
6 60 56.5 3.11 177.46 725.37 0.72537 9 
7 70 66 3.12 207.10 846.52 0.84652 25 
8 80 75.5 3.12 236.74 967.67 0.96767 58 
9 90 85 3.13 266.47 1089.22 1.08922 75 
10 100 94.5 3.12 296.11 1210.37 1.21037 84 
a
 Effective time = reaction time – sampling time (0.5 min) (sampling the reaction mixture 




H-NMR spectroscopic follow-up of the mono-fluorination of protected tricarbonyl 
ester 327 
By plotting percentage of monofluoro-product versus time (Figure 46), we can 
observe the amount of mono-fluorinated product formed up to one molar equivalent 
of F2. After that point, di-fluorinated molecule started to form under batch conditions, 
so the fluorination was stopped to avoid any type of further fluorination. 





























F2 molar equivalents [eq.] 




The Figures 47 and 48 show the resulting 19F-NMR and 13C-NMR spectroscopic 
data obtained from the crude fluorination product, revealing that the main product is 
the mono-fluorinated product. Further purification was not possible due to the end of 
the project period but this methodology indicates that using fluorinated tricarbonyl 























3. Nucleophilic substitutions using 2-fluoro-1,3-dicarbonyl 
substrates 
This chapter part is dedicated to the synthesis of SF5-containing aromatics, their 
properties and applications, and our investigations around nucleophilic aromatic 
substitutions (SNAr) and vicarious nucleophilic substitutions (VNS) using 2-fluoro-
1,3-dicarbonyl starting material. This part of the project was carried out with 
collaborators at UOCHB Prague as part of the EU ITN Fluor21. 
3.1. Preparation and utility of organic pentafluorosulfanyl-containing 
compounds 
Organic compounds containing a SF5 functional group possess a unique set of 
physicochemical properties and any SF5-containing molecule represents an 
increasingly interesting structural shape for the design of bioactive compounds. 
However, we noticed a clear lack of synthetic methodologies for the synthesis of SF5 
basic building blocks, especially with low molecular weight. The synthesis of new Ar-
SF5 by derivatization of 1-fluoro-3-nitro-5-(pentafluorosulfanyl)benzene has already 
been reported by the group of Dr. P. Beier.[168,169] 
Properties of aromatic SF5 compounds have been largely showcased recently. 
Among all the different properties that can be enhanced, there are lipophilicity, with 
an increase on a drug’s bioavailability, electronegativity, as such molecules possess 
a stronger -I effect , higher molecular dipole and electronegativity compared to their 
CF3 analogues, and chemical stability. Indeed aromatic-SF5 compounds are 
resistant to hydrolysis and acid attack, and are thermally stable up to 300°C. 
Aromatic SF5 molecules may potentially be used in various fields, such as 
pharmaceuticals, ionic liquids, agrochemicals, explosives, liquid crystals and 
catalysts (Figure 47). In this project, we were particularly interested in the fluorinated 
nitro(pentafluorosulfanyl)benzene scaffold, as this molecular shape represents a 
widely available primary industrial product and good starting material for further 
synthesis of more complex SF5-benzene derivatives. 





Figure 47 Applications of aromatic-SF5 substrates 
The direct fluorination of 1,2-bis(3-nitrophenyl)disulfane has been recently studied 
and is already applied to multi-kilogram scale by F2 Chemicals Ltd. Indeed, there are 
three different pathways to obtain this target molecule in moderate yields, avoiding 
the formation of di-fluorinated by-products (Scheme 97).[170] 
 
Scheme 97 Synthesis of 5-fluoro-3-nitro-1-(pentafluorosulfanyl)benzene using different 
fluorination synthetic strategies (in blue: direct fluorination of 1,2-bis(3-nitrophenyl)disulfane; 
in red: preparative fluorination of 3-nitro-1-(pentafluorosulfanyl)benzene; in green: 
fluorodenitration method) 




Therefore, we directly fluorinate the 3-nitro-1-(pentafluorosulfanyl)benzene 336, as it 
is commercially available, to gain the 5-fluoro-3-nitro-1-(pentafluorosulfanyl)benzene 
337 (Scheme 98). This synthesis was realized in the laboratories of UOCHB in 
Prague using their fluorination facilities while on secondment as part of the Fluor21 
Network.[170] 
 
Scheme 98 Full fluorination process of 1,2-bis(3-nitrophyl)disulfane 
Monitoring the process by GC-MS, this fluorination reaction is only able to provide 
33% yield by GC-MS (Figure 48), which is characteristic from such a transformation, 
as it is important to avoid any formation of di-fluorinated products. Purification of the 
resulting crude mixture by column chromatography allowed us to isolate the 5-
fluoro-3-nitro-1-(pentafluorosulfanyl)benzene 337 in 12% yield. 
 
Figure 48 GC-MS analysis of the resulting crude mixture from fluorination of 3-nitro-1-
(pentafluorosulfanyl)benzene 336 
After obtaining 5-fluoro-3-nitro-1-(pentafluorosulfanyl)benzene 337, we then 









to act as nucleophiles to attempt to attach them to the SF5-scaffold using different 
nucleophilic substitution conditions. 
3.2. Comparison between nucleophilic aromatic substitutions and 
vicarious nucleophilic substitutions involving pentafluorosulfanyl 
benzene derivative 
We based this part of our research on the ability of 2-fluoro-1,3-dimethylmalonate 
and 2-fluoro-ethylacetoacetate to act as potential nucleophiles using nucleophilic 
aromatic (SNAr) substitutions and vicarious nucleophilic substitutions (VNS). As 
previously reported by Ajenjo et al., the use of 5-fluoro-3-nitro-1-
(pentafluorosulfanyl)benzene and different nucleophiles under various basic 
conditions allowed the synthesis of diverse 5-nitro-1-(pentafluorosulfanyl)benzenes 
substituted in the fluoro-position using SNAr processes (Table 30) and 3-fluoro-5-
nitro-1-(pentafluorosulfanyl)benzenes substituted in position four using VNS (Table 
31).[170] 
Table 30 SNAr reactions using 5-fluoro-3-nitro-1-(pentafluorosulfanyl)benzene and various 
nucleophiles by Ajenjo et al. 
 
    
341a, 85% 341b, 83% 341c, 72% 341d, 70% 
   
341e, 51% 341f, 67% 341g, 63% 
    
341h, 67% 341i, 46% 341j, 33% 341k, 44% 








   
342a, 71% (97:3) 342b, 31% (97:3) 342c, 50% (87:13) 
   
342d, 81% (>98:2) 342e, 60% (96:4) 342f, 85% (>98:2) 
a
 Ratio of products determined by GC-MS under 
parentheses
 
We first focused our investigations on finding synthetic conditions to achieve similar 
processes. Using previously synthesized fluorinated malonates and ketoesters, 
Table 32 summarizes the different synthetic conditions and bases that were 
screened. Among all these tested conditions on both 2-fluoro-1,3-dimethylmalonate 
and 2-fluoro-ethylacetoacetate, no conversion of the starting substrates was 
observed in case of using K2CO3 in dry DMF (4 hours at room temperature), 
LiHMDS in dry toluene (2.5 hours at -78 °C), nBuLi in dry THF or dry Et2O (4 hours 
at -78 °C), LDA in dry THF (at -78 °C for 2 hours using 2-fluoro-1,3-
dimethylmalonate or 24 hours using 2-fluoro-ethylacetoacetate) and tBuOK in dry 
DMF (5 hours at -60 °C or at -78 °C). 
The last conditions tested with tBuOK in dry DMF were realized at a higher 
temperature of -40 °C and we then clearly observe by GC-MS the formation of a 
new product. However, from GC-MS and NMR-spectroscopy analysis, it seemed 
that the same product was obtained in both cases, either starting from 1,3-dimethyl-
2-fluoromalonate 62 or 2-fluoro-ethyl acetoacetate 19. 






















































-60 °C 0 
8b 
9a 
-78 °C  0 
9b 
a









To improve the conversion towards significant amount of product, synthetic 
conditions were modified with the addition of NaH in dry THF on a mixture of the 
starting SF5-benzene derivative and 2-fluoro-ethylacetoacetate or 2-fluoro-1,3-
dimethylmaonate, which was then allowed to stir over 19 hours at room 
temperature, then 3 hours at 50 °C followed by a further addition of NaH, to finally 
let the reaction mixture to stir over 20 hours at room temperature. 







F-NMR spectrum of the crude product of SNAr between 2-fluoro-
ethylacetoacetate and 5-fluoro-3-nitro-1-pentafluorosulfanylbenzene using NaH (59-86 ppm) 
The 19F-NMR spectrum of the crude product of the reaction between 5-fluoro-3-nitro-
1-pentafluorosulfanylbenzene and 2-fluoro-ethyl acetoacetate using NaH revealed 
the formation of a new SF5 compound, as a new set of doublet + quintuplet in a ratio 
close to 1:1 compared to the 19F-NMR shifts of the starting SF5 benzene substrate 
appears (Figure 49). The absence of any 19F-NMR shift corresponding to the 
starting 2-fluoro-ethylacetoacetate (around -190/-200 ppm) indicated full conversion 
of the starting fluorinated dicarbonyl compound. Purification by column 
chromatography using petroleum ether and diethylether as eluent system by a 




F-NMR spectroscopy follow-up of the purification of crude product from SNAr 
reaction between 2-fluoro-ethyl acetoacetate and 5-fluoro-3-nitro-1-
pentafluorosulfanylbenzene 







H-NMR spectroscopy follow-up of the purification of crude product from SNAr 
reaction between 2-fluoro-ethyl acetoacetate and 5-fluoro-3-nitro-1-
pentafluorosulfanylbenzene 
A similar reaction using 2-fluoro-1,3-dimethylmalonate as nucleophile gave a similar 
product, which GC-MS analysis and 1H-, 19F- and 13C-NMR spectroscopy showed 
was the methoxylated compound 345a (48% yield) or ethoxylated compound 345b 
(52% yield), respectively from 2-fluoro-1,3-dimethylmalonate or 2-fluoro-ethyl 
acetoacetate (Scheme 99). 
 
Scheme 99 Synthesis of 5-ethoxy-3-nitro-1-pentafluorosulfanylbenzene from 5-fluoro-3-
nitro-1-pentafluorosulfanylbenzene, 2-fluoro-ethylacetoacetate and NaH 
We assume these products were formed by displacement of methoxide or ethoxide 
by base from 2-fluoro-1,3-dimethylmalonate 62 or 2-fluoro-ethyl acetoacetate 19 
respectively and nucleophilic aromatic substitution. Since no VNS reactions were 
observed, no further research was carried out in this area. 





Direct fluorination methodologies on substrates possessing a similar molecular 
scaffold as the previously studied 2-fluoro-1,3-dicarbonyl substrates still remains 
challenging despite all the conducted investigations, especially on the direct 
fluorination of the tricarbonyl systems. However, progress has been made towards a 
more selective strategy to achieve this fluorination pathway using a protection 
synthetic strategy. Unfortunately, using 2-fluoro-1,3-dicarbonyl substrates in SNAr or 
VNS pathways appears to be unsuccessful, despite accessing fluorinated 
pentafluorosulfanyl benzene via an easy fluorination process. Finally, it seems that 
optimizing the purification process of the obtained crude products from direct 
fluorination of functionalized carbonyl systems appears problematic. However, few 
fluorinated products are obtained via this methodology and could entirely be used in 
further research. 
 




Chapter 7 Flow process development and 
applications 
A target of all our different fluorination projects was to develop first a chemical 
approach by using batch processes and then try to adapt optimized synthetic 
strategies to flow processes. This final chapter is dedicated to the many advantages 
of developing flow process methods, especially related to direct fluorination by F2/N2 
(5-20% v.v-1). Therefore, the key points of chemistry in flow, a few significant 
examples and our applications will be presented here. 
1. Flow process strategies in chemistry 
1.1. Key aspects of process and flow chemistry  
Flow chemistry appears more and more to be a competitive alternative to batch 
chemistry for many reasons. The fact that reactions are run continuously by 
pumping and mixing of all inputs, typically in solution phase chemistry, using a 
choice of pumps, reactors, monitoring and quenching as part of the process, has 
many benefits.[171] 
In fact, as a summary, the transition from batch to flow is like moving from a series 
of linked batch vessels to a stream within a flow tube, by choosing different flow 
regimes (laminar with NRe < 2100, turbulent with NRe > 4000), indicated by 
fluctuations in the values of the Reynolds numbers (NRe: Reynolds number, D: pipe 
diameter, V: fluid velocity, ρ: fluid density, μ: fluid viscosity). 
     
     
 
    
Conventional batch chemistry presents many problems. Scalability, in terms of 
reactor size dependence, emptying and cleaning steps, efficiency, reaction kinetics, 
reliability, reproducibility, safety, dealing with hazardous chemicals, monitoring, 
typically done off-line (HPLC and NMR) with a delay between sampling and data 
analysis, cost, especially in case of high development and maintenance cost at 
process scale, and step-efficiency, with a desirable telescoping process, are all 
problems associated with batch chemistry. 




In contrast to all those problems, flow chemistry showcases a better mixing via T-
pieces, micro-chips and specific mixing elements, better heat transfer, better 
selectivity in many reported reactions, and the large advantage of being able to 
handle highly reactive species. Indeed, the use and generation of hazardous 
reagents can be highly restricted in batch processes. The small volumes of flow 
reactors mean that small quantities are generated at any given time. Many different 
examples have been already reported in recent reviews, such as formation of 
azides, diazo/diazonium synthesis, isocyanides formation, nitration and more 
interestingly in our case fluorination.[172] 
In-line purification in flow has also already been developed, from using aqueous 
extraction to distillation, HPLC, crystallization or common scavenger resins. One of 
the main interests of flow process chemistry is the ability to realize a multistep 
synthesis in flow, such as sequential lithiation chemistry. Moreover, multistep 
synthesis in flow enables chemists to telescope individual steps to one single flow 
sequence, combining it with an in-line purification and analysis. 
Conventional flow chemistry is mainly solution phase chemistry done using flow 
equipment such as syringe pump or HPLC-type piston pump (Figure 52), that allow 
various selected flow-rates. 
 
Figure 52 HPLC-type piston pump (left) and syringe pump (right) 
Reactors such as micro-chip reactors, coiled reactors, such as the one presented in 
Figure 53, and oscillating reactors present different options, adapted to various 
reaction volumes and applications. 





Figure 53 Stainless steel coiled tube reactor 
1.2. Continuous flow process strategies 
To exhibit different examples of various flow process strategies that have been 
recently reported, we discuss methods that are close to our related chemistry, 
previously developed in batch in chapter 2 to 6, i.e. reactions involving dicarbonyl 
scaffolds or Mannich-type processes. 
 
Scheme 100 Flow process synthesis of (S)-Baclofen precursor 
Among all the different examples that have been reported on flow chemistry 
involving dicarbonyl systems, we were particularly interested in the (S)-Baclofen 
synthesis, as it involves derivatized olefins that were attached to the chosen 
dicarbonyl systems, which is a strategy related to Mannich-type chemistry method 
we developed earlier. The (S)-Baclofen precursor 348 was synthesized by 
stereoselective Michael addition of diethylmalonate to 4-chloro-β-styrene promoted 
by Takemoto catalyst under flow conditions. Reaction conditions have been 
screened and developed by Maggini and coworkers in a 10 μL glass microreactor 
and the scale-up was carried out in a 400 μL PTFE tubing (Scheme 100). The 




residence time was shown to be around 5 min for a temperature of 80 °C, affording 
the desired intermediate with 85% yield and 81% enantiomeric excess.[173] 
For Mannich-type flow process reactions, in 2013, M. A. Pericàs et al. developed 
asymmetric anti-Mannich reactions in continuous flow using a packed bed reactor, a 
tubular reactor paced with solid catalyst particles based on a polystyrene-supported 
pyrrolidine-based catalyst. However, despite showing very high activity and 
excellent stereoselectivity, many disadvantages such as undesired thermal 
gradients, poor temperature control, channeling problems and difficult cleaning of 
the unit were discovered.[174] 
Consequently, polymer-supported threonine and proline derivatives were reported to 
catalyze three component Mannich reaction in batch and also particularly in flow 
(Scheme 101).[175] 
 
Scheme 101 Continuous flow enantioselective three-component anti-Mannich reactions 
catalyzed by a polymer-supported threonine derivative 
The main interest of our research has been to conduct direct fluorination in flow and 
adapt it to the different projects that have previously been elaborated. Examples of 
fluorination in flow are outlined below. 
2. Development of flow processes involving continuous 
flow fluorinations using F2 
2.1. Fluorination chemistry in flow 
A basic micro-reactor has been developed at Durham University (Figure 54), 
allowing the control of the delivery of fluorine at one end of the reaction chamber by 
an accurate electronic mass-flow controller whereas reagents were delivered 
downstream by syringe pumping. Gas and liquid mixtures are thus flowing down the 
micro-channel in a laminar flow, improving the fluorination processes.[176] 





Figure 54 Design of single channel reactor
 
This micro-reactor was designed to achieve a variety of different fluorinations in 
flow. Scale-out of this micro-reactor was investigated. An efficient multi-channel 
micro-reactor system was designed, that can be used for larger scale uses, allowing 
the introduction of fluorine and substrate into many channels from one source and 
commercial systems for gas-liquid reactions are now available (Figure 55).[177] 
 
Figure 55 Schematic representation of modular micro-reactor device 
A continuous flow approach has also been investigated from 1,3-diethylmalonate as 
starting substrates in acetonitrile, but gave poor selectivity between mono- and di-
fluorinated products (Scheme 102).[178] But, choosing Meldrum’s acid, also known as 
2,2-dimethyl-1,3-dioxane-4,6-dione, as starting compound, allows a mixture of mono 
and di-fluorinated products to be obtained and separated after work-up (Scheme 
103).[179] 





Scheme 102 Results of direct fluorination of diethylmalonate 
 
Scheme 103 Continuous flow fluorination of Meldrum’s acid 
A one-step continuous flow process involving the reaction of inexpensive cytosine 
with fluorine gas has been recently reported by Harsanyi et al. showing various 
advantages, such as a one-step route, a continuous process, high yield, simple 
purification, API purity (Scheme 104). Last but not least, this process was using 
stainless steel tubular laboratory and pilot-scale silicon carbide reactor devices 
which is readily scalable to a manufacturing process with a low initial capital 
expenditure.[180] 
 
Scheme 104 One-step continuous flow synthesis of antifungal WHO essential medicine 
Flucytosine using fluorine 
Following the previously described chemical flow process, fluorination of diketones 
has been recently investigated, affording cyclization of the intermediate fluoro-
diketone by reaction with hydrazine derivatives, added to the reagent stream by a T-
piece, in a two-step sequential flow-process, giving access to new 4-fluoropyrazoles 
(Figure 56).[68] 










2.2. Synthetic flow process methodology on multi-carbonyl systems 
In this research project, we attempted to develop previously optimized reactions 
discussed in chapters 2-6 to a flow process using helicoïdal stainless steel flow 
reactors and PTFE tubing reactors. The synthetic method presented in this study 
uses helicoïdal reactors with a retention time of 2 to 5 min depending on the flow 
rate and the length of reactors being used. Indeed our approach was to develop a 
shortly timed, non-heated and non-catalyzed option of the synthesis of Mannich-type 
products by a flow process able to involve a continuous flow fluorination step without 
impacting the efficiency of the multi-component reaction (Figure 57). We therefore 
designed our own two-step flow-process system to achieve such transformations. 
 
Figure 57 Schematic flow process system applied to Mannich-type multicomponent 
reactions 
Unfortunately, the only limitations to this process have been proved to be the use of 
copper nitrate as a catalyst during the fluorination step of the 1,3-dimethymalonate, 
which was causing PTFE tubing blocks, meaning that the full two-steps process was 




only applied to the synthesis of β-fluoro(dicarbonyl)ethylamines from 2-fluoro-
ethylacetoacetate. 
Following optimization of continuous flow reactions of ethyl fluoro-ethylacetoacetate 
with amine/formaldehyde mixtures in a one-step liquid-liquid flow process (Table 
33), we adapted our synthetic procedure described above to a two-step gas-liquid, 
liquid-liquid semi-continuous flow process using stainless steel coiled tube reactors 
(previously presented in Figure 53). A schematic diagram of the process is shown in 
Figure 57. 
Fluorine gas in nitrogen was introduced into input 1 of the first coiled steel tube 
reactor and flowed along the tube concurrently with ethyl acetoacetate which was 
simultaneously added to the reactor system via inlet 2. The flow of the gaseous 
reactant stream was controlled by gas mass flow-meter and the liquid dicarbonyl 
reagent solution was introduced by HPLC pump so that the fluorine gas : dicarbonyl 
addition ratio was ca.1.3 : 1. The flow rate of each reagent was adjusted to ensure a 
retention time of 2 to 5 min of the substrate within the tubular reactor. The crude 
product mixture for the fluorination reaction was collected in a gas liquid separator 
flask where liquid is collected and gaseous waste passed through a scrubbing tower 
filled with soda-lime. The crude fluoro-dicarbonyl product mixture was then pumped 
without any work-up procedure directly into input 3 of the second continuous flow 
coiled steel tube reactor while, simultaneously, a solution containing the amine and 
aldehyde solution was added at a controlled flow rate. The crude product mixture for 
the two-step one continuous flow process was collected in Collection vessel 2 and, 
following work-up, allowed the Mannich products to be isolated in good yield and 
purity confirming the efficiency of this flow-process strategy (Table 34). 
 
 




Table 33 Three-component Mannich-type flow process reaction of 2-fluoro-ethyl 
acetoacetate, formaldehyde and a chosen amine 
 






















273i, 95 95 
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Table 34 Synthesis of β-fluoro(dicarbonyl)alkylamines 273 from ethyl acetoacetate, amines 
264 and formaldehyde by semi-continuous flow process 
 
Entry R3 R4 Yield [%]a 
1 CH2CH3 CH2CH3 273e, 71 
2 iPr iPr 273f, 43 
3 -(CH2)4- - 273g, 55 
4 -(CH2)5- - 273h, 59 
5 Bn CH3 273i, 67 
a
 Isolated 
Combined gas-liquid/liquid-liquid sequential flow reaction using fluorine gas have not 
been well developed and only examples demonstrating the synthesis of 
fluoropyrazole derivatives have been recorded,[181] as previously mentioned, but the 
reasonable yields of Mannich products 273 obtained from fluorine, ketoester and 
aminal inputs in the two-step semi-continuous flow process offers further 
opportunities for process intensification of synthetic strategies using fluorine gas. 
Using this flow-process set-up has been tested on the two other projects we 
developed earlier in this report, indeed the CAN-mediated addition of olefin on 2-
fluoro-1,3-dicarbonyl systems and the synthesis of fluorinated functionalized 
pyrimidinones but none of these processes were successful due to the presence of 
residual catalyst preventing any significant flow in the first case and the low solubility 
of the amidines involved in these synthetic pathways in the second case. 
2.3. Fluorination in flow of dimethylacetone-1,3-dicarboxylate 
We also investigated the possibility of achieving the direct fluorination of tricarbonyl 
substrates, as we previously presented its fluorination in batch. Therefore, we were 
using a similar set-up as the first fluorination step of the combined MCR process but 
this time analyzing the different products formed inside the collecting flask by NMR 
spectroscopy. The Table 35 is presenting the various results obtained in different 
conditions of flow and percentages of F2 in N2. 




Table 35 Results of fluorination of dimethylacetone-1,3-dicarboxylate in flow using various 
conditions 
 
Entry 1 2 3 4 
F2/N2 [%] 10 10 10 20 
Flow rate [mL/min] 20 30 40 20 

















12 20 19 19 
 
3 8 8 8 
 
8 6 9 8 
 
63 53 51 52 
 
14 13 13 13 
These collected results showed that a better contact between the reactans inside 
the PTFE tubings provided a larger amount of α,β-bis-mono-fluorinated isomers 




309a-b, but also a larger amount of the directly α,β-bis-di-fluorinated product 303, 
where the batch processes were allowing us to gain access more easily to the α-
mono-β-bis-di-fluorinated isomers 310. Despite this larger amount of tetrafluoro 
products 303, the major products were obtained in more than 60% 19F-NMR ratio in 
all cases, showing that fluorination in flow still remains a better strategy compared to 
the batch process in this case. 
3. Conclusion 
The different advantages of a flow process synthetic strategy over the classic batch 
reactions have been showcased, especially in the case of handling toxic entities 
such as fluorine. Here, we exhibit that this method can perfectly be adapted to the 
direct fluorination of tricarbonyl substrates or multi-component processes, such as 
the Mannich-type reactions. 




Chapter 8 Conclusions and future work 
In this thesis, we presented the various advantages of organofluorine chemistry and 
its multiple applications and firstly described the synthesis of fluorinated dicarbonyl 
molecules using a direct fluorination strategy. Starting from these fluorinated 1,3-
dicarbonyl substrates, we achieved the synthesis of various fluorinated heterocyclic 
systems such as fluoro-pyrimidinones, and, therefore, built a full library of fluorinated 
pyrimidine fragments with various functionalizations. Thanks to our research 
partners at both University of Vienna and UCD Dublin, we were able to study their 
potential activity against β-catenin and their role in biotransformation involving C. 
elegans. 
Radical chemistry was then tested using different catalytic systems to achieve the 
oxidative addition of olefins to the 2-fluoro-1,3-dicarbonyl substrates. Among the 
different tested methodologies, Mn(OAc)3- and CAN-mediated oxidative addition of 
olefins to 2-fluoro-ketoester provided the most successful results. 
As part of the development of new synthetic methods towards fluorinated building-
blocks, we then reported succesful multi-component strategies involving either 2-
fluoroethylacetoacetate or 2-fluoro-1,3-dimethylmalonate as part of a Mannich-type 
reaction pathway using various amines and aldehydes. 
The direct fluorination of various functionalized carbonyl compounds, including 
tricarbonyl systems was then performed and spectroscopic studies have been 
conducted to identify the different products formed. A synthetic methodology 
towards protected tricarbonyl substrates has been developed and we obtained first 
encouraging results by applying them to our direct fluorination process. 
Last but not least, the development of a flow process system combined the 
fluorination step and further transformations, and this methodology proved to be 
more efficient than the usual batch strategy to synthesize Mannich-type reaction 
products in relatively convenient yields. Extension of flow process methodology to 
the use of various dialdehydes as part of MCR synthetic strategy, in addition to the 
potential use of fluorinated tricarbonyl systems, could allow the access of more 
sophisticated fluorinated compounds. 





Scheme 105 Potential synthetic options from fluorinated tricarbonyl molecules (synthetic 
pathways already developed in case of using 2-fluoro-1,3-dicarbonyl substrates) 
One of the area for potential future research is the further exploration of direct 
fluorination of various multi-carbonyl systems, potentially tested with other catalysts 
than copper, and the application of such fluorinated tricarbonyl substrates to the 
processes that have been previously developed with 2-fluoro-1,3-dicarbonyl 
molecules, either the synthesis of diverse fluorinated pyrimidinones, the radical 
oxidative addition of styrene-derivated olefins or any multicomponent reactions 
(Scheme 105). 
Our work on radical chemistry has been largely focused on developing a convenient 
process using 1,3-dimethyl-2-fluoromalonate but most of our successful results have 
been obtained when simple fluorinated keto-esters were chosen as substrates. 
Therefore, it opens an area for future research on the development of oxidative 
addition of olefins on more complex fluorinated keto-esters using various radical 
initiators, potentially deriving from the previously described cerium(IV) reagent. 
Aside of this work, developing other multicomponent reactions involving fluorinated 
dicarbonyl systems still remains an interesting challenge, firstly because this type of 
building-blocks often appears in such synthetic strategies but also because these 
synthetic pathways can be adapted in both batch and flow processes. 




Chapter 9 Experimental 
1. General experimental and instrumentation 
NMR Spectroscopy  
Proton, fluorine and carbon nuclear magnetic resonance spectra (1H, 19F, 13C NMR) 
were obtained using a Bruker 400 Ultrashield spectrometer (1H NMR at 400 MHz, 
19F NMR at 376 MHz and 13C NMR at 101 MHz) and a Varian VNMRS-700 
spectrometer (1H NMR at 700 MHz; 13C NMR at 176 MHz) using residual solvent 
peaks as the internal standard (1H NMR; CDCl3 at 7.26 ppm, 
19F NMR; CFCl3 at 
0.00 ppm and 13C NMR; CDCl3 at 77.16 ppm). NMR spectroscopic data are reported 
as follows: chemical shift (ppm), integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quarter, m = multiplet), coupling constant (Hz) and assignment.  
Mass spectrometry 
GC-MS data were obtained using a Shimadzu QP2010-Ultra equipped with a Rxi-
17Sil MS column (0.15 μm x 10 m x 0.15 mm) under electron ionisation (EI) 
conditions at 70 eV using helium as a carrier gas. Liquid chromatography mass 
spectra (LC-MS) were obtained on a TQD mass spectrometer equipped with an 
Acquity UPLC BEH C18 1.7 μm column (2.1 mm x 50 mm). Accurate mass analysis 
was performed on a Xevo QtoF mass spectrometer (Waters Ltd, UK) with an 
accurate solids analysis probe (ASAP) or a TQD UPLC (Waters) instrument 
operating in electrospray ionization mode. Flash column chromatography purification 
was performed using Silicagel LC60A (40-63 micron). 
IR Spectroscopy, Melting Points and Reagents 
Infrared spectra were recorded on a Perkin Elmer Spectrum 2 FT-IR spectrometer at 
25 °C and melting points were obtained using a Gallencamp melting point apparatus 
at atmospheric pressure. All the chemicals and solvents used were commercially 
purchased from Alfa Aesar, Apollo Scientific, Fluorochem or Sigma Aldrich and, 
unless otherwise stated, were used without any further purification. 
Fluorination set-up 
Fluorinations were carried out in a glass fluorination reactor (100 mL, 250 mL or 500 
mL) unless otherwise stated. The reactor was built from a standard glass bottle with 




GL 45 thread joint and a PTFE screw cap or a glass flange head, equipped with a 
gas inlet/outlet head built of stainless steel, PTFE and FEP Swagelok components. 
Vacuum distillations were carried out using Fisher® micro Spaltrohr®-column MMS 
255 with manual fraction collection. Brooks instruments®- gas mass flow controllers 
were used to control the various flow rates of the corresponding fluorination 
processes. 
2. Experimental to chapter 2 
2-Fluoro-1,3-dimethylmalonate, 62 
Cu(NO3)2·2.5H2O (10.16 g, 43.7 mmol) was added to a solution of 
acetonitrile (550 mL) and 1,3-dimethyl malonate (57.73 g, 437 
mmol) and added to a glass reaction vessel with a PTFE-coated 
mechanical stirrer bar. The reaction vessel was purged with nitrogen for five minutes 
and cooled to 5 °C, before F2 (20% F2/N2 v.v
-1, 220 mmol) was passed through the 
reaction solution at a flow rate of 44 mmol/h for 5 hours. After the reaction had 
progressed to completion, checked by 19F-NMR spectroscopy, the fluorine supply 
was switched off and the reaction vessel was purged with nitrogen for five minutes. 
The reaction mixture was then concentrated in vacuo, dissolved in ethyl acetate (20 
mL), washed with water (3 x 20 mL) and brine (3 x 20 mL) and dried with anhydrous 
magnesium sulfate. The filtrate was again concentrated in vacuo and distilled under 
reduced pressure (4 mbar, 66 °C) yielding 2-fluoro-1,3-dimethylmalonate 62 (85%, 
>98% purity) as a clear oil. 1H NMR (400 MHz, CDCl3) δH 5.31 (1H, d, J = 48.0 Hz, -
C(F)H-), 3.85 (6H, s, 2 x OCH3). 
19F NMR (376 MHz, CDCl3) δF -195.4 (1F, d, J = 
48.0 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 164.3 (d, J = 24.3 Hz, 2 x -
C(O)OCH3), 85.1 (d, J = 196.5 Hz, -C(F)-), 53.3 (s, 2 x –OCH3). MS (ESI) m/z 151 
([M+H]+, 100%). HRMS (ESI) calcd for [M+H]+ C5H8O4F 151.0407; found 151.0388. 
The spectroscopic data is in agreement with assignments reported in the 
literature.[57] 
 




3. Experimental to chapter 3 
3.1. Synthesis of fluorinated pyrimidines from 2-fluoro-1,3-
dimethylmalonate 
General Procedure  
Sodium (0.92 g, 40 mmol) was dissolved in MeOH (100 mL) in a two-necked 250 
mL flask, and amidine hydrochloride and a solution of 2-fluoro-1,3-dimethylmalonate 
62 in acetonitrile (30 mL) were added. The resulting mixture was stirred at 80 oC for 
16 h and cooled to rt before the addition of dilute aqueous HCl (4 mL, 6 M, 24 
mmol). The mixture was filtered and the filtrate was concentrated in vacuo and 
washed with ethanol. The resulting solution was filtered, the filtrate was 
concentrated for a second time, washed with ethanol and filtered again to yield the 
desired fluorinated pyrimidine. 
5-Fluoro-2-phenylpyrimidine-4,6-diol, 111d  
2-Fluoro-1,3-dimethylmalonate 62 (3.03 g, 20 mmol) and 
benzamidine hydrochloride (3.12 g, 20 mmol) gave 5-fluoro-2-
phenylpyrimidine-4,6-diol (3.64 g, 88%) as a yellow powder; mp > 
250 °C. 1H NMR (400 MHz, DMSO-d6) δH 8.03 – 7.94 (2H, m, 2 x 
Hortho), 7.50 – 7.32 (3H, m, 2 x Hmeta + Hpara), 3.80 – 3.20 (2H, br s, OH). 
19F NMR 
(376 MHz, DMSO-d6) δF -180.7 (s, -C(F)-). 
13C NMR (101 MHz, DMSO-d6) δC 157.3 
(d, J = 15.5 Hz, -C(OH)-), 151.5 (d, J = 6.9 Hz, -C-C(CH)5-), 132.5 (d, J = 235.3 Hz, -
C(F)-), 132.2 (-C-C(CH)5-), 131.8 (Cpara), 129.0 (Cmeta), 128.1 (Cortho). MS (ASAP) 
m/z 207 ([M+H]+, 100%), 208 ([M+2H]+, 15.6%). HRMS (ASAP) calcd for [M]+ 
C10H7N2O2F 206.0492; found 206.0495. IR (neat, cm
-1) 2637, 1626, 1581, 1511, 
1445, 1322. 
5-Fluoro-2-(pyridin-2-yl)pyrimidine-4,6-diol, 111c 
2-Fluoro-1,3-dimethylmalonate 62 (2.27 g, 15 mmol) and pyridine-2-
carboxamidine hydrochloride (2.36 g, 15 mmol) gave 5-fluoro-2-
(pyridin-2-yl)pyrimidine-4,6-diol (1.95 g, 63%) as a yellow powder; 
mp > 250 °C. 1H NMR (600 MHz, D2O) δH 8.38 (1H, ddd, J = 4.9,
 
1.8, 0.9 Hz, -C-CHCHCHCH-N-), 7.79 (1H, dt, J = 8.0, 1.2 Hz, -C-CHCHCHCH-N-), 
7.74 (1H, td, J = 8.0, 1.8 Hz, -C-CHCHCHCH-N-), 7.28 (1H, ddd, J = 7.7, 4.9, 1.2 
Hz, -C-CHCHCHCH-N-). 19F NMR (376 MHz, D2O) δF -181.0 (s, -C(F)-). 
13C NMR 




(176 MHz, D2O) δC 164.4 (d, J = 12.5 Hz, 2 x –C(OH)-), 157.0 (d, J = 9.6 Hz, -C-C-
(CH)4-N-), 155.0 (-C-C-(CH)4-N-), 148.4 (-C-CHCHCHCH-N-), 137.9 (-C-
CHCHCHCH-N-), 137.0 (d, J = 230.3 Hz, -C(F)-), 124.3 (-C-CHCHCHCH-N-), 
123.13 (-C-CHCHCHCH-N-). MS (ASAP) 208 ([M+H]+, 100%), 209 ([M+2H]+, 27%). 
HRMS (ASAP) m/z calcd for [M]+ C9H6N3O2F 207.0444; found 207.0431. IR (neat, 
cm-1) 3282, 2521, 1640, 1604, 1327, 1283. 
2-Cyclopropyl-5-fluoropyrimidine-4,6-diol, 111e 
2-Fluoro-1,3-dimethylmalonate 62 (0.60 g, 4.0 mmol) and 
cyclopropyl-carboxamidine hydrochloride (0.48 g, 4.0 mmol) gave 
2-cyclopropyl-5-fluoropyrimidine-4,6-diol (0.55 g, 81%) as a pale 
yellow powder; mp > 250 °C. 1H NMR (700 MHz, D2O) δH 1.57 – 
1.49 (1H, m, -C-CH(CH2)2-), 0.67 – 0.66 (4H, m, -C-CH(CH2)2-), 0.65 – 0.64 (2H, m, 
-C-CH(CH2)2-). 
19F NMR (376 MHz, D2O) δF -185.0 (s, -C(F)-). 
13C NMR (176 MHz, 
D2O) δC 164.4 (d, J = 9.3 Hz, -C-CH(CH2)2-), 164.3 (d, J = 12.3 Hz, 2 x -C(OH)-), 
135.3 (d, J = 223.1 Hz, -C(F)-), 16.37 (-C-CH(CH2)2-), 7.27 (-C-CH(CH2)2-). MS 
(ASAP) m/z 171 ([M+H]+, 100%). HRMS (ASAP) calcd for [M]+ C7H8N2O2F 
171.0570; found 171.0567. IR (neat, cm-1) 2621, 1621, 1536, 1325, 1283, 1176. 
5-Fluoro-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diol, 111f 
2-Fluoro-1,3-dimethylmalonate 62 (3.75 g, 25 mmol) and 1H-1,2,4-
triazole-1-carboxamidine hydrochloride (3.69 g, 25 mmol) gave 5-
fluoro-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diol (2.81 g, 57%) as a 
pale pink solid; mp > 250 oC. 1H NMR (400 MHz, D2O) δH 9.10 (1H, 
s, -N-CH-N-CH-N-), 8.26 (1H, s, -N-CH-N-CH-N-), 3.70-3.10 (2H, br s, 2 x OH). 19F 
NMR (376 MHz, DMSO-d6) δF -177.1 (s, -C(F)-). 
13C NMR (101 MHz, DMSO-d6) δC 
164.7 (d, J = 14.3 Hz, -C-N-CH-N-CH-N-), 151.7 (-N-CH-N-CH-N-), 151.3 (J = 29.8 
Hz, 2 x -C(OH)-), 143.6 (-C-N-CH-N-CH-N-), 136.1 (d, J = 225.3 Hz, -C(F)-). MS 
(ASAP) m/z 197 ([M]+, 21%), 198 ([M+H]+, 100%). HRMS (ASAP) calcd for [M]+ 
C6H4N5O2F 197.0349; found 197.0341. IR (neat, cm
-1) 2981, 1561, 1508, 1445, 
1116. 
 




3.2. Synthesis of fluorinated pyrimidines from 2-fluoro-
ethylacetoacetate 
General Procedure  
Sodium (0.92 g, 40 mmol) was dissolved in MeOH (100 mL) in a two-necked 250 
mL flask and amidine hydrochloride and a solution of 2-fluoro-ethylacetoacetate 19 
in acetonitrile (30 mL) were added. The resulting mixture was stirred at 80 oC for 16 
h and cooled to r.t. before the addition of dilute aqueous HCl (4 mL, 6 M, 24 mmol). 
The mixture was filtered and the filtrate was concentrated in vacuo and washed with 
ethanol. The resulting solution was filtered, the filtrate was concentrated for a 
second time, washed with ethanol and filtered again to yield the desired fluorinated 
pyrimidine. 
5-Fluoro-6-methyl-2-phenylpyrimidin-4-ol, 119d  
2-Fluoro-ethylacetoacetate 19 (, 4.55 g, 30 mmol) and benzamidine 
hydrochloride (4.68 g, 30 mmol) gave 5-fluoro-6-methyl-2-
phenylpyrimidin-4-ol (5.51 g, 91%) as a white powder; mp 202 – 
203 °C. 1H NMR (400 MHz, D2O) δH 7.87 – 7.82 (2H, m, 2 x Hortho), 
7.46 – 7.40 (3H, m, 2 x Hmeta + Hpara), 2.26 (3H, d, J = 3.0 Hz, -CH3). 
19F NMR (376 
MHz, D2O) δF -159.0 (q, J = 3.0 Hz, -C(F)-). 
13C NMR (101 MHz, D2O) δC 165.3 (d, J 
= 14.3 Hz, -C(OH)-), 160.4 (d, J = 8.3 Hz, -C-C-(CH)5-), 148.4 (d, J = 16.3 Hz, -
C(CH3)-), 146.8 (d, J = 247.5 Hz, -C(F)-), 137.8 (-C-C-(CH)5-), 129.7 (Cpara), 128.4 
(Cmeta), 127.8 (Cortho), 15.1 (-C(CH3)-). MS (ASAP) m/z 204 ([M]
+, 15%), 205 
([M+H]+, 100%), 206 ([M+2H]+, 22%). HRMS (ASAP) m/z calcd for [M+H]+ 
C11H10N2OF 205.0777; found 205.0782. IR (neat, cm
-1) 2962, 1652, 1614, 1543, 
1313. 
5-Fluoro-6-methyl-2-(pyridine-2-yl)pyrimidin-4-ol, 119c  
2-Fluoro-ethylacetoacetate 19 (2.22 g, 15 mmol) and pyridine-2-
carboxamidine hydrochloride (2.36 g, 15 mmol) gave 5-fluoro-6-
methyl-2-(pyridine-2-yl)pyrimidin-4-ol (2.81 g, 91%) as a dark 
yellow powder; mp 182 – 184 °C. 1H NMR (400 MHz, D2O) δH 8.45 
(1H, ddd, J = 4.9, 1.7, 1.1 Hz, -C-CHCHCHCH-N-), 7.84 – 7.76 (2H, m, -C-
CHCHCHCH-N-), 7.36 (1H, ddd, J = 6.4, 4.9, 2.6 Hz, -C-CHCHCHCH-N-), 2.20 (3H, 
d, J = 3.0 Hz, -CH3). 
19F NMR (376 MHz, D2O) δF -157.1 (q, J = 3.0 Hz, -C(F)-).
 13C 
NMR (101 MHz, D2O) δC 165.3 (d, J = 14.3 Hz, -C(OH)-), 158.3 (d, J = 8.5 Hz, -C-C-




CHCHCHCH-N-), 154.2 (-C-CHCHCHCH-N-), 148.7 (d, J = 14.1 Hz, -C(CH3)-), 
148.5 (-C-CHCHCHCH-N-), 147.4 (d, J = 220.2 Hz, -C(F)-), 138.0 (-C-CHCHCHCH-
N-), 124.7 (-C-CHCHCHCH-N-), 123.3 (-C-CHCHCHCH-N-), 15.3 (-C(CH3)-). MS 
(ASAP) m/z 206 ([M+H]+, 100%), 207 ([M+2H]+, 29%). HRMS (ASAP) m/z calcd for 
[M+H]+ C10H9N3OF 206.0730; found 206.0730. IR (neat, cm
-1) 2981, 1665, 1615, 
1459, 1426. 
2‐Cyclopropyl‐5‐fluoro‐6‐methylpyrimidin‐4‐ol, 119e 
2-Fluoro-ethylacetoacetate 19 (0.74 g, 5.0 mmol) and 
cyclopropylcarboxamidine hydrochloride (0.60 g, 5.0 mmol) gave 
2‐cyclopropyl‐5‐fluoro‐6‐methylpyrimidin‐4‐ol (0.82 g, 97%) as a 
white powder; mp > 250 °C. 1H NMR (400 MHz, D2O) δH 2.08 (3H, d, 
J = 3.0 Hz, -C(CH3)-), 1.72 (1H, tt, J = 8.2, 5.0 Hz, -C-CH(CH2)2-), 0.84 – 0.69 (4H, 
m, -C-CH(CH2)2-). 
19F NMR (376 MHz, D2O) δF -161.0 (q, J = 2.8 Hz, -C(F)-). 
13C 
NMR (176 MHz, D2O) δC 166.1 (d, J = 8.0 Hz, -C-CH(CH2)2-), 165.3 (d, J = 14.3 Hz, -
C(OH)-), 147.7 (d, J = 15.9 Hz, -C(CH3)-), 146.1 (d, J = 243.8 Hz, -C(F)-), 16.5 (-C-
CH(CH2)2-), 14.9 (d, J = 2.8 Hz, -C(CH3)-), 8.0 (-C-CH(CH2)2-). MS (ASAP) m/z 169 
([M+H]+, 100%). HRMS (ASAP) m/z calcd for [M+H]+ C8H10N2OF 169.0777; found 
169.0768. IR (neat, cm-1) 2467, 1682, 1374, 1286, 1181. 
3.3. Synthesis of chlorinated 5-fluoropyrimidines 
4,6-Dichloro-5-fluoro-2-phenylpyrimidine, 104d  
5-Fluoro-2-phenylpyrimidine-4,6-diol 111d (0.41 g, 2.0 mmol) was 
added to a stirred solution of POCl3 (4.60 g, 30 mmol) and N,N-
dimethylaniline (0.24 g, 2.0 mmol) and heated at reflux temperature 
for 3 h. The reaction mixture was cooled to r.t. and added dropwise 
to a vigorously stirred bath of ice and brine. The mixture was filtered and the filtrate 
was extracted with EtOAc (3 x 30 mL), washed with brine (3 x 30 mL) and dried with 
anhydrous magnesium chloride. The solvent was evaporated under reduced 
pressure and the residue was recrystallised in water/acetone to yield 4,6-dichloro-5-
fluoro-2-phenylpyrimidine (0.15 g, 31%) as a yellow solid. 1H NMR (400 MHz, 
CDCl3) δH 7.39 – 7.28 (2H, m, 2 x Hortho), 6.89 – 6.80 (3H, m, 2 x Hmeta + Hpara). 
19F 
NMR (376 MHz, CDCl3) δF -129.9 (s). 
13C NMR (101 MHz, CDCl3) δC 159.8 (d,
 J = 
10.1 Hz, -C-C-(CH)5-), 148.5 (d, J = 18.1 Hz, -C(Cl)-), 148.4 (d, J = 271.7 Hz, -C(F)-
), 134.3 (-C-(CH)5-), 131.9 (Cpara), 128.8 (Cmeta), 128.7 (Cortho). MS (ASAP) m/z 243 




([M+H]+, 100.0%), 242 ([M]+, 36.1%). HRMS (ASAP) m/z calcd for [M+] C10H5N2FCl2 
241.9814; found 241.9823. 
General procedure for compounds 104c to 123e 
5-Fluoropyrimidine-4,6-diol or 5-fluoro-6-methylpyrimidin-4-ol (for amounts, see 
compound experimentals) was added to a solution of POCl3 (10 – 20 eq.) and 
stirred at r.t. for 15 min under argon. The solution was then heated to 80 oC and 
triethylamine (1.1 eq. per -OH group) was added dropwise over 45 min. The reaction 
mixture was then stirred at 80 °C for a further 45 minutes before being cooled to rt 
and added slowly to a vigorously stirred bath of brine and ice. The mixture was 
filtered and the filtrate was extracted with EtOAc (3 x 30 mL), washed with brine (3 x 
30 mL) and dried with anhydrous magnesium sulfate. The solvent was evaporated 
under reduced pressure and the resulting solid was purified by recrystallization in 
hexane/CHCl3 to yield the desired chlorinated 5-fluoropyrimidine product. 
4,6-Dichloro-5-fluoro-2-(pyridine-2-yl)pyrimidine, 104c 
5-Fluoro-2-(pyridine-2-yl)pyrimidine-4,6-diol 111c (1.45 g, 7.0 mmol), 
POCl3 (9.8 mL, 16.10 g, 105 mmol), benzyltriethylammonium 
chloride (3.64 g, 16 mmol) and triethylamine (2.23 mL, 1.62 g, 16 
mmol) gave 4,6-dichloro-5-fluoro-2-(pyridine-2-yl)pyrimidine (0.46 g, 
27%) as a yellow crystalline solid; mp 87 – 89 °C. 1H NMR (400 MHz, CDCl3) δH 
8.83 (1H, ddd, J = 4.8, 1.8, 0.9 Hz, -C-CHCHCHCH-N-), 8.42 (1H, dt, J = 8.0, 1.1 
Hz, -C-CHCHCHCH-N-), 7.85 (1H, td, J = 7.8, 1.8 Hz, -C-CHCHCHCH-N-), 7.43 
(1H, ddd, J =  7.6, 4.8, 1.2 Hz, -C-CHCHCHCH-N-). 
19F NMR (376 MHz, CDCl3) δF -
126.9 (s, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 158.3 (d, J = 9.9 Hz, -C-C-
CHCHCHCH-N-), 151.5 (-C-CHCHCHCH-N-), 150.4 (-C-CHCHCHCH-N-), 149.5 (d, 
J = 276.7 Hz, -C(F)-), 149.2 (d, J = 18.0 Hz, -C(Cl)-), 137.2 (-C-CHCHCHCH-N-), 
125.7 (-C-CHCHCHCH-N-), 124.2 (-C-CHCHCHCH-N-). MS (EI) m/z 243 ([M]+, 
100%), 208 ([M-Cl]+, 84%), 78 ([C6H6]
+, 91%). HRMS (ASAP) m/z calcd for [M+H]+ 
C9H5N3FCl2 243.9845; found 243.9836. IR (neat, cm
-1) 3056, 1582, 1524, 1405, 
1344, 995. 
4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine, 104e 
2-Cyclopropyl-5-fluoropyrimidine-4,6-diol 111e (0.43 g, 2.5 mmol), 
POCl3 (4.66 mL, 3.83 g, 50 mmol) and triethylamine (0.77 mL, 0.56 g, 
5.5 mmol) gave 4,6-dichloro-2-cyclopropyl-5-fluoropyrimidine as a 




white crystalline solid (0.19 g, 37%); mp 37 – 38 oC. 1H NMR (400 MHz, CDCl3) δH 
2.21 – 2.18 (1H, m, -C-CH(CH2)2-), 1.19 – 1.08 (4H, m, -C-CH(CH2)2-). 
19F NMR 
(376 MHz, CDCl3) δF -132.6 (s, -C(F)-). 
13C NMR (101 MHz, CDCl3) δC 167.9 (d, J = 
9.6 Hz, -C-CH(CH2)2-), 147.9 (d, J = 17.6 Hz, -C(Cl)-), 147.8 (d, J = 267.7 Hz, -C(F)-
) 17.7 (-C-CH(CH2)2-), 11.9 (-C-CH(CH2)2-). MS (EI) m/z 206 ([M]
+, 23%), 170 ([M-
HCl]+, 11%). HRMS (ESI) m/z calcd for [M+H]+ C7H6N2FCl2 206.9892; found 
206.9887. IR (neat, cm-1) 3012, 1524, 1437, 1376, 1337, 932, 813. 
4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine, 123d  
5-Fluoro-4-hydroxy-6-methyl-2-phenylpyrimidine 119d (2.04 g, 10 
mmol), POCl3 (14.0 mL, 23.00 g, 150 mmol) and triethylamine (1.47 
mL, 1.06 g, 10.5 mmol) yielded 4-chloro-5-fluoro-6-methyl-2-
phenylpyrimidine (1.25 g, 56%) as a white crystalline solid; mp 78 – 
79 oC. Rf (19:1, hexane:EtOAc) 0.80. 
1H NMR (400 MHz, CDCl3) δH 8.44 – 8.34 (2H, 
m, 2 x Hortho), 7.55 – 7.44 (3H, m, 2 x Hmeta + Hpara), 2.63 (3H, d, J = 2.7 Hz, -C(CH3)-
). 19F NMR (376 MHz, CDCl3) δF -136.2 (q, J = 2.7 Hz, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 159.5 (d, J =  9.3 Hz, -C-C-(CH)5-), 155.9 (d, J = 15.5 Hz, -C(Cl)-), 151.1 
(d, J = 265.4, -C(F)-), 147.2 (d, J = 18.3 Hz, -C(CH3)-), 135.7 (-C-(CH)5-), 131.0 
(Cpara), 128.6 (Cmeta), 128.3 (Cortho), 18.1 (d, J = 1.6 Hz, -C(CH3)-). MS (EI) m/z 222 
([M]+, 87%), 187 ([M-Cl]+, 100%). HRMS (ASAP) m/z calcd for [M+H]+ C11H9N2FCl 
223.0438; found 223.0422. IR (neat, cm-1) 1574, 1549, 1397, 1341, 1187, 849, 745. 
Single crystals for X-ray diffraction were grown by slow evaporation from acetone. 
4-Chloro-5-fluoro-6-methyl-2-(pyridin-2-yl)pyrimidine, 123c  
5-Fluoro-6-hydroxy-4-methyl-2-(pyridin-2-yl)pyrimidine 119c (2.05 g, 
10 mmol), POCl3 (9.32 mL, 15.33 g, 100 mmol) and triethylamine 
(1.53 mL, 1.11 g, 11.0 mmol) gave 4-chloro-5-fluoro-6-methyl-2-
(pyridin-2-yl)pyrimidine (0.10 g, 5%) as a white crystalline solid; mp 
93 – 94 °C. 1H NMR (400 MHz, CDCl3) δH 8.86 (1H, ddd, J = 4.8, 1.8,
 0.9 Hz, -C-
CHCHCHCH-N-), 8.47 (1H, dt, J = 8.0, 1.1 Hz, -C-CHCHCHCH-N-), 7.87 (1H, td, J = 
7.8, 1.8 Hz, -C-CHCHCHCH-N-), 7.43 (1H, ddd, J = 7.6, 4.8, 1.2 Hz, -C-
CHCHCHCH-N-), 2.71 (3H, d, J = 2.8 Hz, -C(CH3)-). 
19F NMR (376 MHz, CDCl3) δF -
133.1 (q, J = 2.8 Hz, -C(F)-). 
13C NMR (101 MHz, CDCl3) δC 158.2 (d, J = 9.2 Hz, -C-
C-CHCHCHCH-N-), 156.6 (d, J = 15.9 Hz, -C(Cl)-), 152.8 (-C-CHCHCHCH-N-), 
151.9 (d, J = 268.7 Hz, -C(F)-), 150.2 (-C-CHCHCHCH-N-), 147.7 (d, J = 18.5 Hz, -
C(CH3)-), 137.0 (-C-CHCHCHCH-N-), 125.0 (-C-CHCHCHCH-N-), 123.8 (-C-




CHCHCHCH-N-), 18.2 (d, J = 1.5 Hz, -C(CH3)-). MS (ASAP) m/z 224 ([M]
+, 100%). 
HRMS (ASAP) m/z calcd for C10H8N3FCl [M+H]
+ 224.0391; found 224.0374. IR 
(neat, cm-1) 3061, 1552, 1408, 1342, 758. Single crystals suitable for X-ray 
diffraction were grown by slow evaporation from acetone. 
4-Chloro-2-cyclopropyl-5-fluoro-6-methylpyrimidine, 123e 
2-Cyclopropyl-5-fluoro-6-hydroxy-4-methylpyrimidine 119e (0.48 g, 2.8 
mmol), POCl3 (3.73 mL, 6.13 g, 40 mmol) and triethylamine (0.42 mL, 
0.30 g, 3.0 mmol) gave 4-chloro-2-cyclopropyl-5-fluoro-6-
methylpyrimidine (0.22 g, 41 %) as a white crystalline solid; mp 38 – 39 °C. 1H NMR 
(400 MHz, CDCl3) δH 2.48 (3H, d, J = 2.7 Hz, -CH3), 2.18 (1H, tt, J = 8.0, 4.9 Hz, -
CH(CH2)2-), 1.12 – 1.08 (2H, m, -CH(CH2)2-), 1.07 – 1.02 (2H, m, -CH(CH2)2-). 
19F 
NMR (376 MHz, CDCl3) δF -138.9 (q, J = 2.7 Hz, -C(F)-). 
13C NMR (101 MHz, CDCl3) 
δC 167.1 (d, J = 9.1 Hz, -C-CH(CH2)2-), 155.3 (d, J = 15.3 Hz, -C(Cl)-), 150.5 (d, J = 
261.6 Hz, -C(F)-), 146.7 (d, J  = 18.0 Hz, -C(CH3)-), 17.9 (d, J = 1.5 Hz, -CH(CH2)2-), 
17.5 (d, J = 1.6, -C(CH3)-), 11.0 (-CH(CH2)2-). MS (ASAP) m/z 187 ([M+H]
+, 100%). 
HRMS (ASAP) m/z calcd for C8H9N2FCl [M+H]
+ 187.0438; found 187.0434. IR (neat, 
cm-1) 3010, 1547, 1440, 1379, 1183, 1028, 894. 
3.4. Nucleophilic substitution of chlorinated 5-fluoropyrimidines 
4-Ethoxy-5-fluoro-6-methyl-2-phenylpyrimidine, 124a 
K2CO3 (0.28 g, 2.0 mmol) was added to a solution of 4-chloro-5-
fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 0.5 mmol) and 
ethanol (20 mL) and stirred at reflux for 19 h. Completion of the 
reaction was checked by GC analysis. The solvent was removed in vacuo, the 
residue was dissolved in 5% sodium bicarbonate solution (30 mL) and extracted 
with DCM (5 x 20 mL). The organic phase was washed with brine (3 x 20 mL), dried 
with anhydrous magnesium sulfate and the solvent was removed under reduced 
pressure to yield 4-ethoxy-5-fluoro-6-methyl-2-phenylpyrimidine (0.88 g, 76%) as a 
white crystalline solid; mp 42–44 °C. 1H NMR (700 MHz, CDCl3) δH 8.38 – 8.32 (2H, 
m, 2 x Hortho), 7.48 – 7.41 (3H, m, 2 x Hmeta + Hpara), 4.61 (2H, q, J = 7.1 Hz, -
OCH2CH3), 2.50 (3H, d, J = 3.0 Hz, -C(CH3)-), 1.49 (3H, t, J = 7.1 Hz, -OCH2CH3). 
19F NMR (376 MHz, CDCl3) δF -158.2 (q, J = 3.0 Hz, -C(F)-). 
13C NMR (176 MHz, 
CDCl3) δC 157.7 (d, J = 9.4 Hz, -C-C-(CH)5-), 157.5 (d, J = 10.6 Hz, -C(OEt)-), 152.4 
(d, J = 12.8 Hz, -C(CH3)-), 143.6 (d, J = 260.5 Hz, -C(F)-), 137.1 (-C-(CH)5-), 130.1 




(Cpara), 128.3 (Cmeta) , 128.0 (Cortho), 63.0 (-OCH2CH3), 17.3 (-C(CH3)-), 14.4 (-
OCH2CH3). MS (EI) m/z 232 ([M]
+, 62%), 217 ([M-CH3]
+, 100%), 204 ([M-CHCH3]
+, 
80%), 77 ([C6H5]
+, 23%). HRMS (ASAP) m/z calcd for [M+H]+ C13H14N2OF 233.1090; 
found 233.1096. IR (neat, cm-1) 2990, 1602, 1578, 1451, 1384, 1349, 1216, 1079. 
5-Fluoro-4-methyl-6-phenoxy-2-phenylpyrimidine, 124b 
4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 
0.5 mmol) was heated in acetonitrile (25 mL) at 75 oC for 16 h 
in the presence of phenol (0.28 g, 3.0 mmol) and Cs2CO3 
(1.95 g, 6.0 mmol). The reaction was monitored by GC 
analysis and, after it had progressed to completion, the solvent was removed under 
reduced pressure. The resulting residue was dissolved in DCM (20 mL) and washed 
with 10% NaOH (3 x 20 mL), brine (3 x 20 mL) and dried with anhydrous 
magnesium sulfate. After filtration, removal of the solvent in vacuo and 
recrystallization in hexane/CHCl3 yielded 5-fluoro-4-methyl-6-phenoxy-2-
phenylpyrimidine (0.061 g, 44%) as a white crystalline solid; mp 118–120 °C. 1H 
NMR (400 MHz, CDCl3) δH 8.20 – 8.12 (2H, m, 2 x Hortho), 7.56 – 7.24 (8H, m, 
Haromatic), 2.62 (3H, d, J = 2.9 Hz, -C(CH3)-). 
19F NMR (376 MHz, CDCl3) δF -156.5 
(q, J = 2.9 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 157.8 (d, J = 9.7 Hz, -C-C-
(CH)5-), 156.9 (d, J = 10.7 Hz, -C(OPh)-), 154.6 (d, J = 13.0 Hz, -C(CH3)-), 152.2 (-
O-C-(CH)5-), 143.6 (d, J =  262.6 Hz, -C(F)-), 136.5 (-C-C-(CH)5-), 130.4 (Cpara), 
129.4 (Cmeta(phenol)), 128.4 (Cmeta), 128.0 (Cortho), 125.5 (Cpara(phenol)), 121.6 (s, 
Cortho(phenol)), 17.6 (-C(CH3)-). MS (ASAP) m/z 281 ([M+H]
+, 100%). HRMS 
(ASAP) m/z calcd for [M+H]+ C17H14N2OF 281.1090; found 281.1085. IR (neat, cm
-1) 
2963, 1575, 1428, 1387, 1220, 1196, 1024. Single crystals suitable for X-ray 
diffraction were grown by slow evaporation from acetone. 
5-Fluoro-4-methyl-2-phenyl-6-(piperidin-1-yl)pyrimidine, 124c 
Piperidine (0.13 g, 0.15 mL, 1.5 mmol) was added to a solution of 
4-chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 0.5 
mmol) and Cs2CO3 (0.49 g, 1.5 mmol) in DMF (15 mL) and 
stirred at 50 oC for 16 h. The reaction mixture was quenched with 
dilute aqueous HCl (1M, 3 mL), diluted with water (100 mL) and extracted with 
diethyl ether (5 x 20 mL). The organic fractions were combined, washed with brine 
(3 x 30 mL) and dried with anhydrous magnesium sulfate. After filtration, the solvent 
of the filtrate was removed under reduced pressure to yield 5-fluoro-4-methyl-2-




phenyl-6-(piperidin-1-yl)pyrimidine (0.097 g, 71%) as a white crystalline solid; mp 84 
– 86 °C. 1H NMR (400 MHz, CDCl3) δH 8.39 – 8.27 (2H, m, 2 x Hortho), 7.53 – 7.36 
(3H, m, 2 x Hmeta + Hpara), 3.84 – 3.78 (4H, m, -NCH2(CH2)3CH2-), 2.46 (3H, d, J = 3.7 
Hz, -C(CH3)-), 1.77 – 1.67 (6H, m, -NCH2(CH2)3CH2-). 
19F NMR (376 MHz, CDCl3) 
δF -148.2 (q, J = 3.7 Hz, -C(F)-). 
13C NMR (101 MHz, CDCl3) δC 157.8 (d, J = 8.1 Hz, 
-C-C-(CH)5-), 151.7 (d, J = 17.4 Hz, -C(N-)-), 151.3 (d, J = 5.7 Hz, -C(CH3)-), 144.3 
(d, J = 255.8 Hz, -C(F)-), 138.0 (-C-(CH)5-), 129.6 (Cpara), 128.2 (Cmeta), 128.0 
(Cortho), 47.5 (d, J = 7.7 Hz, -NCH2CH2CH2CH2CH2-), 26.0 (-NCH2CH2CH2CH2CH2-), 
24.9 (-NCH2CH2CH2CH2CH2-), 17.5 (d, J = 1.2 Hz, -C(CH3)-). MS (EI) m/z 271 ([M]
+, 
100%), 84 ([C5H10N]
+, 62%). HRMS (ASAP) m/z calcd for [M+H]+ C16H19N3F 
272.1563; found 272.1550. IR (neat, cm-1) 2930, 2849, 1597, 1405, 1211, 751, 697. 
Single crystals suitable for X-ray diffraction were grown by slow evaporation from 
acetone. 
5-Fluoro-4-methyl-2-phenyl-6-(piperazin-1-yl)pyrimidine, 124d 
4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.011 g, 
0.5 mmol) was added to a boiling solution of piperazine (0.22 g, 
2.5 mmol) in ethanol (20 mL) and stirred under reflux conditions 
for 16 h. After the reaction had progressed to completion by 
monitoring of LC-MS spectra, the reaction mixture was allowed to cool and the 
solvent was removed under reduced pressure. The residue was suspended in water 
and extracted with dichloromethane (3 x 20 mL). The combined organic layers were 
washed with brine (3 x 20 mL) and dried with anhydrous magnesium sulfate, before 
evaporation of the filtrate under reduced pressure yielded 5-fluoro-4-methyl-2-
phenyl-6-(piperazin-1-yl)pyrimidine (0.12 g, 91%) as a white solid; mp 89 – 90 °C. 
1H NMR (400 MHz, CDCl3) δH 8.35 – 8.25 (2H, m, 2 x Hortho), 7.46 – 7.36 (3H, m, 2 x 
Hmeta + Hpara), 3.86 – 3.72 (4H, m, 2 x –NCH2CH2N(H)CH2CH2-), 3.00 – 2.94 (4H, m, 
2 x -NCH2CH2N(H)CH2CH2-), 2.43 (3H, d, J = 3.6 Hz, -C(CH3)-), 1.82 (1H, s, NH). 
19F NMR (376 MHz, CDCl3) δF -148.3 (q, J = 3.6 Hz, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 157.8 (d, J = 8.2 Hz, -C-C-(CH)5-), 152.1 (d, J = 17.2 Hz, -C(N-)-), 151.2 
(d, J =  5.3 Hz, -C(CH3)-), 144.3 (d, J = 256.1 Hz, -C(F)-), 137.9 (-C-(CH)5-), 129.7 
(Cpara), 128.2 (Cmeta), 128.0 (Cortho), 47.5 (d, J = 7.5 Hz, -NCH2CH2N(H)CH2CH2-), 
46.2 (-NCH2CH2N(H)CH2CH2-)), 17.5 (-C(CH3)-). MS (ASAP) m/z 273 ([M+H]
+, 
100%), 230 ([M-C2H4N]
+, 4%). HRMS (ASAP) m/z calcd for [M+H]+ C15H18N4F 
273.1516; found 273.1523. IR (neat, cm-1) 3198, 2846, 1596, 1576, 1487, 1212, 
746, 692. 





A solution of benzylamine (0.27 g, 0.28 mL, 2.5 mmol), 4-
chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 0.5 
mmol) and triethylamine (.25 g, 0.35 mL, 2.5 mmol) in 
acetonitrile (10 mL) was stirred for 16 h at room temperature. 
The reaction mixture was monitored by LC-MS analysis and, 
on completion, the solvent was removed in vacuo prior to dissolution of the residue 
in ethyl acetate (20 mL). The organic phase was washed with water (3 x 20 mL) and 
brine (3 x 20 mL) and dried with anhydrous magnesium sulfate. Following filtration, 
the solvent was removed under reduced pressure and the crude product was 
recrystallised in hexane/CHCl3 to yield N-benzyl-5-fluoro-6-methyl-2-
phenylpyrimidin-4-amine (0.12 g, 84%) as a brown crystalline solid; mp 90 – 91 °C. 
1H NMR (400 MHz, CDCl3) δH 8.42 – 8.32 (2H, m, 2 x Hortho), 7.51 – 7.27 (8H, m, 
Haromatic), 5.29 (1H, t, J = 5.8 Hz, NH), 4.83 (2H, d, J = 5.8 Hz, -N(H)CH2-), 2.45 (d, J 
= 2.9 Hz, -C(CH3)-). 
19F NMR (376 MHz, CDCl3) δF -161.1 (q, J = 2.9 Hz, -C(F)-). 
13C 
NMR (101 MHz, CDCl3) δC 158.5 (d, J = 8.8 Hz, -C-C-(CH)5-), 151.6 (d, J = 11.5 Hz, 
-C(N(H)-)-), 148.2 (d, J = 12.3 Hz, -C(CH3)-), 143.4 (d, J = 253.5 Hz, -C(F)-), 138.7 (-
N(H)CH2-C-), 137.9 (-C-(CH)5-), 129.8 (Cpara), 128.8 (Cmeta(benzyl)), 128.3 (Cmeta), 
128.0 (Cortho), 127.9 (Cortho(benzyl)), 127.6 (Cpara(benzyl)), 44.6 (-N(H)CH2-), 17.0 (-
C(CH3)-). MS (ESI) m/z 294 ([M+H]
+, 100%), 124 ([C7H7NF]
+, 32%). HRMS (ESI) 
m/z calcd for [M+H]+ C18H17N3F 294.1407; found 294.1409. IR (neat, cm
-1) 3419, 
2928, 1210, 1386, 750, 693. 
5-Fluoro-6-methyl-N,2-diphenylpyrimidin-4-amine, 124f 
Aniline (0.27 g, 0.27 mL, 3.0 mmol) was added to a solution of 
4-chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 
0.5 mmol) in ethanol (15 mL) and stirred at reflux for 30 h. The 
reaction was monitored by LC-MS analysis and, upon 
completion, the mixture was cooled to r.t. and the solvent was removed under 
reduced pressure. The residue was suspended in water and extracted with 
dichloromethane (3 x 15 mL). The combined organic fractions were washed with 
dilute aqueous HCl (1M, 3 x 20 mL), brine (3 x 20 mL) and dried with anhydrous 
magnesium sulfate. After filtration, the organic phase of the filtrate was removed in 
vacuo and the crude product was recrystallised in hexane/CHCl3 to yield 5-fluoro-6-
methyl-N,2-diphenylpyrimidin-4-amine (0.10 g, 69%) as a white crystalline solid; mp 
154 – 155°C. 1H NMR (700 MHz, CDCl3) δH 8.37 (2H, dt, J = 6.0, 1.5 Hz, 2 x Hortho), 




7.80 – 7.76 (2H, m, 2 x Hortho(aniline)), 7.50 – 7.43 (3H, m, 2 x Hmeta + Hpara), 7.45 – 
7.40 (2H, m, 2 x Hmeta(aniline)), 7.15 (1H, tt, J =  7.7, 2.8 Hz, Hpara(aniline)), 6.86 
(1H, br s, NH), 2.52 (3H, d, J = 2.8 Hz, -C(CH3)-). 
19F NMR (376 MHz, CDCl3) δF -
158.6 (s, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 158.4 (d, J = 9.2 Hz, -C-C-(CH)5-), 
149.4 (d, J = 13.1 Hz, -C(N(H)-)-), 149.1 (d, J = 9.4 Hz, -C(CH3)-), 143.0 (d, J =  
256.1 Hz, -C(F)-), 138.3 (-N(H)-C-), 137.5 (-C-(CH)5-), 130.1 (Cpara), 129.0 
(Cmeta(aniline)), 128.4 (Cmeta), 128.1 (Cortho), 123.6 (Cpara(aniline)), 120.1 
(Cortho(aniline)), 17.2 (-C(CH3)-). MS (ESI) m/z 280 ([M+H]
+, 100%). HRMS (ESI) 
m/z calcd for [M+H]+ C17H15N3F 280.1250; found 280.1249. IR (neat, cm
-1) 3386, 
1576, 1451, 1386, 752, 697. Single crystals suitable for X-ray diffraction were grown 
by slow evaporation from DCM. 
5-Fluoro-4,6-bis(piperazin-1-yl)-2-(pyridin-2-yl)pyrimidine, 125 
4,6-Dichloro-5-fluoro-2-(pyridin-2-yl)pyrimidine 104d (0.24 g, 1.0 
mmol) was added to a boiling solution of piperazine (0.44 g, 5.0 
mmol) in ethanol (30 mL) and stirred under reflux conditions for 
72 h after which the reaction was complete, confirmed by 19F 
NMR spectral analysis. The reaction mixture was allowed to 
cool and the solvent was removed under reduced pressure. The residue was 
suspended in water and extracted with dichloromethane (3 x 20 mL). The combined 
organic layers were washed with brine (3 x 20 mL) and dried with anhydrous 
magnesium sulfate, before evaporation of the filtrate under reduced pressure to 
yield 5-fluoro-4,6-bis(piperazin-1-yl)-2-(pyridin-2-yl)pyrimidine (0.25 g, 74%) as a 
waxy yellow solid; mp > 250 °C. 1H NMR (400 MHz, CDCl3) δH 8.71 – 8.61 (1H, m, -
C-CHCHCHCH-N-), 8.29 – 8.12 (1H, m, -C-CHCHCHCH-N-), 7.73 – 7.57 (1H, m, -
C-CHCHCHCH-N-), 7.32 – 7.16 (1H, m, -C-CHCHCHCH-N-), 3.74 – 3.51 (8H, m, 2 
x –NCH2CH2N(H)CH2CH2-), 2.99 – 2.84 (8H, m, 2 x –NCH2CH2N(H)CH2CH2-), 1.84 
(2H, s, NH). 19F NMR (376 MHz, CDCl3) δF -156.3 (s, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 155.7 (d, J = 8.1 Hz, -C-C-CHCHCHCH-N-), 155.6 (-C-CHCHCHCH-N-), 
153.0 (d, J = 7.0 Hz, -C(N-)-), 152.8 (d, J = 7.1 Hz, -C(N-)-), 149.6 (-C-CHCHCHCH-
N-), 136.4 (-C-CHCHCHCH-N-), 134.9 (d, J = 254.5 Hz, -C(F)-), 123.8 (-C-
CHCHCHCH-N-), 123.6 (-C-CHCHCHCH-N-), 51.7 (-NCH2CH2N(H)CH2CH2-), 48.2 
(d, J = 6.7 Hz, -NCH2CH2N(H)CH2CH2-), 47.0 (-NCH2CH2N(H)CH2CH2-), 46.2 (-
NCH2CH2N(H)CH2CH2-). MS (ASAP) m/z 344 ([M+H]
+, 100%). HRMS (ASAP) m/z 
calcd for [M+H]+ C17H23N7F 344.1999; found 344.1990. IR (neat, cm
-1) 3275, 2835, 
1580, 1444, 1390, 1001, 735. 





4,6-Dichloro-2-cyclopropyl-5-fluoropyrimidine 104e (0.075 g, 
0.36 mmol) was added to a boiling solution of piperazine (0.22 g, 
2.5 mmol) in ethanol (20 mL) and stirred under reflux conditions 
for 16 h. The reaction mixture was allowed to cool and the 
solvent was removed under reduced pressure. The residue was suspended in water 
and extracted with dichloromethane (3 x 20 mL). The combined organic layers were 
washed with brine (3 x 20 mL) and dried with anhydrous magnesium sulfate, before 
evaporation of the filtrate under reduced pressure. The crude product was purified 
by column chromatography on silica gel using a gradient of 
dichloromethane/methanol (0–6% methanol) as the eluent to yield 4-chloro-2-
cyclopropyl-5-fluoro-6-(piperazin-1-yl)pyrimidine (0.066 g, 71%) as a white solid; mp 
89 – 90 °C. Rf (19:1, DCM:MeOH) 0.35. 
1H NMR (400 MHz, CDCl3) δH 3.83 – 3.64 
(4H, m, 2 x –NCH2CH2N(H)CH2CH2-), 3.02 – 2.85 (4H, m, 2 x –
NCH2CH2N(H)CH2CH2-), 2.00 (1H, tt, J = 8.0, 5.0 Hz, -CH(CH2)2-), 1.77 (1H, br s, 
NH), 0.98 (2H, dt, J = 5.0,
 2.7 Hz, -CH(CH2)2-), 0.94 (2H, dt,
 J = 8.0,
 2.7 Hz, -
CH(CH2)2-). 
19F NMR (376 MHz, CDCl3) δF -146.1 (s, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 165.5 (d, J = 8.6 Hz, -C-CH(CH2)2-), 151.7 (d, J = 4.6 Hz, -C(Cl)-), 145.6 
(d, J =18.8 Hz, -C(N-)-), 139.7 (d, J = 258.0 Hz, -C(F)-), 47.4 (d, J = 7.5 Hz, -
NCH2CH2N(H)CH2CH2-), 46.1 (-NCH2CH2N(H)CH2CH2-), 17.5 (d, J = 1.6 Hz, -
CH(CH2)2-), 10.2 (-CH(CH2)2-). MS (ASAP) m/z 257 ([M+H]
+, 100%). HRMS (ASAP) 
m/z calcd for [M+H]+ C11H15N4FCl 257.0969; found 257.0963. IR (neat, cm
-1) 3312, 
2916, 1575, 1435, 1227, 990, 792. Single crystals suitable for X-ray diffraction were 
grown by slow evaporation from toluene. 
4-Ethoxy-5-fluoro-6-methyl-2-(pyridin-2-yl)pyrimidine, 127 
4-Chloro-5-fluoro-6-methyl-2-(pyridin-2-yl)pyrimidine 123c (0.067 
g, 0.30 mmol) was added to a boiling solution of piperazine (0.13 
g, 1.5 mmol) in ethanol (15 mL) and stirred under reflux 
conditions for 72 h, after which Cs2CO3 (0.49 g, 1.5 mmol) was 
added. The reaction mixture was stirred for a further 24 h followed by cooling to rt 
and removal of the solvent under reduced pressure. The residue was suspended in 
water and extracted with dichloromethane (3 x 20 mL). The combined organic layers 
were washed with brine (3 x 20 mL) and dried with anhydrous magnesium sulfate, 
before evaporation of the filtrate under reduced pressure yielded 4-ethoxy-5-fluoro-
6-methyl-2-(pyridin-2-yl)pyrimidine (0.031 g, 38%) as a white solid; mp 76 – 77 °C. 




1H NMR (400 MHz, CDCl3) δH 8.80 (1H, ddd, J = 4.8, 1.8,
 0.9 Hz, -C-CHCHCHCH-
N-), 8.36 (1H, dt, J = 7.9, 1.1 Hz, -C-CHCHCHCH-N-), 7.80 (1H, td, J = 7.9,
 1.8 Hz, -
C-CHCHCHCH-N-), 7.35 (1H, ddd, J = 7.6,
 4.8, 1.1 Hz, -C-CHCHCHCH-N-), 4.63 
(2H, q, J = 7.1 Hz, -OCH2CH3), 2.58 (3H, d, J = 3.0 Hz, -C(CH3)-), 1.48 (3H, t, J = 7.1 
Hz, -OCH2CH3). 
19F NMR (376 MHz, CDCl3) δF -155.3 (q, J = 3.1 Hz, -C(F)-). 
13C 
NMR (101 MHz, CDCl3) δC 157.8 (d, J = 10.9 Hz, -C(OEt)-), 156.7 (d, J = 9.4 Hz, -C-
C-CHCHCHCH-N-), 154.2 (-C-CHCHCHCH-N-), 153.4 (d, J = 13.2 Hz, -C(CH3)-), 
150.0 (-C-CHCHCHCH-N-), 144.4 (d, J = 262.6 Hz, -C(F)-), 136.8 (-C-CHCHCHCH-
N-), 124.4 (-C-CHCHCHCH-N-), 123.5 (-C-CHCHCHCH-N-), 63.3 (-OCH2CH3), 17.5 
(-C(CH3)-), 14.4 (-OCH2CH3). MS (ASAP) m/z 234 ([M+H]
+, 100%). HRMS (ASAP) 
m/z calcd for [M+H]+ C12H13N3OF 234.1043; found 234.1045. IR (neat, cm
-1) 2978, 
1602, 1454, 1384, 1349. 
5-Fluoro-6-methyl-N-[(1S)-1-phenylethyl]-2-phenylpyrimidin-4-amine, 128 
4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine 123d (0.11 g, 
0.5 mmol) was added to a solution of (S)-(-)-1-
phenylethylamine (0.30 g, 2.5 mmol) in acetonitrile (15 mL) 
and stirred at 80 oC for 24 h. Following the addition of 
triethylamine (0.14 mL, 1.0 mmol), the solution was stirred at 80 oC for a further 12 h 
before cooling to r.t. and removal of the solvent in vacuo. The resulting residue was 
dissolved in EtOAc and washed with water (3 x 25 mL), dilute aqueous HCl (1M, 2 x 
20 mL), brine (3 x 25 mL) and dried with anhydrous magnesium sulfate. The filtrate 
was exaporated under reduced pressure and the crude product was purified by 
column chromatography on silica gel using hexane/ethyl acetate (8% ethyl acetate) 
to yield 5-fluoro-6-methyl-N-[(1S)-1-phenylethyl]-2-phenylpyrimidin-4-amine (0.066 
g, 43%) as a pale yellow oil. Rf (19:1, hexane:EtOAc) 0.30. 
1H NMR (400 MHz, 
CDCl3) δH 8.36 – 8.23 (2H, m, 2 x Hortho), 7.59 – 7.28 (8H, m, Haromatic), 5.50 (1H, p, 
J = 7.0 Hz, -N(H)CH(CH3)-), 5.27 – 5.17 (1H, m, NH), 2.44 (3H, d, J = 2.9 Hz, -
C(CH3)-), 1.69 (3H, d, J = 7.0 Hz, -N(H)CH(CH3)-). 
19F NMR (376 MHz, CDCl3) δF -
160.9 (s, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 158.4 (d, J = 8.8 Hz, -C-C-(CH)5-), 
150.9 (d, J = 11.4 Hz, -C(N(H)-)-), 148.1 (d, J = 12.4 Hz, -C(CH3)-), 143.9 (s, -
N(H)CH(CH3)-C-), 143.3 (d, J = 255.5 Hz, -C(F)-), 138.0 (-C-(CH)5)-), 129.7 (Cpara), 
128.7 (Cmeta(α-methylbenzyl)), 128.2 (Cmeta), 128.0 (Cortho), 127.4 (Cpara(α-
methylbenzyl)), 126.2 (Cortho(α-methylbenzyl)), 50.1 (-N(H)CH(CH3)-), 22.4 (-
N(H)CH(CH3)-), 17.0 (-C(CH3)-). MS (ESI) m/z 308 ([M+H]
+, 100%), 309 ([M+2H]+, 




49%). HRMS (ESI) m/z calcd for [M+H]+ C19H19FN3 308.1563; found 308.1578. IR 
(neat, cm-1) 3426, 2925, 1610, 1503, 1388, 754, 697. 
4. Experimental to chapter 4 
4.1. Mn(III)-induced oxidative addition of olefins to 2-fluoro-1,3-
dimethylmalonate 
General procedure 
In a Schlenk tube were added manganese catalyst (see table 36), 1,3-dimethyl-2-
fluoromalonate 62 (1.5 g, 10 mmol or 0.75 g, 5 mmol) in acetic acid (20 mL). Then 
the mixture was warmed up to 100 °C under inert atmosphere and olefin (see table 
36) was added to the reaction mixture. The resulting mixture was allowed to stir and 
then, after a certain reaction time, cooled down to room temperature. Then water 
(50 mL) was added and the product was extracted with dichloromethane (50 mL), 
washed twice with sat. NaHCO3 solution (50 mL), with water (50 mL), dried over 
anhydrous sodium sulfate and dichloromethane was removed under reduced 
pressure to give a crude product mixture, which was analyzed by NMR 
spectroscopy. 










1-Octene 0.78 mL Mn(OAc)3 1.34 g 
5 - 
2 10 20 17 
3b 10 20 18 
4 10 Cyclo- 
hexene 
0.5 mL Mn(OAc)3 1.34 g 
24 7 
5b 10 24 10 
6 5 





 0.79 g 72 - 
7 5 Mn(acac)3 1.76 g 72 - 






 With Cu(OAc)2 (10 mol%) 




4.2. Mn(OAc)3-induced oxidative addition of 1-octene to 2-fluoro-1,3-
dicarbonyl substrates 
Ethyl 2-octyl-2-fluoro-3-oxobutanoate, 139a 
In a Schlenk tube were added manganese acetate dihydrate (2.68 
g, 10 mmol), 2-fluoro-ethylacetoacetate 19 (1.5 mL, 10 mmol) in 
acetic acid (20 mL). Then the mixture was warmed up to 100 °C 
under inert atmosphere and 1-octene (1.57 mL, 10 mmol) was added to the reaction 
mixture. The resulting mixture was allowed to stir and then, after a certain reaction 
time, cooled down to room temperature. Then water (50 mL) was added and the 
product was extracted with dichloromethane (50 mL), washed twice with sat. sodium 
hydrogencarbonate solution (50 mL), with water (50 mL), dried over anhydrous 
sodium sulfate and dichloromethane was removed under reduced pressure to give a 
crude product mixture, which was distilled via Kugelrohr distillation (10 mbar, 150 
°C), and then purified by column chromatography using a gradient of ethyl acetate 
and hexane. 1H NMR (400 MHz, CDCl3) δH 0.75 – 0.98 (m, 3H, -CH3), 1.07 – 1.44 
(m, 15H, -OCH2CH3 + -C(F)CH2(CH2)6CH3), 1.89 – 2.19 (m, 2H, -C(F)CH2-), 2.26 - 
2.34 (m, 3H, -C(O)CH3), 4.11 – 4.38 (m, 2H, -OCH2CH3). 
19F NMR (376 MHz, 
CDCl3) δF -167.39 (ddq, J = 25.2, 22.3, 4.8 Hz, -C(F)-), -166.56 (tq, J = 24.3, 4.8 Hz, 
-C(F)-, trace from di-substituted compound). 13C NMR (101 MHz, CDCl3) δC 13.97, 
14.02 (-OCH2CH3 + -C(F)CH2(CH2)6CH3), 22.58, 25.75, 29.04, 29.14, 29.31, 31.74 (-
C(F)CH2(CH2)6CH3), 33.84 (d, J = 20.9 Hz, -C(F)CH2(CH2)6CH3), 62.43 (-OCH2CH3), 
100.49 (d, J = 197.3 Hz, -C(F)-), 166.30 (d, J = 25.8 Hz, -C(O)OCH2CH3), 202.17 (d, 
J = 27.6 Hz, -C(O)CH3). MS (ESI) m/z 259 ([M-H]
+, 100%), 260 ([M]+, 17%), 261 
([M+H]+, 48%). HRMS (ESI) m/z calcd for [M+H]+ C14H26FO3 261.1866; found 
261.1876. 
Dimethyl-2-fluoro-2-octylmalonate, 140a 
In a Schlenk tube were added manganese acetate dihydrate, 1,3-
dimethyl-2-fluoromalonate 62 (see Table 37) in acetic acid (20 mL). 
Then the mixture was warmed up to 100°C under inert atmosphere 
and 1-octene (1.57 mL, 10 mmol) was added to the reaction 
mixture. The resulting mixture was allowed to stir and then, after a certain reaction 
time, cooled down to room temperature. Then water (50 mL) was added and the 
product was extracted with dichloromethane (50 mL), washed twice with sat. sodium 
hydrogencarbonate solution (50 mL), with water (50 mL), dried over anhydrous 




sodium sulfate and dichloromethane was removed under reduced pressure to give a 
crude product mixture, which was distilled via Kugelrohr distillation (10 mbar, 150 
°C), and then purified by column chromatography using a gradient of ethyl acetate 
and hexane. 1H NMR (400 MHz, CDCl3) δH 0.83-0.92 (m, 3H, --C(F)CH2(CH2)6CH3), 
1.13 – 1.44 (m, 12H, -C(F)CH2(CH2)6CH3), 1.91 – 2.21 (m, 2H, -C(F)CH2(CH2)6CH3), 
3.78 – 3.88 (m, 6H, 2 x –OCH3). 
19F NMR (376 MHz, CDCl3) δF -167.22 (t, J = 23.9 
Hz, -C(F)-), -166.45 (t, J = 24.2 Hz, -C(F)-, trace from di-substituted compound). 13C 
NMR (101 MHz, CDCl3) δ 14.03 C(F)CH2(CH2)6CH3), 22.16 – 22.95 (m), 28.25 – 
29.61 (m), 31.43 – 31.92 (m) (-C(F)CH2(CH2)6CH3), 33.98 – 35.00 (m) (-
C(F)CH2(CH2)6CH3), 53.18 (-OCH3), 53.23 (-OCH3), 94.68 (d, J = 199.5 Hz, -C(F)-), 
94.98 (d, J = 198.7 Hz, -C(F)-), 166.32 (d, J = 25.6 Hz, -C(O)OCH3), 166.74 (d, J = 
25.7 Hz, -C(O)OCH3). MS (ESI) m/z 261 ([M-H]
+, 100%), 262 ([M]+, 19%), 263 
([M+H]+, 10%). HRMS (ESI) m/z calcd for [M+H]+ C13H24FO4 263.1659; found 
263.1664. 
Table 37 Addition of 1-octene to 1,3-dimethyl-2-fluoromalonate using Mn(OAc)3 
Entry Time [h] 62 Mn(OAc)3 Yield [%]
b 
1 24 0.75 g 5 mmol 1.34 g 5 mmol 22 
2 72 0.75 g 5 mmol 2.68 g 10 mmol 77 
3 72 1.5 g 10 mmol 2.68 g 10 mmol 20 
4 72 1.5 g 10 mmol 1.34 g 5 mmol 25 
5 72 3.0 g 20 mmol 1.34 g 5 mmol 45 
6a 72 7.5 g 50 mmol 1.34 g 5 mmol 39 
7a 72 11.25 g 75 mmol 1.34 g 5 mmol 50 
8a 72 15.0 g 100 mmol 2.68 g 10 mmol 93 
9a 72 22.5 g 150 mmol 2.68 g 10 mmol 95 
10a 72 30.0 g 200 mmol 2.68 g 10 mmol quant. 
a
 Without AcOH; 
b
 Isolated 
4.3. Oxidative addition of 1-octene to 2-fluoro-1,3-dimethylmalonate 
using other Manganese-based initiators 
General procedure using Mn(OAc)2 initiator 
A mixture of potassium acetate (0.875 g, 9 mmol), 2-fluoro-1,3-dimethylmalonate 62 
(25 mmol), and acetic acid (9 mL) was heated to 75 °C under inert atmosphere. 1-
Octene (0.39 mL, 2.5 mmol) and manganese(III) acetate dihydrate (1.34 g, 5 mmol) 




were added and the solution was stirred at 75 °C. The mixture was then cooled to 
room temperature, diluted with water (50 mL) and extracted with DCM (3 x 50 mL). 
The combined organic extracts were washed with saturated NaHCO3 solution (2 x 
50 mL), water (50 mL), dried over Na2SO4 and concentrated. The excess of 
malonate was removed by distillation (100 °C, 10 mbar) and the crude product was 
analyzed by NMR spectroscopy, showing no significant conversion and many by-
products, so no further purification was carried out. 
General procedure using Mn(OAc)2 initiator combined with KMnO4 
A mixture of potassium acetate (0.875 g, 9 mmol), a few crystals of manganese(II) 
acetate tetrahydrate (cat.), 2-fluoro-1,3-dimethylmalonate 62 (25 mmol) and acetic 
acid (9 mL) was heated to 75°C under inert atmosphere. After the addition of the 1-
octene (0.39 mL, 2.5 mmol), solid potassium permanganate (0.16 g, 0.4 eq.) was 
added in very small portions at 75 °C over a period of 4-10 hours. The mixture was 
then cooled to room temperature, diluted with water (50 mL) and extracted with 
DCM (3 x 50 mL). The combined organic extracts were washed with saturated 
NaHCO3 solution (2 x 50 mL), water (50 mL), dried over Na2SO4 and concentrated. 
Due to the presence of many by-products observed on NMR spectroscopy, no 
further purification was carried out. 
General procedure using Mn(II) / Co(II) / O2 
To a solution of 2-fluoro-1,3-dimethylmalonate 62 (3.75 g, 15 eq.), Mn(OAc)2 (52 
mg, 2 mol %) and Co(OAc)2 (26 mg, 1 mol %) in a two-necked flask equipped with a 
balloon filled with an appropriate concentration of O2 (0.5 bar of O2 diluted in 3.5 bar 
of N2) was added 1-octene (0.31 mL, 2 mmol), and the mixture was stirred at 90 °C 
for 3 hours. After evaporation of AcOH, the excess of 1,3-dimethyl-2-fluoromalonate 
was removed by distillation (100 °C, 10 mbar). NMR spectroscopy of the crude 
mixture did not show any conversion of the starting 2-fluoro-1,3-dimethylmalonate 
and many by-products, therefore no further purification was carried out.  
4.4. Oxidative addition of olefins to 2-fluoro-1,3-dimethylmalonate 
using ditertbutylperoxide (tBuO)2 
General procedure 
In a 50 mL flask were added 1,3-dimethyl-2-fluoromalonate 62, ditertbutylperoxide 
(55 µL, 0.3 mmol)  and olefin (see table 38). This mixture was then allowed to stir 




over four days at 105 °C under inert atmosphere. Then, the resulting mixture was 
allowed to cool at room temperature and was distilled under reduced pressure (120 
°C, 10 mbar), and then distilled again by Kugelrohr distillation (150 °C, 5 mbar) and 
the crude product was analyzed by NMR spectroscopy. No further purification was 
carried out due to the small scale of these reactions and the polymerized by-
products that were obtained. 
Table 38 Addition of olefin to 1,3-dimethyl-2-fluoromalonate using (
t
BuO)2 
Entry 62 Olefin Yield [%]a 
1 9.0 g 60 mmol 1-octene 313 µL 2 mmol 66 
2 4.5 g 30 mmol styrene 344 µL 3 mmol - 
3 4.5 g 30 mmol vinylcyclohexane 410 µL 3 mmol - 
4 4.5 g 30 mmol cyclohexene 303 µL 3 mmol - 





4.5. Oxidative addition of olefins to 2-fluoro-1,3-dimethylmalonate 
using Bu3SnH / AIBN 
General procedure 
In a 50 mL flask were added 1,3-dimethyl-2-fluoromalonate 62, 1-octene, tributyltin 
hydride and a few crystals of AIBN in toluene or benzene (see Table 39). This 
mixture was then allowed to stir over four days at 85 °C under inert atmosphere. 
Then, the resulting mixture was allowed to cool at room temperature and a few 
crystals of I2 were added to convert Bu3SnSnBu3 and unreacted Bu3SnH to Bu3SnI. 
The mixture was then diluted with diethyl ether (50 mL), water was added (50 mL), 
aqueous layer was removed and the organic layer was washed 2-3 times with 1M 
aqueous solution of KF (50 mL). Bu3SnF precipitate formed at organic/aqueous 
phase interface (solution was filtered through Celite in some cases). Then the 
mixture was washed with saturated brine solution (50 mL), washed with sodium 
sulfite saturated solution to remove unreacted I2, dried over MgSO4, and the solvent 
was removed under reduced pressure. NMR spectroscopy of the crude product 
indicates the formation of Bu3SnF and no product was observed, therefore no 
further purification was carried out. 
 




Table 39 Addition of 1-octene to 1,3-dimethyl-2-fluoromalonate using Bu3SnH / AIBN 
Entry 62 1-octene Bu3SnH Solvent 
1 
0.26 g 1.71 mmol 0.26 mL 1.71 mmol 
0.5 g 1.71 mmol 
toluene 2 1.0 g 3.42 mmol 
3 1.5 g 5.13 mmol 
4 0.5 g 1.71 mmol benzene 
5 0.52 g 3.42 mmol 0.52 mL 3.42 mmol 2.0 g 6.84 mmol toluene 
4.6. Oxidative addition of olefins to 2-fluoro-ethylacetoacetate using 
Co(OAc)2 
General procedure 
In a 50 mL flask were added Co(OAc)2 (1.77 g, 10 mmol), acetic acid (20 mL), then 
2-fluoroethylacetoacetate (1.25 mL, 10 mmol), and olefin (see Table 40). This 
mixture was then allowed to stir for a certain time. Then, the resulting mixture was 
allowed to cool at room temperature, acetic acid was removed under reduced 
pressure and the residue was taken into diethyl ether (20 mL), washed with 
NaHCO3 saturated solution (50 mL). The organic phase was then washed with 
ammonium chloride saturated solution (50 mL), washed with distillated water and 
dried over anhydrous Na2SO4. Diethyl ether was then removed under reduced 
pressure. Purification via Kugelrohr distillation (10 mbar, 150 °C) and column 
chromatography column chromatography using a gradient of ethyl acetate and 
hexane was carried out when appropriate. 
Table 40 Addition of olefin to 2-fluoroethylacetoacetate using Co(OAc)2 
Entry Olefin Temp. Reaction time Yield [%]a 
1 1-octene 2.33 mL 15 mmol 
r.t. 3 days 
24 
2 Styrene 2.33 mL 20 mmol 15b 















4.7. Oxidative addition of olefins to 2-fluoro-1,3-dimethylmalonate 
using CAN / Cu(OAc)2 
General procedure 
Olefin (2 mmol, see table 41) was added to a solution of 1,3-dimethyl-2-
fluoromalonate (see Table 41) in 30 mL of solvent under inert atmosphere. Then 
CAN (2.2 g, 4.0 mmol) was added (plus Cu(OAc)2 (0.4 g, 2 mmol) if the reaction 
was carried out in acetic acid) and the resulting mixture was stirred at room 
temperature for 3 days. Acetonitrile was evaporated under reduced pressure, water 
(100 mL) was added to the residue and the resulting mixture extracted with DCM (3 
x 50 mL), the organic phase was then removed under vacuo and crude product was 
analyzed by NMR spectroscopy. For reactions carried out in acetic acid, the reaction 
mixture was poured into water (100 mL) and extracted with DCM. The organic 
phase was then washed with as saturated NaHCO3 solution (3 x 50 mL), then water 
and finally dried with Na2SO4. The crude product was then analyzed by 
19F-NMR 
spectroscopy. No further purification was carried out due to the low yields. 
Table 41 Addition of 2-fluoro-1,3-dimethylmalonate to olefins using CAN / Cu(OAc)2 
Entry Olefin [2 mmol] 62  Solvent 
Yield 
[%]a 
1 1-Octene 0.31 mL 5 mmol 0.76 g MeCN - 
2b 1-Octene 0.31 mL 5 mmol 0.76 g AcOH 11 
3 Cyclohexene 0.23 mL 5 mmol 0.76 g MeCN - 
4b Cyclohexene 0.23 mL 5 mmol 0.76 g AcOH 12 
5 Cyclohexene 0.23 mL 2 mmol 0.30 g MeCN - 






 With Cu(OAc)2 (2 mmol) 
4.8. CAN-induced oxidative addition of olefins to 2-
fluoroethylacetoacetate 
General procedure  
Olefin (2 mmol) was added to a solution of 2-fluoro-ethyl acetoacetate 19 (0.63 mL, 
5.0 mmol) in 20 mL of acetonitrile under inert atmosphere. Then ceric ammonium 
nitrate (2.2 g, 4.0 mmol) was added and the resulting mixture was stirred at room 
temperature for 3 days. Acetonitrile was evaporated under reduced pressure, water 
(100 mL) was added to the residue and the resulting mixture extracted with 
dichloromethane (3 x 50 mL), the organic phase was then washed with brine (2 x 25 




mL), dried over magnesium sulfate and the solvent was removed under reduced 
pressure. The crude mixture was then purified by column chromatography eluting 
with dichloromethane to give the desired product as a pale yellow oil. 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)-4-phenylbutanoate, 219a (350 mg, 56%) 
1H NMR (400 MHz, CDCl3) δH 1.26 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.39 (td, J = 7.1, 5.3 Hz, 3H, -OCH2CH3), 2.29 (d, J = 4.4 Hz, 3H, -
C(O)CH3), 2.38 (d, J = 5.0 Hz, 3H, -C(O)CH3), 2.46 (ddd, J = 15.8, 
11.3, 3.3 Hz, 1H, -C(F)CH2-), 2.69 (td, J = 15.4, 4.7 Hz, 1H, -
C(F)CH2-), 2.83 – 2.96 (m, 1H, -C(F)CH2-), 2.95 – 3.09 (m, 1H, -C(F)CH2-), 4.05 – 
4.24 (m, 2H, -OCH2CH3), 4.27 – 4.48 (m, 2H, -OCH2CH3), 5.99 – 6.15 (m, 2H, 2 x -
C(H)ONO2), 7.31 – 7.57 (m, 10H, 2 x 5Haromatic). 
19F NMR (376 MHz, CDCl3) δF -
167.78 (ddq, J = 22.4, 15.1, 4.9 Hz, -C(F)-), -166.92 (ddq, J = 29.1, 11.3, 4.4 Hz, -
C(F)-). 13C NMR (101 MHz, CDCl3) δC 13.82 (-C(O)CH3), 13.93 (-C(O)CH3), 25.03 (-
OCH2CH3), 25.15 (-OCH2CH3), 38.19 (d, J = 2.9 Hz, -C(F)CH2-), 38.39 (d, J = 2.4 
Hz, -C(F)CH2-), 63.12 (-OCH2CH3), 63.29 (-OCH2CH3), 79.46 (d, J = 4.3 Hz, -
C(H)ONO2), 80.02 (d, J = 4.9 Hz, -C(H)ONO2), 96.72 (d, J = 198.7 Hz, -C(F)-), 
97.31 (d, J = 201.1 Hz, -C(F)-), 126.52, 126.69 (d, J = 2.3 Hz), 128.95, 129.01, 
129.47, 129.48, 136.44, 136.78 (10C, Caromatic), 165.21 (d, J = 25.0 Hz, -C(O)CH3), 
165.70 (d, J = 25.9 Hz, -C(O)CH3), 199.73 (d, J = 27.7 Hz, -C(O)OCH2CH3), 201.23 
(d, J = 28.6 Hz, -C(O)OCH2CH3). IR (ATR) υ 2987 (m), 2173 (w), 2150 (w), 1754 
(vs), 1736 (vs), 1636 (vs), 1587 (m), 1563 (m), 1530 (w), 1496 (m), 1457 (m), 1419 
(w), 1359 (m), 1273 (vs), 1233 (m), 1194 (m), 1147 ( m), 1105 (w), 1074 (w), 1057 
(w), 1013 (s), 844 (vs), 753 (s), 698 (vs), 589 (m), 528 (s) cm-1. m/z (EI+)  251 (63%, 
[M-ONO2]
+), 152 (100%, [C7H6NO3
•]+). m/z (ASAP) 231 (100%, [M-F-ONO2
•]+). 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)decanoate, 219b (225 mg, 35%) 
1H NMR (400 MHz, CDCl3) δH 0.86 – 0.93 (m, 3H, -
C(H)ONO2-CH2(CH2)4CH3), 1.21 – 1.52 (m, 11H, -C(H)ONO2-
CH2(CH2)4CH3 + -OCH2CH3), 1.58 – 1.97 (m, 2H, -C(H)ONO2-
CH2(CH2)4CH3), 2.31 (d, J = 1.5 Hz, 3H, -C(O)CH3), 2.33 (d, J 
= 2.1 Hz, 3H, -C(O)CH3), 2.35 – 2.65 (m, 4H, 2 x -C(F)CH2-), 4.13 – 4.44 (m, 2H, -
OCH2CH3), 4.57 – 4.70 (m, 2H, -OCH2CH3), 5.21 – 5.37 (m, 2H, 2 x -C(H)ONO2-). 
19F NMR (376 MHz, CDCl3) δF -167.42 (tq, J = 20.7, 4.8 Hz, -C(F)-), -166.97 (ddq, J 
= 28.1, 14.6, 4.4 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δ 13.85, 13.87, 13.96, 
13.98 (4C, 2 x -OCH2CH3 + -C(H)ONO2-CH2(CH2)4CH3), 22.43, 22.46, 23.08, 24.54, 




24.64, 24.69, 25.03, 25.06, 28.69, 28.73, 28.84, 30.47, 30.57, 31.42, 31.50, 33.32, 
33.59, 34.35, 34.52 (12C, 2 x -C(O)CH3 + 2 x -C(H)ONO2-(CH2)5CH3), 35.86 (d, J = 
10.7 Hz, -C(F)CH2-), 36.07 (d, J = 10.4 Hz, -C(F)CH2-), 63.18 (-OCH2CH3), 78.79 (d, 
J = 2.8 Hz, -C(H)ONO2), 79.33 (d, J = 3.1 Hz, -C(H)ONO2), 97.22 (d, J = 198.2 Hz, -
C(F)-), 98.01 (d, J = 200.8 Hz, -C(F)-), 165.54 (d, J = 21.1 Hz, -C(O)CH3), 165.79 (d, 
J = 22.3 Hz, -C(O)CH3), 200.16 (d, J = 28.1 Hz, -C(O)OCH2CH3), 201.33 (d, J = 
25.8 Hz, -C(O)OCH2CH3). IR (ATR) υ 2932 (m), 2861 (w), 1737 (s), 1631 (vs), 1558 
(s), 1466 (w), 1358 (w), 1274 (vs), 1189 (w), 1154 (w), 1096 (w), 1014 (w), 844 (vs), 
753 (m), 696 (m), 551 (w). m/z (EI+) 43 (100%), 69 (46%), 81 (25%), 109 (19%). 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)-4-4-chlorophenylbutanoate, 219d (390 mg, 
56%) 
1H NMR (400 MHz, CDCl3) δH 1.27 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.37 (t, J = 7.2 Hz, 3H, -OCH2CH3), 2.30 (d, J = 4.4 Hz, 3H, -
C(O)CH3), 2.37 (d, J = 5.0 Hz, 3H, -C(O)CH3), 2.42 (ddd, J = 15.8, 
11.2, 3.3 Hz, 1H, -C(F)CH2-), 2.65 (td, J = 15.2, 4.7 Hz, 1H, -
C(F)CH2-), 2.87 (ddd, J = 22.3, 15.5, 9.7 Hz, 1H, -C(F)CH2-), 2.96 
(ddd, J = 28.6, 15.6, 10.5 Hz, 1H, -C(F)CH2-), 4.09 – 4.23 (m, 2H, -OCH2CH3), 4.27 
– 4.46 (m, 2H, -OCH2CH3), 5.99 (dd, J = 9.1, 4.0 Hz, 1H, -C(H)ONO2), 6.02 (dd, J = 
10.1, 2.6 Hz, 1H, -C(H)ONO2), 7.31 – 7.42 (m, 4H, Haromatic).
19F NMR (376 MHz, 
CDCl3) δF -167.75 (ddq, J = 22.3, 14.9, 4.9 Hz, -C(F)-), -166.81 (ddq, J = 29.0, 10.9, 
4.3 Hz, -C(F)-).13C NMR (101 MHz, CDCl3) δC 13.82 (-C(O)CH3), 13.92 (-C(O)CH3), 
25.01 (-OCH2CH3), 25.12 (-OCH2CH3), 37.98 (d, J = 2.9 Hz, -C(F)CH2-), 38.18 (d, J 
= 2.2 Hz, -C(F)CH2-), 63.21 (-OCH2CH3), 63.35 (-OCH2CH3), 78.66 (d, J = 4.3 Hz, -
C(H)ONO2), 79.20 (d, J = 5.2 Hz, -C(H)ONO2), 96.57 (d, J = 199.1 Hz, -C(F)-), 
97.15 (d, J = 201.3 Hz, -C(F)-), 127.94 (-C-C(H)C(H)C(Cl)C(H)C(H)-), 128.13 (-C-
C(H)C(H)C(Cl)C(H)C(H)-), 129.22 (-C-C(H)C(H)C(Cl)C(H)C(H)-), 129.28 (-C-
C(H)C(H)C(Cl)C(H)C(H)-), 134.95 (-C-C(H)C(H)C(Cl)C(H)C(H)-), 135.30 (-C-
C(H)C(H)C(Cl)C(H)C(H)-), 135.46 (-C-C(H)C(H)C(Cl)C(H)C(H)-), 135.50 (-C-
C(H)C(H)C(Cl)C(H)C(H)-), 165.12 (d, J = 24.9 Hz, -C(O)CH3), 165.58 (d, J = 25.9 
Hz, -C(O)CH3), 199.58 (d, J = 27.6 Hz, -C(O)OCH2CH3), 201.13 (d, J = 28.8 Hz, -
C(O)OCH2CH3). IR (ATR) υ 2982 (m), 1754 (vs), 1735 (vs), 1637 (vs), 1598 (w), 
1494 (s), 1416 (m), 1359 (m), 1272 (vs), 1233 (w), 1192 (m), 1148 (w), 1118 (w), 
1092 (vs), 1058 (w), 1014 (vs), 963 (w), 836 (vs), 752 (m), 722 (w), 688 (m), 649 
(w), 600 (w), 530 (s) cm-1. m/z (EI+) 285 (34%, [M-ONO2]
+), 152 (100%, 





2•]+). Elemental analysis calcd for C14H15ClFNO6, C: 48.36, H: 4.35, N: 
4.03; found C: 47.96, H: 4.35, N: 3.94. 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)-4-2-chlorophenylbutanoate, 219e 
(390 mg, 57%)  
1H NMR (400 MHz, CDCl3) δH 1.31 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.39 (t, J = 7.2 Hz, 3H, -OCH2CH3), 2.34 (d, J = 4.3 Hz, 3H, -
C(O)CH3), 2.40 (d, J = 5.0 Hz, 3H, -C(O)CH3), 2.45 (dd, J = 9.2, 2.8 
Hz, 1H, -C(F)CH2-), 2.49 (dd, J = 9.2, 2.8 Hz, 1H, -C(F)CH2-), 2.65 – 
2.84 (m, 1H , -C(F)CH2-), 2.82 – 2.96 (m, 1H, -C(F)CH2-), 4.21 – 
4.31 (m, 2H, -OCH2CH3), 4.30 – 4.47 (m, 2H, -OCH2CH3), 6.48 (dd, J = 10.3, 3.9 Hz, 
1H, -C(H)ONO2), 6.52 (dd, J = 11.0, 2.8 Hz, 1H, -C(H)ONO2), 7.29 – 7.48 (m, 8H, 
Haromatic). 
19F NMR (376 MHz, CDCl3) δF -168.27 (ddq, J = 24.8, 13.2, 5.1 Hz, -C(F)-
), -167.64 (ddq, J = 31.1, 8.9, 4.3 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 13.88 
(-C(O)CH3), 13.94 (-C(O)CH3), 25.00 (-OCH2CH3), 25.19 (-OCH2CH3), 37.08 (d, J = 
2.5 Hz, -C(F)CH2-), 37.28 (d, J = 1.8 Hz, -C(F)CH2-), 63.24 (-OCH2CH3), 63.30 (-
OCH2CH3), 75.81 (d, J = 4.4 Hz, -C(H)ONO2), 76.31 (d, J = 4.8 Hz, -C(H)ONO2), 
96.45 (d, J = 199.6 Hz, -C(F)-), 97.28 (d, J = 201.8 Hz, -C(F)-), 126.50, 126.72, 
127.69, 127.73, 130.01 (d, J = 5.8 Hz), 130.27 (d, J = 4.3 Hz), 132.00, 132.17, 
134.83, 135.03 (2 x 5C, Caromatic), 165.18 (d, J = 24.9 Hz, -C(O)CH3), 165.68 (d, J = 
26.0 Hz, -C(O)CH3), 199.51 (d, J = 27.7 Hz, -C(O)OCH2CH3), 201.45 (d, J = 28.9 
Hz, -C(O)OCH2CH3). IR (ATR) υ 2987 (m), 1755 (vs), 1735 (vs), 1641 (vs), 1594 
(m), 1477 (m), 1444 (m), 1419 (w), 1359 (s), 1273 (vs), 1231 (m), 1192 (s), 1136 
(m), 1102 (m), 1052 (m), 1037 (w), 1013 (m), 962 (w), 835 (vs), 756 (vs), 691 (s), 
665 (w), 595 (m), 538 (s) cm-1. m/z (EI+)  285 (76%, [M-ONO2]
+), 152 (100%, 
[C7H5NO3
2•]+). m/z (ASAP) 265 (100%, [M-F-ONO2
•]+). Elemental analysis calcd for 
C14H15ClFNO6, C: 48.36, H: 4.35, N: 4.03; found C: 48.34, H: 4.35, N: 3.83. 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)-4-2,6-dichlorophenylbutanoate, 219f (451 
mg, 59%)  
1H NMR (400 MHz, CDCl3) δH 1.30 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.39 (t, J = 7.1 Hz, 3H, -OCH2CH3), 2.34 (d, J = 4.4 Hz, 2H, -
C(O)CH3), 2.41 (d, J = 4.9 Hz, 3H, -C(O)CH3), 2.47 (ddd, J = 15.9, 
9.8, 3.5 Hz, 1H, -C(F)CH2-), 2.78 (ddd, J = 15.5, 14.6, 4.6 Hz, 1H, -
C(F)CH2-), 3.37 (ddd, J = 24.4, 15.5, 10.0 Hz, 1H, -C(F)CH2-), 3.50 
(ddd, J = 30.9, 15.8, 10.8 Hz, 1H, -C(F)CH2-), 4.18 – 4.51 (m, 3H, -OCH2CH3), 4.68 




(ddd, J = 16.2, 12.9, 3.0 Hz, 1H, -OCH2CH3), 5.38 (dd, J = 15.1, 10.0 Hz, 0.5H, -
C(H)ONO2), 5.92 (dd, J = 16.1, 8.8 Hz, 0.5H, -C(H)ONO2), 6.80 (dd, J = 10.0, 4.6 
Hz, 0.5H, -C(H)ONO2), 6.86 (dd, J = 10.8, 3.4 Hz, 0.5H, -C(H)ONO2), 7.18 – 7.56 
(m, 2 x 3H, Haromatic), 7.86 (d, J = 14.0 Hz, trace), 8.27 (d, J = 13.9 Hz, trace). 
19F 
NMR (376 MHz, Chloroform-d) δF -168.58 (ddq, J = 24.4, 14.7, 4.9 Hz, -C(F)-), -
167.97 (ddd, J = 30.8, 14.2, 4.4 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 13.85 (-
C(O)CH3), 13.94 (-C(O)CH3), 25.02 (-OCH2CH3), 25.23 (-OCH2CH3), 34.54 (d, J = 
19.8 Hz, -C(F)CH2-), 34.64 (d, J = 20.3 Hz, -C(F)CH2-), 63.29 (-OCH2CH3), 63.36 (-
OCH2CH3), 72.70, 72.82 (traces), 75.38 (d, J = 4.8 Hz, -C(H)ONO2), 75.64 (trace), 
75.88 (d, J = 5.0 Hz, -C(H)ONO2), 80.27 (trace) , 96.67 (d, J = 199.1 Hz, -C(F)-), 
97.47 (d, J = 201.9 Hz, -C(F)-), 129.27, 129.83, 130.76, 130.81, 130.88, 131.18, 
131.61, 131.85, 132.04, 132.38 (2 x 5C, Caromatic), 165.14 (d, J = 25.0 Hz, -
C(O)CH3), 165.52 (d, J = 26.2 Hz, -C(O)CH3), 199.49 (d, J = 27.5 Hz, -
C(O)OCH2CH3), 201.01 (d, J = 28.4 Hz, -C(O)OCH2CH3). IR (ATR) υ 2985 (m), 
2023 (w), 1754 (vs), 1736 (vs), 1642 (vs), 1563 (vs), 1533 (m), 1438 (s), 1359 (w), 
1341 (w), 1276 (vs), 1232 (w), 1208 (w), 1185 (s), 1153 (w), 1091 (m), 1059 (w), 
1014 (m), 962 (m), 900 (w), 834 (vs), 774 (vs), 750 (w), 696 (m), 638 (w), 608 (w), 
542 (s) cm-1. m/z (EI+)  319 (93%, [M-ONO2]
+), 152 (100%, [C7H4NO3
3•]+). m/z 
(ASAP) 299 (100%, [M-F-ONO2
•]+). 
Ethyl-2-acetyl-2-fluoro-4-(nitrooxy)-4-4-fluorophenylbutanoate, 219g (397 mg, 
60%) 
1H NMR (400 MHz, CDCl3) δ 1.26 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.36 (t, J = 7.2 Hz, 3H, -OCH2CH3), 2.28 (d, J = 4.4 Hz, 3H, -
C(O)CH3), 2.36 (d, J = 4.9 Hz, 3H, -C(O)CH3), 2.43 (ddd, J = 15.8, 
11.4, 3.4 Hz, 1H, -C(F)CH2-), 2.66 (td, J = 15.4, 4.8 Hz, 1H, -
C(F)CH2-), 2.81 – 3.05 (m, 2H, -C(F)CH2-), 4.09 – 4.21 (m, 2H, -OCH2CH3), 4.28 – 
4.47 (m, 2H, -OCH2CH3), 5.98 – 6.07 (m, 1H, -C(H)ONO2), 7.09 (t, J = 8.6 Hz, 2H, 2 
x Hmeta), 7.35 – 7.42 (m, 2H, 2 x Hortho). 
19F NMR (376 MHz, CDCl3) δF -167.80 (ddq, 
J = 22.3, 15.1, 4.9 Hz, -C(F)-), -166.92 (ddq, J = 28.8, 11.4, 4.4 Hz, -C(F)-), -111.33 
(dtt, J = 17.9, 8.4, 5.2 Hz, -CFpara). 
13C NMR (101 MHz, CDCl3) δC 13.79 (-C(O)CH3), 
13.89 (-C(O)CH3), 24.98 (-OCH2CH3), 25.08 (-OCH2CH3), 38.03 (d, J = 2.9 Hz, -
C(F)CH2-), 38.23 (d, J = 2.3 Hz, -C(F)CH2-), 63.16 (-OCH2CH3), 63.32 (-OCH2CH3), 
78.76 (d, J = 4.4 Hz, -C(H)ONO2), 79.30 (d, J = 5.2 Hz, -C(H)ONO2), 96.62 (d, J = 
198.9 Hz, -C(F)-), 97.19 (d, J = 201.2 Hz, -C(F)-), 115.92 (d, J = 6.5 Hz, -C-
C(H)C(H)C(F)C(H)C(H)-), 116.14 (d, J = 6.3 Hz, -C-C(H)C(H)C(F)C(H)C(H)-), 




128.62 (d, J = 8.5 Hz, -C-C(H)C(H)C(F)C(H)C(H)-), 128.81 (d, J = 8.7 Hz, -C-
C(H)C(H)C(F)C(H)C(H)-), 132.26 (d, J = 3.4 Hz, -C(H)(ONO2)-C-), 132.62 (d, J = 3.3 
Hz, -C(H)(ONO2)-C-), 161.94 (d, J = 2.4 Hz, -C-C(H)C(H)C(F)C(H)C(H)-), 164.42 (d, 
J = 2.5 Hz, -C-C(H)C(H)C(F)C(H)C(H)-), 165.14 (d, J = 25.1 Hz, -C(O)CH3), 165.61 
(d, J = 25.9 Hz, -C(O)CH3), 199.64 (d, J = 27.5 Hz, -C(O)OCH2CH3), 201.12 (d, J = 
28.6 Hz, -C(O)OCH2CH3). IR (ATR) υ 2989 (m), 2036 (w), 1753 (vs), 1735 (vs), 
1637 (vs), 1607 (m), 1563 (w), 1512 (vs), 1447 (w), 1420 (w), 1360 (m), 1274 (vs), 
1227 (vs), 1192 (w), 1159 (m), 1113 (w), 1092 (m), 1057 (w), 1013 (m), 963 (w), 837 
(vs), 753 (m), 725 (w), 696 (w), 665 (w), 606 (w), 568 (w), 531 (m) cm-1. m/z (EI+)  
269 (97%, [M-ONO2]
+), 152 (100%, [C7H5NO3




219h (500 mg, 62%) 
1H NMR (400 MHz, CDCl3) δH 1.32 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.38 (t, J = 7.1 Hz, 3H, -OCH2CH3), 2.33 (d, J = 4.4 Hz, 3H, -
C(O)CH3), 2.38 (d, J = 4.8 Hz, 3H, -C(O)CH3), 2.55 (ddd, J = 15.4, 
10.7, 4.4 Hz, 1H, -C(F)CH2-), 2.79 (td, J = 15.7, 5.3 Hz, 1H, -
C(F)CH2-), 3.14 (ddd, J = 22.0, 15.4, 8.9 Hz, 1H, -C(F)CH2-), 3.25 
(ddd, J = 29.3, 15.7, 9.8 Hz, 1H, -C(F)CH2-), 4.25 – 4.47 (m, 4H, 2 x -OCH2CH3), 
6.07 (d, J = 48.7 Hz, trace), 6.35 (dd, J = 9.0, 5.4 Hz, 1H, -C(H)ONO2), 6.40 (dd, J = 
9.8, 4.4 Hz, 1H, -C(H)ONO2), 7.84 (d, J = 14.0 Hz, trace), 8.05 (d, J = 14.0 Hz, 
trace). 19F NMR (376 MHz, CDCl3) δF -168.17 (ddq, J = 21.1, 15.4, 4.9 Hz, -C(F)-), -
167.47 (ddq, J = 29.5, 9.0, 4.5 Hz, -C(F)-), -160.26 – -160.06 (m, 2F, -CFmeta), -
150.43 (tdt, J = 20.9, 11.7, 3.1 Hz, 2F, -CFpara), -141.14 – -141.00 (m, 1F, -CFortho), -
141.00 – -140.86 (m, 1F, -CFortho). 
13C NMR (101 MHz, CDCl3) δC 13.78 (-C(O)CH3), 
13.83 (-C(O)CH3), 24.87 (-OCH2CH3), 25.06 (-OCH2CH3), 35.12 (d, J = 10.7 Hz, -
C(F)CH2-), 35.32 (d, J = 11.5 Hz, -C(F)CH2-), 63.50 (-OCH2CH3), 63.56 (-
OCH2CH3), 69.67 (br s, -C(H)ONO2), 70.12 (br s, -C(H)ONO2), 96.32 (d, J = 199.0 
Hz, -C(F)-), 97.09 (d, J = 201.6 Hz, -C(F)-), 136.46, 138.98, 140.92, 143.48, 143.85, 
146.37 (6 x m, 6C, Caromatic), 164.84 (d, J = 24.8 Hz, -C(O)CH3), 165.13 (d, J = 26.0 
Hz, -C(O)CH3), 199.15 (d, J = 27.5 Hz, -C(O)OCH2CH3), 200.57 (d, J = 28.4 Hz, -
C(O)OCH2CH3). IR (ATR) υ 2990 (m), 2073 (w), 1756 (vs), 1738 (vs), 1651 (vs), 
1523 (s), 1507 (vs), 1427 (w), 1361 (m), 1309 (w), 1276 (s), 1224 (w), 1198 (w), 
1151 (w), 1135 (m), 1109 (w), 1061 (w), 998 (s), 969 (w), 946 (w), 836 (vs), 750 (m), 
683 (m), 625 (w), 575 (w), 534 (m) cm-1. m/z (EI+)  341 (93%, [M-ONO2]
+), 152 





6•]+). m/z (ASAP) 321 (100%, [M-F-ONO2
•]+). Elemental analysis 
calcd for C14H11F6NO6, C: 41.70, H: 2.75, N: 3.47; found C: 41.43, H: 2.61, N: 3.57. 
5. Experimental to chapter 5 
General procedure 
In a 50 mL two-necked flask containing dichloromethane (10 mL) were added the 
amine (17 mmol)  followed by chosen aldehyde (15 mmol) and the resulting reaction 
mixture was allowed to stir at r.t. for 2 h., before the fluorinated dicarbonyl system 
was added (10 mmol). The reaction mixture was stirred at r.t. for 16 h, evaporated 
and the residue dissolved in dichloromethane (20 mL), washed with distilled water (2 
x 20 mL), dried over magnesium sulfate and evaporated, to give the desired 
product. Further purification by distillation or column chromatography eluting from 
hexane/ethyl acetate was carried out when appropriate. 
5.1. Mannich reactions of 2-fluoro-ethylacetoacetate and formaldehyde 
Ethyl-2-((benzylamino)methyl)-2-fluoro-3-oxobutanoate, 273a 
1H NMR (400 MHz, CDCl3) δH 1.31 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.97 (s, 1H, NH), 2.39 (d, J = 4.8 Hz, 3H, -C(O)CH3), 3.80 – 4.08 (m, 
2H, -CF-CH2-NH-), 4.28 (q, J = 7.1 Hz, 2H, -OCH2CH3), 6.63 – 6.95 
(m, 3H, -NH-C-CHCHCHCHCH-), 7.12 – 7.24 (m, 2H, -NH-C-
CHCHCHCHCH-). 19F NMR (376 MHz, CDCl3) δF -169.37 (tq, J = 
22.4, 4.8 Hz, -C(F)-), -167.73 - -167.50 (m). 13C NMR (101 MHz, CDCl3) δC 13.97 (-
OCH2CH3), 26.27 (-C(O)CH3), 47.53 (d, J = 20.5 Hz, -CF-CH2-N-), 62.96 (-
OCH2CH3), 100.23 (d, J = 198.8 Hz, -C(F)-), 113.62 (-NH-C-CHCHCHCHCH-), 
118.80 (-NH-C-CHCHCHCHCH-), 129.27 (-NH-C-CHCHCHCHCH-), 147.17 (-NH-
C-CHCHCHCHCH-), 165.01 (d, J = 25.4 Hz, -C(O)OCH2CH3), 201.35 (d, J = 28.6 
Hz, -C(O)CH3). MS (ESI) m/z 115.02 (100%), 123.98 (68.4%), 224.12 (62.7%), 










1H NMR (400 MHz, CDCl3) δH 0.87 (t, J = 7.1 Hz, 6H, 2 x –
NCH2CH3), 1.22 (t, J = 7.1 Hz, 3H, -OCH2CH3), 2.23 (s, 1.5 H, -
C(O)CH3), 2.24 (s, 1.5 H, -C(O)CH3), 2.51 (qd, J = 7.1, 1.0 Hz, 4H, 2 
x –NCH2CH3), 3.05 (s, 1H, -CF-CH2-N-), 3.12 (s, 1H, -CF-CH2-N-), 
4.18 (q, J = 7.1 Hz, 2H, -OCH2CH3). 
19F NMR (376 MHz, CDCl3) δF -166.64 (tq, J = 
26.1, 5.0 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 11.45 (2 x –NCH2CH3), 13.86 (-
OCH2CH3), 26.41 (-C(O)CH3), 47.89 (d, J = 2.5 Hz, 2 x –NCH2CH3), 56.42 (d, J = 
18.4 Hz, -CF-CH2-N-), 62.18 (-OCH2CH3), 102.21 (d, J = 199.1 Hz, -C(F)-), 165.39 
(d, J = 26.0 Hz, -C(O)OCH2CH3), 201.94 (d, J = 29.6 Hz, -C(O)CH3). MS (ESI) m/z 
234.07 ([M+H]+, 100%), 86.04 ([M-C6H8FO3]
+, 95.3%), 266.10 (81.7%). HRMS (ESI) 
m/z calcd for [M+H]+ C11H21FNO3 234.1505; found 234.1504. 
Ethyl-2-((diisopropylamino)methyl)-2-fluoro-3-oxobutanoate, 273f 
1H NMR (400 MHz, CDCl3) δH 0.97 (dd, J = 6.7, 3.9 Hz, 12H, 2 x -N-
CH-(CH3)2), 1.21 (d, J = 6.2 Hz, 3HB, -OCH2CH3), 1.32 (t, J = 7.1 Hz, 
3HA, -OCH2CH3), 2.32 (d, J = 5.1 Hz, 3HA, -C(O)CH3), 2.38 (d, J = 
4.7 Hz, 3HB, -C(O)CH3), 3.08 (hept, J = 6.6 Hz, 2H, -C(F)-CH2-N-), 
3.24 (dq, 2H, 2 x -N-CH-(CH3)2), 4.13 – 4.39 (m, 2H, -OCH2CH3).
19F NMR (376 
MHz, CDCl3) δF -163.81 (ddq, J = 22.3, 20.8, 4.7 Hz, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 13.98 (-OCH2CH3), 20.66 (d, J = 11.0 Hz, 2 x -N-CH-(CH3)2), 26.87 (-
C(O)CH3), 48.66 (d, J = 2.8 Hz, 2 x -N-CH-(CH3)2), 49.45 (d, J = 18.7 Hz, -C(F)-CH2-
N-), 62.29 (-OCH2CH3), 102.78 (d, J = 198.7 Hz, -C(F)-), 165.72 (d, J = 26.0 Hz, -
C(O)OCH2CH3), 202.63 (d, J = 30.3 Hz, -C(O)CH3). MS (ESI) m/z 102.10 ([M-
C7H10FO3
•]+, 100%), 114.10 ([M-C6H8FO3
•]+, 77.9%), 262.13 ([M+H]+, 74.3%), 294.2 
(55.8%). HRMS (ESI) m/z calcd for [M+H]+ C13H25FNO3 262.1818; found 262.1803. 
Ethyl-2-(pyrrolidin-1-methyl)-2-fluoro-3-oxobutanoate, 273g 
1H NMR (400 MHz, CDCl3) δH 1.25 (tdd, J = 7.1, 2.1, 1.3 Hz, 3H, -
OCH2CH3), 1.66 (ddt, J = 6.9, 5.1, 2.6 Hz, 4H, -NCH2CH2CH2CH2-), 
2.27 (s, 3H, -C(O)CH3), 2.49-2.65 (m, 4H, -NCH2CH2CH2CH2-), 3.06-
3.31 (m, 2H, -CF-CH2-N-), 4.10-4.36 (m, 2H, -OCH2CH3). 
19F NMR 
(376 MHz, CDCl3) δF -166.84 (ddq, J = 29.7, 25.1, 4.8 Hz, -C(F)-). 
13C NMR (101 
MHz, CDCl3) δC 13.93 (-OCH2CH3), 23.83 (-NCH2CH2CH2CH2-), 26.23 (-C(O)CH3), 
55.28 (-NCH2CH2CH2CH2-), 58.41 (d, J = 19.4 Hz, -CF-CH2-N-), 62.34 (-OCH2CH3), 
101.62 (d, J = 199.2 Hz, -C(F)-), 165.35 (d, J = 25.8 Hz, -C(O)OCH2CH3), 201.39 (d, 




J = 28.6 Hz, -C(O)CH3). MS (ESI) m/z 232.10 ([M+H]
+, 100%), 264.18 (56.4%), 
84.01 ([M-C5H6FO4
•]+, 49.3%). HRMS (ESI) m/z calcd for [M+H]+ C11H19FNO3 
232.1349; found 231.1350. 
Ethyl-2-(piperidin-1-methyl)-2-fluoro-3-oxobutanoate, 273h 
1H NMR (400 MHz, CDCl3) δH 1.29 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.35 (q, J = 6.0 Hz, 2H, -NCH2CH2CH2CH2CH2-), 1.48 (p, J = 5.5 Hz, 
4H, -NCH2CH2CH2CH2CH2-), 2.30 (d, J = 4.9 Hz, 3H, -C(O)CH3), 
2.49 (q, J = 5.9 Hz, 4H, -NCH2CH2CH2CH2CH2-), 3.02 (d, J = 26.8 
Hz, -CF-CH2-N-), 4.09 – 4.43 (m, 2H, -OCH2CH3). 
19F NMR (376 MHz, CDCl3) δF -
165.59 (tq, J = 26.6, 4.9 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 14.01 (-
OCH2CH3), 23.84 (-NCH2CH2CH2CH2CH2-), 26.18 (-NCH2CH2CH2CH2CH2-), 26.40 
(-C(O)CH3), 55.82 (d, J = 2.5 Hz, -NCH2CH2CH2CH2CH2-), 61.10 (d, J = 18.5 Hz, -
CF-CH2-N-), 62.30 (-OCH2CH3), 102.16 (d, J = 199.9 Hz, -C(F)-), 165.40 (d, J = 25.8 
Hz, -C(O)OCH2CH3), 201.75 (d, J = 29.3 Hz, -C(O)CH3). MS (ESI) m/z 246.31 
([M+H]+, 100%). HRMS (ESI) m/z calcd for [M+H]+ C12H21FNO3 246.1505; found 
246.1508. 
Ethyl-2-((benzylmethylamino)methyl)-2-fluoro-3-oxobutanoate, 273i 
1H NMR (400 MHz, CDCl3) δH 1.30 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
2.26 (d, J = 0.8 Hz, 3H, -C(O)CH3), 2.34 (d, J = 4.7 Hz, 3H, -NCH3), 
3.24 (dq, J = 26.0, 14.7 Hz, 2H, -CF-CH2-N-), 3.63 (d, J = 5.1 Hz, 2H, 
-N(CH3)-CH2-C-), 4.28 (q, J = 7.2 Hz, 2H, -OCH2CH3), 7.09 – 7.41 (m, 
5H, Haromatic). 
19F NMR (376 MHz, CDCl3) δF -166.35 (tq, J = 25.8, 4.8 
Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 14.02 (-OCH2CH3), 26.27 (-C(O)CH3), 
43.40 (d, J = 3.2 Hz, -NCH3), 59.84 (d, J = 18.4 Hz, -CF-CH2-N-), 62.50 (-
OCH2CH3), 63.51 (d, J = 2.5 Hz, -N(CH3)-CH2-C-), 102.16 (d, J = 199.5 Hz, -C(F)-), 
127.12 (-CH2-C-CHCHCHCHCH-), 128.22 (-CH2-C-CHCHCHCHCH-), 128.90 (-
CH2-C-CHCHCHCHCH-), 138.59 (-CH2-C-CHCHCHCHCH-), 165.36 (d, J = 26.0 
Hz, -C(O)OCH2CH3), 201.13 (d, J = 28.8 Hz, -C(O)CH3). MS (ESI) m/z 122.23 
([C8H10N
•]+, 100%), 282.23 ([M+H]+, 90.5%), 300.36 (72.4%). HRMS (ESI) m/z calcd 
for [M+H]+ C15H20FNO3 282.1505 ; found 282.1516. 
 
 





1H NMR (400 MHz, CDCl3) δH 0.85 – 1.27 (m), 1.41 – 1.55 (m), 
1.55 – 1.70 (m), 1.64 – 1.86 (m) (23H, 2 x -N-CH-(CH2)5- + -
OCH2CH3), 2.19 (d, J = 5.2 Hz, 3HA, -C(O)CH3), 2.25 (d, J = 4.7 
Hz, 3HB, -C(O)CH3), 2.36 – 2.56 (m, 2H, 2 x –N-CH-(CH2)5-), 3.14 
- 3.35 (m, 2H, -C(F)-CH2-), 3.90 – 4.26 (m, 2HA+B, -OCH2CH3). 
19F 
NMR (376 MHz, CDCl3) δF -171.87 (ddq, J = 26.6, 21.8, 4.8 Hz, 1FB, -C(F)-), -
164.36 (tq, J = 26.5, 5.2 Hz, 1FA, -C(F)-). 
13C NMR (101 MHz, CDCl3) δC 13.83 (-
OCH2CAH3), 13.96 (-OCH2CBH3), 25.16, 25.92, 26.00, 26.42, 26.44 (-C(O)CH3 + 2 x 
-N-CH-CH2(CH2)3CH2-), 26.57 (-C(O)CBH3), 26.75 (-C(O)CAH3), 31.74, 31.86, 33.80 
(-N-CH-CA+BH2(CH2)3CA+BH2-), 50.28 (d, J = 18.5 Hz, -C(F)-CAH2-), 52.92 (2 x -N-
CAH-(CH2)5-), 58.89 (d, J = 2.4 Hz, 2 x -N-CBH-(CH2)5-), 62.07 (-OCAH2CH3), 62.35 
(-OCBH2CH3), 63.04 (d, J = 20.7 Hz, -C(F)-CBH2-), 100.78 (d, J = 199.6 Hz, -CB(F)-), 
102.82 (d, J = 198.9 Hz, -CA(F)-), 164.77 (d, J = 25.2 Hz, -CB(O)OCH2CH3), 165.55 
(d, J = 26.0 Hz, -CA(O)OCH2CH3), 201.46 (d, J = 28.5 Hz, -CB(O)CH3), 202.48 (d, J 
= 30.3 Hz, -CA(O)CH3). MS (ESI) m/z 182.2 ([C12H22N
•+H]+, 100%), 191.3 ([M-
C6H8FO3
•]+, 28.9%), 312.4 (38.5%), 342.4 ([M+H]+, 31.5%), HRMS (ESI) m/z calcd 
for [M+H]+ C19H33FNO3 342.2444, found 342.2445. 
5.2. Mannich reactions of fluorinated dicarbonyl systems and 
benzaldehyde 
Ethyl-2-(phenyl(benzylmethylamino)methyl)-2-fluoro-3-oxobutanoate, 275a 
1H NMR (400 MHz, CDCl3) δH 0.96 (t, J = 7.1 Hz, 3HA, -
OCH2CH3), 1.36 (t, J = 7.1 Hz, 3HB, -OCH2CH3), 2.13 (d, J = 5.6 
Hz, 3HA, -C(O)CH3), 2.16 (s, 3HA, -NCH3), 2.21 (s, 3HB, -NCH3), 
2.52 (d, J = 5.5 Hz, 3HB, -C(O)CH3), 3.32 (d, J = 12.9 Hz, 1H, -
N(CH3)-CH2-), 3.46 (d, J = 13.0 Hz, 1H, -N(CH3)-CH2), 3.67 (d, J = 12.9 Hz, 1H, -
N(CH3)-CH2), 3.78 (d, J = 8.4 Hz, 1H, -N(CH3)-CH2), 3.96 – 4.13 (m, 2HA, -
OCH2CH3), 4.41 (qd, J = 7.2, 1.5 Hz, 2HB, -OCH2CH3), 4.88 (dd, J = 35.0, 33.1 Hz, 
1H, -C(F)-CH-), 7.08 – 7.97 (m, 10H, Haromatic).
19F NMR (376 MHz, CDCl3) δF -
176.64 (dq, J = 34.6, 5.5 Hz, 1FA, -C(F)-), -174.89 (dq, J = 35.1, 5.5 Hz, 1FB, -C(F)-). 
13C NMR (101 MHz, CDCl3) δC 13.59 (-C(O)OCH2CAH3), 14.16 (-C(O)OCH2CBH3), 
26.40 (-C(O)CBH3), 26.99 (-C(O)CAH3), 38.92 (d, J = 4.9 Hz, -NCAH3), 39.23 (d, J = 
4.2 Hz, -NCBH3), 59.87 (d, J = 3.7 Hz, -N(CH3)-CBH2-C-), 61.00 (d, J = 3.0 Hz, -
N(CH3)-CAH2-C-), 62.39 (-C(O)OCAH2CH3), 62.70 (-C(O)OCBH2CH3), 69.82 (d, J = 




16.0 Hz, -C(F)-CBH-), 70.79 (d, J = 15.8 Hz, -C(F)-CAH-), 105.73 (d, J = 209.4 Hz, -
CA(F)-), 106.66 (d, J = 207.7 Hz, -CB(F)-), 126.98, 127.08, 128.15, 128.19, 128.25, 
128.41, 128.74, 129.00, 129.74 (Caromatic), 130.25 (d, J = 3.5 Hz, -N(CH3)-CH2-CA-), 
130.71 (d, J = 3.7 Hz, -N(CH3)-CH2-CB-), 131.64, 132.02, 134.44 (Caromatic), 138.99 
(-C(F)-CH2-CA-), 139.17 (-C(F)-CH2-CB-), 164.57 (d, J = 25.5 Hz, -CA(O)OCH2CH3), 
165.20 (d, J = 27.5 Hz, -CB(O)OCH2CH3), 200.38 (d, J = 29.7 Hz, -CB(O)CH3), 
201.85 (d, J = 30.6 Hz, -CA(O)CH3). MS (ESI) m/z 122.2 ([C8H10N
•], 100%), 282.3 
([M-C6H5
•+H]+, 26.6%), 358.2 ([M+H]+, 6.0%) HRMS (ESI) m/z calcd for [M+H]+ 
C21H24FNO3 358.1818; found 358.1825. 
Ethyl-2-(phenyl(phenylamino)methyl)-2-fluoro-3-oxobutanoate, 275b 
1H NMR (400MHz, CDCl3) δH 1.12 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.25 (t, J = 7.1 Hz, 3H, -OCH2CH3), 1.96 (d, J = 5.8 Hz, 3H, -OCH3), 
2.41 (d, J = 5.0 Hz, 3H, -OCH3), 4.13 (qd, J = 7.1, 1.4 Hz, 2H, -
OCH2CH3), 4.23 – 4.35 (m, 2H, -OCH2CH3), 5.47 (dd, J = 27.9, 7.0 
Hz, 2H, 2 x -CF-CH-), 6.63 – 6.87 (m, 5H, Haromatic), 7.23 – 7.48 (m, 
4H, Haromatic), 7.23 – 7.48 (m, 11H, Haromatic), 7.48 – 7.56 (m, 2H, Haromatic), 7.90 – 
8.01 (m, 1H, Haromatic), 8.50 (s, 1H, NH). 
19F NMR (376 MHz, CDCl3) δF -179.28 (dq, 
J = 28.1, 5.9 Hz, -C(F)-), -178.69 (d, J = 24.6 Hz, -C(F)-), -109.51. 13C NMR (101 
MHz, CDCl3) δC 13.80 (-OCH2CBH3), 13.99 (-OCH2CAH3), 26.65 (-C(O)CAH3), 26.81 
(-C(O)CBH3), 60.51 (d, J = 18.3 Hz, -CF-CAH-), 61.07 (d, J = 18.6 Hz, -CF-CBH-), 
62.80 (-OCBH2CH3), 63.10 (-OCAH2CH3), 102.32 (d, J = 206.2 Hz, -CB(F)-), 103.03 
(d, J = 204.7 Hz, -CA(F)-), 114.47, 114.86, 115.10, 118.52, 118.93, 119.29 (2 x -NH-
C-CA+BHCHCHCHCA+BH-), 120.89, 125.95, 128.20, 128.43, 128.48 – 128.66 (m), 
128.81, 129.12 – 129.34 (m), 131.39 (Caromatic), 135.47 (-C(F)-CH-CA-), 136.05 (d, J 
= 39.8 Hz, -CF-CH-CB-), 145.46 (-NH-CA-CHCHCHCHCH-), 152.11 (-NH-CB-
CHCHCHCHCH-), 160.42 (-CB(O)OCH2CH3), 164.61 (-CA(O)OCH2CH3), 200.75 (-
CB(O)CH3), 201.05 (-CA(O)CH3). MS (ESI) m/z 182.08 ([M- C6H8FO3
•]+, 100%), 











1H NMR (400 MHz, CDCl3) δH 1.27 (t, J = 7.2 Hz, 3H, -OCH2CH3), 
1.94 (d, J = 5.7 Hz, 3H, -C(O)CH3), 3.70 (s, 3H, -OCH3), 4.24-4.39 
(m, 2H, -OCH2CH3), 5.34 (d, J = 28.2 Hz, 1H, -CF-CH-), 6.60-6.73 
(m, 4H, -NH-C-(CH)2-C(OMe)-(CH)2-), 6.68-6.73 (m, 2H), 7.13-7.46 
(m, 5H, -CH-C-(CH)5-). 
19F NMR (376 MHz, CDCl3) δF -179.57 (q, J = 
5.8 Hz, -C(F)-), -179.49 (q, J = 5.8 Hz, -C(F)-). 13C NMR (101 MHz, 
CDCl3) δC 14.01 (-OCH2CH3), 26.63 (-C(O)CH3), 55.55 (-OCH3), 61.74 (d, J = 18.2 
Hz, -CF-CH-), 63.01 (-OCH2CH3), 103.21 (d, J = 204.6 Hz, -C(F)-), 114.67 (-NH-C-
CHCH-C(OMe)-CHCH-), 116.18 (-NH-C-CHCH-C(OMe)-CHCH-), 128.43 – 128.59 
(m, Caromatic), 135.56 (-C(F)-CH-C-), 139.37 (-NH-C-CHCH-C(OMe)-CHCH-), 153.04 
(-NH-CHCH-C(OMe)-CHCH-), 164.57 (d, J = 26.7 Hz, -C(O)OCH2CH3), 200.99 (d, J 
= 29.5 Hz, -C(O)CH3). MS (ASAP) m/z 212.11 ([M-C6H8FO3
•]+, 100%), 360.17 
([M+H]+, 1.9%). HRMS (ASAP) m/z calcd for [M]+ C20H22FNO4 359.1533; found 
359.1538. 
Dimethyl-2-(phenyl(benzylmethylamino)methyl)-2-fluoromalonate, 275d 
1H NMR (400MHz, CDCl3) δH 2.22 (s, 3H, -NCH3), 3.40 (d, J = 
13.0 Hz, 1H, -N(CH3)-CH2-), 3.60 (s, 3H, -C(O)OCH3), 3.73 (d, J 
= 13.1 Hz, 1H, -N(CH3)-CH2-), 3.95 (s, 3H, -C(O)OCH3), 4.87 
(d, J = 33.8 Hz, 1H, -C(F)-CH-), 7.05 – 7.72 (m, 10H, Haromatic). 
19F NMR (376 MHz, CDCl3) δF -176.52 (d, J = 33.7 Hz, -C(F)-). 
13C NMR (101 MHz, 
CDCl3) δC 39.14 (d, J = 4.5 Hz, -NCH3), 53.28 (-C(O)OCH3), 53.43 (-C(O)OCH3), 
60.37 (d, J = 3.2 Hz, -N(CH3)-CH2-), 69.90 (d, J = 16.1 Hz, -C(F)-CH-), 100.63 (d, J 
= 211.5 Hz, -C(F)-), 127.07, 128.22, 128.23, 128.73, 129.02, 129.73, 130.51, 130.54 
(Caromatic), 134.46 (-N(CH3)-CH2-C-), 139.12 (-C(F)-CH-C-), 165.11 (d, J = 25.7 Hz, -
C(O)OCH3), 165.90 (d, J = 27.6 Hz, -C(O)OCH3).MS (ESI) m/z 122.2 ([C8H10N
•], 
100%), 346.2 (10.3%), 360.4 ([M+H]+, 7.2%) HRMS (ESI) m/z calcd for [M+H]+ 










1H NMR (400 MHz, CDCl3) δH 1.24 (t, J = 7.1 Hz, 3H, -OCH2CH3), 
1.59 (s, 1H, NH), 3.71 (s, 3H, -OCH3), 4.26 (dq, J = 10.7, 7.1 Hz, 
2H, -OCH2CH3), 4.31 – 4.43 (m, 2H, -OCH2CH3), 5.68 (dd, J = 
28.6, 11.8 Hz, 1H, -CF-CH-), 6.61 – 6.78 (m, 4H, -NH-C-(CH)2-
C(OMe)-(CH)2-), 7.16 – 7.27 (m, 3H, -CF-CH-C-CHCHCHCHCH-), 
7.34 – 7.46 (m, 4H, -CF-CH-C-CHCHCHCHCH- + -
C(O)CHCHCHCHCH-), 7.47 – 7.58 (m, 1H, -C(O)CHCHCHCHCH-), 7.84 (ddd, J = 
8.6, 2.1, 1.3 Hz, 2H, -C(O)CHCHCHCHCH-). 19F NMR (376 MHz, CDCl3) δF -173.71 
(t, J = 2.0 Hz, -C(F)-), -173.64 (q, J = 2.0 Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 
14.01 (-OCH2CH3), 55.57 (-OCH3), 61.83 (d, J = 18.6 Hz, -CF-CH-), 63.13 (-
OCH2CH3), 103.63 (d, J = 206.5 Hz, -C(F)-), 114.65 (-NH-C-CHCH-C(OMe)-CHCH-
), 116.23 (-NH-C-CHCH-C(OMe)-CHCH-), 127.97, 128.24, 128.38, 128.99, 129.00, 
129.45, 129.52 (Caromatic), 133.68 (-CF-C(O)-C-), 136.20 (-CF-CH-C-), 139.63 (-NH-
C-CHCH-C(OMe)-CHCH-), 153.01 (-NH-CHCH-C(OMe)-CHCH-), 165.72 (d, J = 
27.1 Hz, -C(O)OCH2CH3), 191.74 (d, J = 26.5 Hz, -C(O)CH3). MS (ASAP) m/z 
212.11 ([M-C11H10FO3
•]+, 100%), 421.19 ([M]+, 1.9%). HRMS (ASAP) m/z calcd for 
[M]+ C25H25FNO4 421.1689; found 421.1674. 
5.3. Mannich reactions of 2-fluoro-1,3-dimethymalonate and 
formaldehyde 
Dimethyl-2-((diethylamino)methyl)-2-fluoromalonate, 274c 
1H NMR (400 MHz, CDCl3) δH 0.91 (t, J = 7.1 Hz, 6H, 2 x –CH2CH3), 
2.57 (q, J = 7.1 Hz, 4H, 2 x CH2CH3), 3.17 (d, J = 26.2 Hz, 2H, -CF-
CH2-N-), 3.78 (s, 6H, 2 x -OCH3). 
19F NMR (376 MHz, CDCl3) δF -
166.73 (t, 1F, J = 26.1 Hz, -C(F)-), -135.15 (tt, 1F, J = 26.8, 13.7 
Hz). 13C NMR (101 MHz, CDCl3) δC 11.62 (-NCH2CH3), 11.74 (-NCH2CH3), 47.97 (d, 
J = 2.5 Hz, -NCH2CH3), 48.25 (d, J = 2.0 Hz, -NCH2CH3), 52.99 (2 x -OCH3), , 56.38 
(d, J = 18.7 Hz, -CF-CH2-N-), 56.82 (d, J = 19.1 Hz, -CF-CH2-N-), 97.27 (d, J = 
200.0 Hz, -C(F)-), 165.82 (d, J = 26.3 Hz, 2 x -C(O)OCH3). MS (ESI) m/z 236.14 
([M+H]+, 100%), 178.08 ([M-C2H3O2
•+2H]+, 64.1%), 122.04 (43.1%), 86.02 ([M-
C5H6FO4
•]+, 36.9%). HRMS (ESI) m/z calcd for [M+H]+ C10H19FNO4 236.1298; found 
236.1299. 





1H NMR (400 MHz, CDCl3) δH 0.95 (d, J = 6.7 Hz, 12HA, 2 x -N-CH-
(CH3)2), 1.25 (d, J = 6.7 Hz, 12HB, 2 x -N-CH-(CH3)2), 2.97 – 3.13 
(m, 2H, -C(F)-CH2-N-), 3.29 (d, J = 26.8 Hz, 2HA, 2 x -N-CH-
(CH3)2), 3.80 (s, 6HA, 2 x -OCH3), 3.86 (s, 6HB, 2 x -OCH3), 4.18 (d, 
J = 21.9 Hz, 2HB, 2 x -N-CH-(CH3)2).
19F NMR (376 MHz, CDCl3) δF
 -172.83 (t, J = 
21.8 Hz, 1FB, -C(F)-), -163.14 (t, J = 26.7 Hz, 1FA, -C(F)-).
 13C NMR (101 MHz, 
CDCl3) δC 20.62 (2 x -N-CH-(CAH3)2), 21.13 (2 x -N-CH-(CBH3)2), 48.42 (d, J = 3.0 
Hz, 2 x -N-CAH-(CH3)2), 49.05 (d, J = 1.9 Hz, 2 x -N-CBH-(CH3)2), 49.51 (d, J = 19.1 
Hz, -C(F)-CAH2-N-), 50.48 (d, J = 19.3 Hz, -C(F)-CBH2-N-), 52.96 (-C(O)OCAH3), 
53.49 (-C(O)OCBH3), 94.87 (d, J = 199.6 Hz, -CB(F)-), 97.98 (d, J = 199.3 Hz, -
CA(F)-), 165.10 (d, J = 25.4 Hz, -CB(O)OCH3), 166.05 (d, J = 26.4 Hz, -CA(O)OCH3). 
MS (ESI) m/z 102.26 ([M-C6H8FO4
•]+, 100%), 114.10 ([M-C5H6FO4
•]+, 49.6%), 264.29 
([M+H]+, 68.5%). HRMS (ESI) m/z calcd for [M+H]+ C12H23FNO4 264.1620; found 
264.1611. 
Dimethyl-2-(pyrrolidin-1-methyl)-2-fluoromalonate, 274e 
1H NMR (400 MHz, CDCl3) δH 1.63 – 1.74 (m, 4H, -
NCH2CH2CH2CH2-), 2.54 – 2.66 (m, 4H, -NCH2CH2CH2CH2-), 3.24 
(d, J = 26.6 Hz, 2H, -C(F)-CH2-N-), 3.81 (s, 6H, 2 x –C(O)OCH3). 
19F NMR (376 MHz, CDCl3) δF -166.92 (t, J = 26.7 Hz, -C(F)-). 
13C 
NMR (101 MHz, CDCl3) δC 23.89 (-NCH2CH2CH2CH2-), 53.18 (2 x -C(O)OCH3), 
55.26 (d, J = 1.8 Hz, -NCH2CH2CH2CH2-), 58.67 (d, J = 19.5 Hz, -CF-CH2-N-), 96.43 
(d, J = 200.4 Hz, -C(F)-), 165.81 (d, J = 25.9 Hz, -C(O)OCH3). MS (ESI) m/z 152.23 
([M-C5H6FO4
•]+, 50.4%), 234.21 ([M+H]+, 100%). HRMS (ESI) m/z calcd for [M+H]+ 
C10H17FNO4 234.1142; found 234.1145. 
Dimethyl-2-(piperidin-1-methyl)-2-fluoromalonate, 274f 
1H NMR (400 MHz, CDCl3) δH 1.24-1.38 (m, 2H, - 
NCH2CH2CH2CH2CH2-), 1.44 (ddt, J = 24.9, 11.0, 5.6 Hz, 4H, - 
NCH2CH2CH2CH2CH2-), 2.35 (d, J = 5.8 Hz, 2H, - 
NCH2CH2CH2CH2CH2-), 2.44 (d, J = 5.3 Hz, 2H, - 
NCH2CH2CH2CH2CH2-), 3.00 (d, J = 26.6 Hz, 2H, -C(F)-CH2-), 3.74 (s, 6H, 2 x -
OCH3).
19F NMR (376 MHz, CDCl3) δF -165.65 (t, J = 26.6 Hz, -C(F)-). 
13C NMR (101 
MHz, CDCl3) δ 23.79 (-NCH2CH2CH2CH2CH2-), 25.73, 26.17 (-
NCH2CH2CH2CH2CH2-, 52.88 (-C(O)OCH3), 52.98 (-C(O)OCH3), 55.60, 55.62 (-




NCH2CH2CH2CH2CH2-), 61.11 (d, J = 18.8 Hz, -CF-CH2-N-), 97.11 (d, J = 200.9 Hz, 
-C(F)-), 165.71 (d, J = 26.1 Hz, 2 x -C(O)OCH3). MS (ESI) m/z 85.85 ([M-
C6H8FO4
•+H]+, 100%), 190.10 ([M-C2H3O2
•+H]+, 95.7%), 248.15 ([M+H]+, 73.6%). 
HRMS (ESI) m/z calcd for [M+H]+ C11H19FNO4 248.1298; found 248.1296. 
Dimethyl-2-((benzylmethylamino)methyl)-2-fluoromalonate 274g 
1H NMR (400 MHz, CDCl3) δH 2.31 (d, J = 21.2 Hz, 3H, -NCH3), 
3.31 (d, J = 25.9 Hz, 1H, -C(F)-CH2-), 3.68 (d, J = 5.9 Hz, 2H, -
N(CH3)-CH2-C-), 3.85 (s, 6H, 2 x -OCH3), 7.11 – 7.55 (m, 5H, 
Haromatic). 
19F NMR (376 MHz, CDCl3) δF -166.08 (t, J = 25.9 Hz, -
C(F)-). 13C NMR (101 MHz, CDCl3) δC 40.48, 43.53 (d, J = 3.3 Hz, -
NCH3), 53.22 (-C(O)OCH3), 59.48, 59.89 (d, J = 18.7 Hz, -CF-CH2-N-), 63.46 (d, J = 
2.3 Hz, -N(CH3)-CH2-C-), 97.03 (d, J = 200.2 Hz, -C(F)-), 126.76, 127.16, 128.18, 
128.25, 128.90 (Caromatic), 138.73, 139.62 (-N(CH3)-CH2-C-), 165.73 (d, J = 26.1 Hz, 
2 x -C(O)OCH3). MS (ESI) m/z 122.09 ([M-C6H8FO4
•+2H]+, 100%), 90.98 ([M-
C7H11FNO4
•]+, 65.3%), 284.12 ([M+H]+, 44.8%). HRMS (ESI) m/z calcd for [M+H]+ 
C14H19FNO4 284.1298; found 284.1301. 
Dimethyl-2-((dicyclohexylamino)methyl)-2-fluoromalonate, 274h 
1H NMR (400 MHz, CDCl3) δH 0.96 – 1.33 (m), 1.42 – 1.98 (m) 
(22H, 2 x -N-CH-(CH2)5-), 2.42 – 2.70 (m, 2H, 2 x –N-CH-(CH2)5-
), 3.39 (d, J = 26.4 Hz, 2HA, -C(F)-CH2-), 3.79 (s), 3.83 (s) (6H, 2 
x -OCH3), 4.14 (d, J = 23.6 Hz, 2HB, -C(F)-CH2-).
19F NMR (376 
MHz, CDCl3) δF -171.85 (t, J = 23.7 Hz, -C(F)-), -166.39 (dd, J = 
21.9, 18.4 Hz, -C(F)-), -163.94 (t, J = 26.3 Hz, -C(F)-), -159.36 (dd, J = 32.0, 17.8 
Hz, -C(F)-). 13C NMR (101 MHz, CDCl3) δC 25.23, 26.01, 26.51 (2 x -N-CH-
CH2(CH2)3CH2-), 31.93 , 33.57 (2 x -N-CH-CH2(CH2)3CH2-), 50.64 (d, J = 18.9 Hz, -
C(F)-CH2-), 52.96 (d, J = 9.5 Hz, -N-CH-(CH2)5-), 58.77 (d, J = 2.5 Hz, -N-CH-
(CH2)5-), 63.47 (d, J = 21.5 Hz, -C(F)-CH2-), 95.59 (d, J = 199.9 Hz, -C(F)-), 98.02 
(d, J = 200.0 Hz, -C(F)-), 165.28 (d, J = 25.5 Hz, -C(O)OCH3), 166.09 (d, J = 26.4 
Hz, -C(O)OCH3). MS (ESI) m/z 182.31 ([C12H22N
•+H]+, 100%), 194.34 ([M-
C5H6FO4
•]+, 79.3%), 344.20 ([M+H]+,15.8%). HRMS (ESI) m/z calcd for [M+H]+ 
C18H31FNO4 344.2237, found 344.2247. 




6. Experimental to chapter 6 
6.1. Direct fluorination of functionalized carbonyl compounds 
General procedure 
In a 100 mL glass reaction vessel fitted with a PTFE coated mechanical stirrer, a 
FEP gas delivery tube and an exit tube to a scrubber filled with soda lime was 
charged with carbonyl compound, hydrated cupric nitrate, and acetonitrile (50 mL) 
before being cooled to 5-8 °C (see Table 42). The vessel was purged with nitrogen 
and then fluorine diluted to 10% v.v-1 with nitrogen was passed through the stirred 
solution at a rate of 40.0 mmol/h for 5 hours. When the fluorine supply has been 
turned off, the reaction vessel was purged with nitrogen. The reaction mixture was 
then evaporated under reduced pressure, washed two times with 100 mL of sat. 
NaCl solution, extracted with ethyl acetate (2 x 50 mL). Then anhydrous sodium 
sulfate was added and the mixture was filtered over Celite, and then concentrated 
under reduced pressure yielding a mixture of di-fluoro and mono-fluoro products, 
which was analyzed by NMR spectroscopy. Further purifications were carried out on 
the resulting mixture from fluorination with methylnitroacetate using multiple 
distillations under reduced pressure (5 mbar, 150 °C). 
Table 42 Direct fluorination of carbonyl compounds 







30 mmol 0.70 g 




























6.2. Direct fluorination of tricarbonyl systems 
General procedure 
In a 100 mL glass reaction vessel fitted with a PTFE coated mechanical stirrer, a 
FEP gas delivery tube and an exit tube to a scrubber filled with soda lime was 
charged with tricarbonyl compound 307, hydrated cupric nitrate (10 mol%), and 
acetonitrile (50 mL) before being cooled to 0-5 °C (see Table 44). The vessel was 
purged with nitrogen and then fluorine diluted with nitrogen was passed through the 
stirred solution at a chosen rate. When the fluorine supply has been turned off, the 
reaction vessel was purged with nitrogen. The reaction mixture was then evaporated 
under reduced pressure, washed two times with 100 mL of sat. NaCl solution, 
extracted with ethyl acetate (2 x 50 mL). Then anhydrous sodium sulfate was added 
and the mixture was filtered over Celite, and then concentrated under reduced 
pressure yielding a mixture of di-fluoro and mono-fluoro products, which was 
analyzed by NMR spectroscopy. 19F-NMR data for each of these products is 














Table 44 Fluorination of dimethylacetone-1,3-dicarboxylate in batch using various conditions 
Entry 1a 2a 3a 4b 5b 6b 
F2/N2 [%] 10 10 10 20 20 10 
Flow rate [mL/min] 20 40 20 80 20 40 
Reaction time [min] 180 180 300 180 168 168 

















6 8 9 39 29 1 
 
9 20 18 31 29 6 
 
15 17 24 7 14 8 
 
60 47 35 20 21 65 
 
8 8 8 2 7 20 
a
 Reaction achieved on 30 mmol scale; 
b
 Reaction achieved on 25 mmol scale 
 
 




6.3. Synthesis of various tricarbonyl systems 
Methyl 3,5-dioxohexanoate, 323 
Magnesium turnings (2.6 g, 107 mmol) were dissolved in 500 mL 
methanol and dehydroacetic acid 322 (12 g, 70 mmol) in methanol 
(100 mL) was added. The reaction mixture was heated under reflux overnight, after 
which the solvent was removed under reduced pressure. The residue was taken up 
in ethyl acetate and acidified with aqueous 1M HCl (~ 200 mL) and extracted with 
ethyl acetate (5 x 50 mL). The combined organic layers were washed with brine, 
dried over MgSO4 and concentrated under reduced pressure. The crude product 
was then distilled under reduced pressure (110 °C / 15 mbar) to afford 323 as a 
colorless liquid (8.3 g, 75%). 1H NMR spectrum indicated the presence of 72% of an 
enol form. 1H NMR (400 MHz, CDCl3) enol: δH 2.00 (s, 3H, -C(OH)CH3), 3.26 (s, 2H, 
-CH2-C(O)OCH3), 3.66 (s, 3H, -C(O)OCH3), 5.55 (s, 1H, Henol), ketone: δH 2.17 (s, 
3H, -C(O)CH3), 3.50 (s, 2H, -CH2-C(O)OCH3), 3.66 (s, 3H, -C(O)CH3), 3.69 (s, 2H, -
CH2-C(O)CH3). 
13C NMR (101 MHz, CDCl3) enol: δC 24.19 (1C, -C(OH)CH3),  44.78  
(1C, -CH2-C(O)OCH3), 52.31 (1C, -C(O)OCH3), 100.45 (1C, -C(Henol)-, 167.89 (1C, -
C(O)OCH3), 187.11 (1C, -C(OH)CH3), 190.04 (1C, -C(Henol)-C(O)-CH2-), ketone: 
30.66 (1C, -C(O)CH3), 49.07 (1C, -CH2-C(O)OCH3), 52.31 (1C, -C(O)OCH3), 57.11 
(1C, -CH2--C(O)CH3), 167.31 (1C, -C(O)OCH3), 196.81 (1C, -C(O)CH3), 201.70 (1C, 
-CH2-C(O)-CH2-). IR (ATR) 2983 (w), 1728 (vs), 1713 (vs), 1614 (vs), 1417 (w), 
1373 (m), 1360 (m), 1239 (vs), 1157 (w), 1045 (s), 1003 (w), 939 (w), 913 (m), 847 
(w), 780 (m), 629 (w), 606 (m), 530 (w), 510 (w), 480 (w), 446 (w), 404 (w). MS (EI, 
70 eV): m/z (%) = 87 (100), 43 (47), 129 (13), 113 (8). 
(2-Methyl-1,3-dioxolan-2-yl) acetic acid, 325 
To a solution of ethyl 2-(2-methyl-1,3-dioxolan-2-yl) acetate (15.0 g, 
86.1 mmol) in ethanol (75 mL) an aqueous solution of KOH (2M, 64.6 
mL, 126.2 mmol) was added dropwise. After stirring the reaction mixture at room 
temperature for 1.5 h, ethanol was removed under reduced pressure. The aqueous 
phase was then washed with MTBE (2 x 25 mL), acidified to pH 3 using 2M HCl and 
extracted with ethyl acetate (5 x 50 mL). The combined organic fractions were dried 
over MgSO4 and the solvent was then removed under reduced pressure giving a 
colorless oil (11.4 g, 91%). 1H NMR (400 MHz, CDCl3) δH 1.43 – 1.52 (m, 3H, -CH2-
C(O(CH2)2O-)-CH3), 2.62 – 2.73 (m, 2H, -CH2-C(O(CH2)2O-)-CH3), 3.94 – 3.98 (m, 
4H, -CH2-C(O(CH2)2O-)-CH3), 10.07 (br s, 1H, OH). 
13C NMR (101 MHz, CDCl3) δC 




24.30 (1C, -CH2-C(O(CH2)2O-)-CH3), 43.88 (1C, -CH2-C(O(CH2)2O-)-CH3), 64.72 
(2C, -CH2-C(O(CH2)2O-)-CH3), 107.42 (1C, -CH2-C(O(CH2)2O-)-CH3), 174.78 (1C, -
C(O)OH). IR (ATR) 2981 (m), 2891 (m), 1711 (vs), 1379 (s), 1306 (w), 1184 (s), 
1120 (w), 1093 (w), 1041 (vs), 950 (s), 855 (s), 838 (s), 799 (w), 746 (w), 645 (s), 




Meldrum’s acid (4.53 g, 31.5 mmol), DCC (7.15 g, 34.6 mmol) 
and DMAP (4.23 g, 34.6 mmol) were dissolved in freshly distilled 
dichloromethane (50 mL). The solution was cooled to 0 °C and a 
solution of 2-(2-Methyl-1,3-dioxolan-2-yl) acetic acid 325 (4.6 g, 
31.5 mmol) in anhydrous dichloromethane (20 mL) was added dropwise over an 
hour. The resulting solution was stirred in an ice bath over night (~ 18 hours), during 
which time crystals of dicyclohexylurea were formed. After filtration and evaporation 
of the solvent, water was added and the mixture was acidified with KHSO4 to pH 2-3 
and extracted with diethyl ether (3 x 50 mL). The combined organic layers were 
washed with 2% KHSO4, water and dried over anhydrous magnesium sulfate. After 
filtration and evaporation of the solvent, the residual mixture was re-dissolved in hot 
petroleum ether and filtrated over celite. The clear solution was concentrated under 
reduced pressure affording 326 as a pale yellow oil (7.9 g, 93%). 1H NMR (400 
MHz, CDCl3) δH 1.50 (s, 3H, -CH2-C(O(CH2)2O-)-CH3), 1.74 (s, 6H, -C(CH3)2), 3.54 
(s, 2H, -CH2-C(O(CH2)2O-)-CH3), 3.88 – 4.07 (m, 4H, -CH2-C(O(CH2)2O-)-CH3). 
13C 
NMR (101 MHz, CDCl3) δC 25.33 (1C, -CH2-C(O(CH2)2O-)-CH3), 26.71 (2C, -
C(CH3)2), 43.52 (1C, -CH2-C(O(CH2)2O-)-CH3), 65.04 (2C, -CH2-C(O(CH2)2O-)CH3), 
93.85 (1C, -CH2-C(OH)-C-), 104.77 (1C, -C(CH3)2), 108.55 (1C, -CH2-C(O(CH2)2O-)-
CH3), 160.53, 170.35 (2C, 2 x –C(OH)-C-(C(O))2-), 191.78 (1C, -CH2-C(OH)-C-). IR 
(ATR) 3661 (w), 2981 (m), 2890 (m), 2338 (w), 1737 (vs), 1661 (vs), 1574 (vs), 1403 
(s), 1381 (s), 1292 (m), 1267 (s), 1201 (s), 1149 (s), 1105 (w), 1030 (vs), 970 (m), 
950 (m), 929 (s), 893 (w), 841 (w), 810 (w), 790 (w), 746 (m), 727 (m), 680 (w), 642 
(m), 608 (w), 547 (w), 506 (m), 464 (m), 407 (m), 383 (w). MS (EI, 70 eV): m/z (%) = 
85 (100), 43 (71), 126 (40), 117 (23), 69 (21). 
 
 




Methyl 4-(2-methyl-1,3-dioxolan-2-yl)-3-oxobutanoate, 327 
5-(1-hydroxy-2-(2-methyl-1,3-dioxolan-2-yl)ethylidene)-2,2-
dimethyl-1,3-dioxane-4,6-dione 326 (2.75 g, 20.2 mmol) was 
dissolved in toluene (25 mL) and methanol (1.86 mL, 45.6 mmol) was added. The 
mixture was then stirred at 90 °C for 3 hours and concentrated to afford 
quantitatively the desired product 327 as a pale yellow oil (4.0 g, 99%). 1H NMR 
(400 MHz, CDCl3) δH 1.41 (s, 3H, -CH2-C(O(CH2)2O-)-CH3), 2.89 (s, 2H, -CH2-
C(O(CH2)2O-)-CH3), 3.59 (s, 2H, -CH2-C(O)OCH3), 3.74 (s, 3H, -CH2-C(O)OCH3), 
3.96 – 4.01 (m, 4H, -CH2-C(O(CH2)2O-)-CH3). Presence of the enol form (< 5%) δH 
3.64 (s, 3H, -CH2-C(O)OCH3), 5.11 (s, 1H, -C(Henol)-), 12.06 (s, 1H, OH). 
13C NMR 
(101 MHz, CDCl3) δC, keto: 24.48 (1C, -CH2-C(O(CH2)2O-)-CH3), 50.08 (1C, -CH2-
C(O)-), 51.71 (1C, -CH2-C(O)OCH3), 52.25 (1C, -C(O)OCH3), 64.65 (2C, CH2-
C(O(CH2)2O-)-CH3), 107.75 (1C, -CH2-C(O(CH2)2O-)-CH3), 167.66 (1C, -CH2-C(O)-
CH2-), 199.89 (1C, -C(O)OCH3), enol: 24.27 (1C, -CH2-C(O(CH2)2O-)-CH3), 43.96, 
44.64 (2C, -CHenol-C(OH)-CH2-C(O)OCH3 or -CH2-C(O)-CHenol-C(OH)OCH3), 51.16 
(1C, -C(O)OCH3), 64.77 (2C, CH2-C(O(CH2)2O-)-CH3), 91.79 (1C, -C(Henol)), 108.34 
(1C, -CH2-C(O(CH2)2O-)-CH3), 172.81 (1C, -C(OH)), 173.77 (1C, -C(OH)). IR (ATR) 
2981 (m), 1745 (vs), 1713 (vs), 1657 (s), 1596 (w), 1438 (m), 1379 (m), 1326 (w), 
1238 (w), 1206 (w), 1148 (m), 1042 (vs), 1014 (w), 970 (w), 950 (s), 895 (w), 840 
(s), 789 (w), 761 (w), 732 (w), 630 (w), 583 (w), 524 (m), 462 (w), 405 (w), 385 (w). 
MS (EI, 70 eV) m/z (%) = 87 (100), 43 (60), 131 (46), 89 (33). 
6.4. Direct fluorination of protected tricarbonyl ester 
In a 100 mL glass reaction vessel fitted with a PTFE coated mechanical stirrer, a 
FEP gas delivery tube and an exit tube to a scrubber filled with soda lime was 
charged with tricarbonyl compound 327 (5.0 mmol, 1.0 g), hydrated cupric nitrate 
(115 mg, 10 mol%), and acetonitrile (20 mL) before being cooled to 0-5 °C. The 
vessel was purged with nitrogen and then fluorine diluted with nitrogen (1.1 eq., 10% 
v.v-1) was passed through the stirred solution at 7 mL/min for 190 min. When the 
fluorine supply has been turned off, the reaction vessel was purged with nitrogen. 
The reaction mixture was then evaporated under reduced pressure, washed two 
times with 100 mL of sat. NaCl solution, extracted with ethyl acetate (2 x 50 mL). 
Then anhydrous sodium sulfate was added and the mixture was filtered over Celite, 
and then concentrated under reduced pressure yielding a mixture of di-fluoro and 
mono-fluoro products, which was analyzed by NMR spectroscopy, giving a 85:15 




ratio of mono-fluorinated methyl-4-(2-methyl-1,3-dioxolan-2-yl)-3-oxobutanoate to di-
fluorinated methyl-4-(2-methyl-1,3-dioxolan-2-yl)-3-oxobutanoate by 19F-NMR. No 
further purification was carried out due to the end of the project period. 
6.5. Synthesis of pentafluorosulfanyl benzene derivative 
3-fluoro-5-nitro-1-(pentafluorosulfanyl)benzene, 337 
 A solution of 3-nitro-1-(pentafluorosulfanyl)benzene 336 (1.0 g, 4.0 
mmol) in MeCN (25 mL) was added to a nitrogen flushed PFA reactor 
with a magnetic stirring bar. A mixture of 10% F2/N2 (v.v
-1) was 
bubbled for 1.38 h at a rate of 30 L/hour while maintaining the temperature of the 
bath at -3 ºC. The mixture was flushed with N2 for 10 min. and solvent was removed 
under reduced pressure yielding residue containing 33% of 3-fluoro-5-nitro-1-
(pentafluorosulfanyl)benzene 337 (by GC–MS). Purification by flash 
chromatography (Et2O/petroleum ether, 10:90) afforded 3-fluoro-5-nitro-1-
(pentafluorosulfanyl)benzene 337 (128 mg, 12% yield). 1H NMR (400 MHz, CDCl3) 
δH 8.48 (d, J = 1.4 Hz, 1H, -C(NO2)-C(H)-C(SF5)-), 8.15 (dt, J = 7.5, 2.3 Hz, 1H, -
C(NO2)-C(H)-C(F)-), 7.86 (dt, J = 7.8, 2.1 Hz, 1H, -C(F)-C(H)-C(SF5)-). 
13C NMR 
(101 MHz, CDCl3) δC 161.68 (d, J = 256.3 Hz, -C(F)-), 154.78 (quintd, J = 21.3, 7.5 
Hz, -C(SF5)-), 148.81 (d, J = 7.0 Hz, -C(NO2)-), 120.30 (dquint, J = 26.2, 4.6 Hz, -
C(F)-C-C(SF5)-), 117.84 (sextet, J = 4.9 Hz, -C(NO2)-C-C(SF5)-), 114.76 (d, J = 26.1 
Hz, -C(NO2)-C-C(F)-). 
19F NMR (377 MHz, CDCl3) δF 80.03-78.27 (m, 1F, -S(F)4F), 
62.44 (d, J = 151.2 Hz, 4F, -S(F)4F), -105.00 (s, 1F, -C(F)-). HRMS (EI) m/z calcd 
for C6H3F6NO2S [M]
+ 266.9789, found 266.9788. 
6.6. SNAr – VNS reactions 
General procedure 
In a Schlenk tube under inert atmosphere was added the selected base to a solution 
of 2-fluoro-1,3-dimethylmalonate 62 or 2-fluoro-ethylacetoacetate 19 in a selected 
solvent (see table 43). The reaction mixture was allowed to stir over one hour before 
the addition of 3-fluoro-5-nitro-1-(pentafluorosulfanyl)benzene (1 eq.). The reaction 
mixture was allowed to stir over a certain time at the chosen temperature (see Table 
43). The reaction was then quenched when appropriate and water was added (10 
mL). Then the organic layer was taken and the aqueous phase was washed with 
ethyl acetate. The combined organic layers were washed with brine (2 x 50 mL), 




water (50 mL), dried over MgSO4 and solvent was removed under reduced 
pressure. The crude product was then analyzed by GC-MS spectrometry and NMR 
spectroscopy. 
Table 43 SNAr – VNS of 5-fluoro-3-nitro-1-pentafluorosulfanylbenzene 
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-60 °C 0 
8b 
9a 
-78 °C  0 
9b 
a





 LDA prepared by adding nBuLi (3.75 mmol, 2.34 mL, 1.6M in Hexane) to 
a solution of diisopropylamine (4.4 mmol, 0.61 mL) in dry THF at -78 °C, then stirred 
at 0 °C for 15 min 
 




General procedure to access products 345 
To a solution of 2-fluoro-1,3-dimethylmalonate 62 or 2-fluoro-ethylacetoacetate 19 (2 
mmol, 0.3 g) in dry THF (10 mL) was added a solution of NaH (1.41 mmol, 57 mg, 3 
eq.) in dry THF, then the reaction mixture was allowed to stir for 30 min, before 3-
fluoro-5-nitro-1-(pentafluorosulfanyl)benzene (0.47 mmol, 126 mg) was added. The 
reaction mixture is then allowed to stir for 19 hours at room temperature, then 3 
hours at 50 °C, then NaH (0.47 mmol, 190 mg) in dry THF was added and the 
obtained mixture was stirred for a further 20 hours at room temperature. Water was 
then added to the resulting mixture, a solution of NaOH (10 mL, 0.5M) was added 
and the product was extracted with Et2O (4 x 20 mL) and the combined organic 
layers were washed with water (20 mL), brine (20 mL), dried over MgSO4 and the 
solvent was removed under reduced pressure. The crude product was then purified 
by column chromatography using petroleum ether and diethyl ether (gradient 90:10 
to 70:30) and the resulting product was analyzed by GC-MS spectrometry and NMR 
spectroscopy, allowing us to identify the corresponding products 345a and 345b, 
respectively from 2-fluoro-1,3-dimethylmalonate 62 and 2-fluoro-ethyl acetoacetate 
19, as their data are in agreement with assignments reported in the literature.[170] 
3-methoxy-5-nitro-1-(pentafluorosulfanyl)benzene, 345a 
1H NMR (400 MHz, CDCl3) δH 8.25 (t, J = 1.9 Hz, 1H, -C(NO2)-C(H)-
C(SF5)-), 7.91 (t, J = 2.2 Hz, 1H, -C(SF5)-C(H)-C(OMe)-), 7.63 (t, J = 
2.1 Hz, 1H, -C(NO2)-C(H)-C(OMe)-), 3.99 (s, 3H, -OCH3). 
13C NMR 
(101 MHz, CDCl3) δC 160.25 (-C(OMe)-), 154.65 (quint, J = 19.7 Hz, -C(SF5)-), 
148.80 (-C(NO2)-), 119.00 (quint, J = 4.7 Hz, -C(NO2)-C-C(SF5)-), 113.73 (quint, J = 
4.9 Hz, -C(SF5)-C-C(OMe)-), 111.06 (-C(NO2)-C-C(OMe)-), 56.56 (-OCH3). 
19F NMR 
(377 MHz, CDCl3) δF 81.03 (quint, J = 149.0 Hz, 1F, -S(F)4F), 62.76 (d, J = 151.2 
Hz, 4F, -S(F)4F). m/z (EI
+) 279 (100%, [M]+), 63 (37%), 110 (33%), 125 (30%), 233 
(23%). 
3-ethoxy-5-nitro-1-(pentafluorosulfanyl)benzene, 345b 
1H NMR (400 MHz, CDCl3) δH 8.23 (t, J = 1.9 Hz, 1H, -C(NO2)-C(H)-
C(SF5)-), 7.89 (t, J = 2.1 Hz, 1H, -C(SF5)-C(H)-C(OEt)-), 7.62 (t, J = 
2.2 Hz, 1H, -C(NO2)-C(H)-C(OEt)-), 4.20 (q, J = 7.0 Hz, 2H, -
OCH2CH3), 1.52 (t, J = 7.0 Hz, 3H, -OCH2CH3). 
13C NMR (101 MHz, CDCl3) δC 
159.42 (-C(OEt)-), 154.64 (quint, J = 19.8 Hz, -C(SF5)-), 148.77 (-C(NO2)-), 119.38 
(quint, J = 4.7 Hz, -C(NO2)-C-C(SF5)-), 113.50 (quint, J = 4.8 Hz, -C(SF5)-C-C(OEt)-




), 111.44 (-C(NO2)-C-C(OEt)-), 65.27 (-OCH2CH3), 14.40 (-OCH2CH3). 
19F NMR 
(377 MHz, CDCl3) δF 82.45–79.75 (m, 1F, -S(F)4F), 62.73 (d, J = 149.5 Hz, 4F, -
S(F)4F). m/z (EI
+) 264 (100%, [M-Et]+), 293 (80%, [M]+), 63 (26%), 111 (20%), 219 
(23%). 
7. Experimental to chapter 7 
7.1. Mannich-type reaction by continuous flow one-step process  
General procedure 
After purging the continuous flow reactor apparatus with nitrogen, the 2-fluoro-
ethylacetoacetate solution in acetonitrile (10 mL, 1 mmol/mL) was injected by a 
HPLC pump into the flow reactor channel at a prescribed flow rate through the first 
substrate Input (5 mL/h). A two-hours previously reacted mixture of formaldehyde 
and the chosen amine was then injected by a HPLC pump into the flow reactor 
channel at a prescribed flow rate through the second substrate Input. The molar 
ratio [1:1.5:1.7] was applied to the [2-fluoro-ethylacetoacetate:formaldehyde:amine] 
three-component system. The liquid flow stream was passed through the reactor 
and the product mixture was collected in a two-neck round-bottom flask. The 
collected mixture was then poured into water, extracted with dichloromethane (3 × 
50 mL) and washed with brine (20 mL) and water (20 mL). The combined extracts 
were then dried (MgSO4), filtered and the solvent evaporated to give a yellow oil, 
which was purified by micro-distillation or column chromatography on silica gel using 
hexane/ethyl acetate as eluent system when appropriate. 
7.2. Mannich-type reaction by semi-continuous flow two-step process  
General procedure 
After purging the continuous flow reactor apparatus with nitrogen, a 10% mixture of 
fluorine in nitrogen (v.v-1) (11 mmol, 1.1 eq.) was passed through the first flow 
reactor via Input 1 at a prescribed flow rate that was controlled by a gas mass flow 
controller (Brooks Instruments). The flow reactor was cooled by an external cryostat 
to 0-5 °C. The ethyl-acetoacetate solution in acetonitrile (10 mL, 1 mmol/mL) was 
injected by a HPLC pump into the flow reactor channel at a prescribed flow rate 
through Input 2 (5 mL/h). The gas-liquid flow stream was passed through the first 
reactor and the product mixture was collected in a three-neck round-bottomed flask.  




This collected mixture was directly injected by a HPLC pump into the second flow 
reactor at a prescribed flow rate (5 mL/h). Formaldehyde (15 mmol) and the amine 3 
(17 mmol) were mixed together in acetonitrile for 2 h at rt and then injected by HPLC 
pump into the second flow reactor channel at a prescribed flow rate through the 
corresponding substrate Input via a T-piece. The molar ratio of fluorinated 
ethylacetoacetate:formaldehyde:amine was ca. 1:1.5:1.7. The liquid flow stream was 
passed through the second reactor and the product mixture was collected in a 
second two-neck round-bottomed flask. All flow streams were passed through the 
reactor and the product mixture was collected in a two-neck round-bottom flask. The 
collected mixture was then poured into water, extracted with dichloromethane (3 × 
50 mL) and washed with brine (20 mL) and water (20 mL). The combined extracts 
were then dried (MgSO4), filtered and the solvent evaporated to give a yellow oil, 
which was purified by micro-distillation or column chromatography on silica gel using 
hexane/ethyl acetate as eluent system when appropriate. 
7.3. Fluorination in flow of dimethylacetone-1,3-dicarboxylate  
General procedure 
After purging the continuous flow reactor apparatus with nitrogen, a mixture of 
fluorine in nitrogen (see Table 45) was passed through the first flow reactor via Input 
1 at a prescribed flow rate that was controlled by a gas mass flow controller (Brooks 
Instruments). The flow reactor was cooled by an external cryostat to 0-5 °C. The 
dimethylacetone-1,3-dicarboxylate solution in acetonitrile (10 mL, 1 mmol/mL) was 
injected by a HPLC pump into the flow reactor channel at a prescribed flow rate 
through Input 2 (5 mL/h). The gas-liquid flow stream was passed through the first 
reactor and the product mixture was collected in a three-neck round-bottomed flask. 
When the fluorine supply has been turned off, the reaction vessel was purged with 
nitrogen. The reaction mixture was then evaporated under reduced pressure, 
washed two times with 100 mL of sat. NaCl solution, extracted with ethyl acetate (2 
x 50 mL). Then anhydrous sodium sulfate was added and the mixture was filtered 
over Celite, and then concentrated under reduced pressure yielding a mixture of di-
fluoro and mono-fluoro products, which were analyzed by NMR spectroscopy (see 
Table 45). 19F-NMR data for each of these products is included in chapter 6 (Table 
26). 
 




Table 45 Fluorination of dimethylacetone-1,3-dicarboxylate in flow using various conditions 
Entry 1 2 3 4 
F2/N2 [%] 10 10 10 20 
Flow rate [mL/min] 20 30 40 20 

















12 20 19 19 
 
3 8 8 8 
 
8 6 9 8 
 
63 53 51 52 
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